Note	O
：	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Alumine	O
(	O
PRPCA	O
),	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Zingibere	O
et	O
Alumine	O
(	O
PRPZA	O
),	O
and	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
(	O
PRP	O
).	O

The	O
extracted	O
patterns	O
were	O
classified	O
as	O
“	O
breakfast	O
skipper	O
,”	O
“	O
dinner	O
skipper	O
,”	O
“	O
fast	O
food	O
,”	O
“	O
hydrogenated	O
oil	O
consumption	O
,”	O
“	O
lunch	O
skipper	O
,”	O
“	O
poor	O
nutrition	O
,”	O
“	O
salty	O
snacks	O
,”	O
“	O
sweetened	O
beverages	O
,”	O
and	O
“	O
sweats	O
.”	O
The	O
most	O
common	O
pattern	O
was	O
“	O
breakfast	O
skipper	O
”	O
as	O
there	O
were	O
five	O
studies	O
for	O
this	O
pattern	O
,	O
followed	O
by	O
“	O
sweetened	O
beverages	O
”	O
and	O
“	O
salty	O
snacks	O
”	O
with	O
four	O
studies	O
for	O
each	O
.	O

PHARE	B-BT
utilized	O
two	O
different	O
pipelines	O
for	O
scRNA	O
-	O
seq	O
and	O
bulk	O
RNA	O
-	O
seq	O
data	O
to	O
predict	O
physiological	O
age	O
from	O
new	O
datasets	O
(	O
Fig	O
.	O

2a	O
Illustration	O
of	O
a	O
typical	O
pyHiM	B-BT
analysis	O
on	O
mouse	O
tissues	O
:	O
examples	O
of	O
raw	O
data	O
are	O
shown	O
in	O
the	O
top	O
row	O
and	O
the	O
most	O
relevant	O
pyHiM	B-BT
outputs	O
are	O
shown	O
in	O
the	O
bottom	O
row	O
.	O

Troubleshooting	O
2	O
....#	O
Load	O
sam	O
/	O
bedtoolsmodule	O
load	O
bedtools	O
/	O
2	O
.	O
29	O
.	O
0module	O
load	O
samtools	B-BT
/	O
1	O
.	O
16	O
.	O
1	O
#	O
Convert	O
BAM	O
files	O
BEDPE	O
files	O
using	O
bedtoolsfor	O
f	O
in	O
$(	O
find	O
$	O
fbam_dir	O
-	O
maxdepth	O
1	O
-	O
iname	O
"""∗."	O
bam	O
""""	O
-	O
type	O
f	O
)	O
do	O
id	O
=$(	O
basename	O
-	O
a	O
-	O
s	O
f1	O
.	O
bam	O
$	O
f	O
|	O
cut	O
-	O
d	O
""""	O
_	O
""""	O
-	O
f	O
1	O
)	O
#	O
Files	O
must	O
be	O
sorted	O
bam	O
before	O
converting	O
to	O
BEDPE	O
samtools	B-BT
sort	O
-	O
n	O
$	O
f	O
|	O
\	O
#	O
Convert	O
to	O
BEDPE	O
file	O
bedtools	O
bamtobed	O
-	O
i	O
-	O
-	O
bedpe	O
|\	O
#	O
Calculate	O
insert	O
size	O
and	O
add	O
‘	O
chr	O
’	O
to	O
chromosome	O
fields	O
awk	O
'	O
OFS	O
=	O
"""\"	O
t	O
""""	O
{	O
print	O
""""	O
chr	O
"""$"	O
1	O
,	O
$	O
2	O
,	O
$	O
3	O
,	O
""""	O
chr	O
"""$"	O
4	O
,	O
$	O
5	O
,	O
$	O
6	O
,	O
$	O
7	O
,	O
$	O
8	O
,	O
$	O
9	O
,	O
$	O
10	O
,	O
$	O
6	O
-$	O
2	O
}'	O
-	O
>	O
$	O
beddir	O
/${	O
id	O
}.	O
bedpedone3	O
.	O
Run	O
‘	O
03	O
-	O
filter_frags_gc	O
.	O
sh	O
’	O
to	O
filter	O
out	O
cfDNA	O
fragments	O
from	O
problematic	O
regions	O
of	O
the	O
reference	O
genome	O
.	O
Note	O
:	O
Problematic	O
regions	O
of	O
the	O
genome	O
consist	O
of	O
regions	O
such	O
as	O
repetitive	O
elements	O
(	O
e	O
.	O
g	O
.,	O
satellite	O
,	O
telomeric	O
,	O
and	O
centromeric	O
repeats	O
)	O
that	O
result	O
in	O
high	O
rates	O
multi	O
-	O
mapping	O
reads	O
that	O
can	O
produce	O
artifacts	O
and	O
spurious	O
signals	O
in	O
downstream	O
sequence	O
analysis	O
.	O
a	O
.	O
Define	O
input	O
and	O
output	O
file	O
directories	O
.	O
PROJECT_DIR	O
=/	O
user	O
/	O
projectcd	O
"""$"	O
PROJECT_DIR	O
"""#"	O
Define	O
directories	O
for	O
input	O
and	O
output	O
filesbed_dir	O
"=""${"	O
PROJECT_DIR	O
}/	O
02	O
-	O
bamtobed	O
""""	O
#	O
BEDPE	O
filesout_dir	O
"=""${"	O
PROJECT_DIR	O
}/	O
03	O
-	O
filter_frags_gc	O
""""	O
#	O
filtered	O
fragmentshg19	O
"=""${"	O
PROJECT_DIR	O
}/	O
files	O
/	O
hg19	O
.	O
fa	O
""""	O
#	O
h19	O
reference	O
genomefilter	O
"=""${"	O
PROJECT_DIR	O
}/	O
files	O
/	O
hg19	O
-	O
blacklist	O
.	O
v2	O
.	O
bed	O
""""	O
#	O
blacklisted	O
regiongap	O
"=""${"	O
PROJECT_DIR	O
}/	O
files	O
/	O
gaps	O
.	O
hg19	O
.	O
bed	O
""""	O
#	O
genomic	O
gapsmkdir	O
-	O
p	O
"""$"	O
out_dir	O
""""	O
#	O
Create	O
directories	O
if	O
needed	O
...	O
b	O
.	O
Convert	O
BEDPE	O
file	O
into	O
BED	O
format	O
.	O
Note	O
:	O
The	O
‘	O
bedtools	O
nuc	O
’	O
does	O
not	O
support	O
BEDPE	O
file	O
format	O
.	O

In	O
the	O
Abstract	O
,	O
the	O
github	O
link	O
was	O
connecting	O
to	O
an	O
incorrect	O
url	O
and	O
has	O
been	O
updated	O
to	O
https	O
://	O
github	O
.	O
com	O
/	O
dmitrymyl	O
/	O
BaRDIC	B-BT
.	O

GEMLI	B-BT
resulted	O
in	O
high	O
percentages	O
of	O
cells	O
correctly	O
assigned	O
to	O
their	O
crypt	O
or	O
organoid	O
of	O
origin	O
with	O
default	O
lineage	O
size	O
parameters	O
and	O
parameters	O
in	O
the	O
ground	O
truth	O
lineage	O
size	O
range	O
,	O
allowing	O
the	O
recovery	O
of	O
mid	O
-	O
sized	O
lineages	O
(	O
Fig	O
.	O

Marker	O
genes	O
for	O
different	O
clusters	O
were	O
identified	O
from	O
prior	O
studies	O
(	O
Alchahin	O
et	O
al	O
.,	O
2022	O
)	O
with	O
the	O
assistance	O
of	O
the	O
automatic	O
annotation	O
tool	O
“	O
MetaTiME	B-BT
”	O
(	O
Zhang	O
et	O
al	O
.,	O
2023	O
).	O

We	O
developed	O
scPrisma	B-BT
,	O
a	O
spectral	O
analysis	O
framework	O
that	O
uses	O
topological	O
priors	O
over	O
underlying	O
signals	O
in	O
single	O
-	O
cell	O
data	O
,	O
to	O
allow	O
for	O
their	O
inference	O
,	O
enhancement	O
and	O
filtering	O
.	O

Finally	O
,	O
the	O
outputs	O
of	O
tiny	O
-	O
count	O
and	O
tiny	O
-	O
deseq	O
are	O
used	O
to	O
produce	O
publication	O
-	O
ready	O
plots	O
with	O
the	O
tinyRNA	B-BT
plotter	O
tool	O
,	O
tiny	O
-	O
plot	O
.	O

Our	O
Interrupting	O
Prolonged	O
sitting	O
with	O
ACTivity	O
(	O
InPACT	O
)	O
at	O
Home	O
program	O
,	O
for	O
example	O
,	O
confirmed	O
the	O
importance	O
of	O
parental	O
support	O
.	O

We	O
also	O
designed	O
the	O
cell	O
-	O
calling	O
loss	O
to	O
allow	O
BIDCell	B-BT
to	O
capture	O
cell	O
-	O
type	O
specific	O
morphologies	O
.	O

The	O
PIFiA	B-BT
computational	O
pipeline	O
offers	O
a	O
tool	O
for	O
predictions	O
of	O
protein	O
function	O
based	O
on	O
genome	O
-	O
scale	O
comparative	O
analysis	O
of	O
features	O
extracted	O
from	O
images	O
of	O
single	O
cells	O
endogenously	O
expressing	O
GFP	O
-	O
fusion	O
proteins	O
(	O
Razdaibiedina	O
et	O
al	O
.	O

Only	O
scNovel	B-BT
and	O
scLearn	O
successfully	O
detect	O
all	O
Megakaryocyte	O
cells	O
,	O
while	O
scmap	O
-	O
cell	O
,	O
scmap	O
-	O
cluster	O
,	O
and	O
scPred	O
miss	O
a	O
part	O
of	O
Megakaryocyte	O
cells	O
.	O

For	O
a	O
specific	O
synteny	O
block	O
,	O
SyntenyViewer	B-BT
generates	O
an	O
image	O
to	O
show	O
the	O
homologous	O
gene	O
pairs	O
,	O
and	O
the	O
image	O
can	O
be	O
zoomed	O
in	O
or	O
out	O
for	O
different	O
views	O
(	O
Figure	O
2B	O
).	O

The	O
Station	O
d	O
'	O
Ecologie	O
Théorique	O
et	O
Expérimentale	O
has	O
a	O
national	O
agreement	O
for	O
use	O
of	O
animals	O
in	O
the	O
laboratory	O
(	O
number	O
B09583	O
),	O
and	O
our	O
experiments	O
are	O
made	O
in	O
accordance	O
with	O
French	O
ethics	O
regulations	O
(	O
Ethics	O
permits	O
number	O
APAFIS	O
#	O
15897	O
‐	O
2018070615164391	O
v3	O
for	O
toe	O
clipping	O
and	O
APAFIS	O
#	O
19523	O
‐	O
201902281559649	O
v3	O
for	O
other	O
experimental	O
procedures	O
,	O
including	O
the	O
maintenance	O
of	O
lizards	O
in	O
the	O
Metatron	O
).	O

We	O
trained	O
ML	O
models	O
on	O
the	O
datadiscovery	O
using	O
a	O
Five	O
-	O
fold	O
cross	O
-	O
validation	O
,	O
the	O
generalization	O
test	O
is	O
performed	O
on	O
datainfer	O
by	O
using	O
the	O
datatest	O
as	O
the	O
test	O
data	O
.	O

In	O
particular	O
,	O
a	O
mutation	O
in	O
a	O
signal	O
peptide	O
,	O
p	O
.	O
Gln25Leu	O
,	O
did	O
not	O
influence	O
ACE	O
levels	O
,	O
similarly	O
to	O
the	O
non	O
-	O
frameshifting	O
insertion	O
,	O
p	O
.	O
L18_L19insPL	O
,	O
tested	O
earlier	O
[	O
2	O
],	O
which	O
is	O
not	O
associated	O
with	O
AD	O
risk	O
[	O
27	O
].	O

Start	O
Skipper	B-BT
run	O
.	O

Most	O
of	O
the	O
information	O
about	O
these	O
bioactive	O
peptides	O
is	O
available	O
in	O
various	O
databases	O
such	O
as	O
TumorHoPe	O
[	O
75	O
],	O
Biopep	O
-	O
UWM	O
,	O
StraPep	O
,	O
FeptideDB	O
,	O
ACEpepDB	O
,	O
BioPD	O
,	O
APD	O
,	O
BACTIBASE	O
[	O
76	O
],	O
CAMP	O
,	O
PenBase	O
[	O
77	O
],	O
RAPD	O
[	O
78	O
],	O
Hmrbase	B-BT
[	O
79	O
],	O
PhytAMP	O
[	O
80	O
],	O
PeptideDB	O
,	O
ACEpepDB	O
[	O
81	O
],	O
Amper	O
[	O
82	O
],	O
and	O
BAGEL3	O
[	O
83	O
].	O

In	O
addition	O
we	O
found	O
36	O
,	O
198	O
(	O
H1	O
)	O
and	O
47	O
,	O
651	O
(	O
HFFc6	O
)	O
high	O
frequency	O
bins	O
that	O
were	O
not	O
identified	O
by	O
cooltools	B-BT
.	O

We	O
investigated	O
the	O
expression	O
patterns	O
of	O
all	O
the	O
identified	O
StSET	O
genes	O
in	O
15	O
tissues	O
,	O
namely	O
pollen	O
,	O
style	O
,	O
flower	O
,	O
fruit	O
,	O
leaf	O
,	O
petiole	O
,	O
stem	O
,	O
shoot	O
,	O
root	O
,	O
stolon	O
,	O
tuber	O
,	O
tuber	O
meristem	O
,	O
tuber	O
periderm	O
,	O
tuber	O
flesh	O
,	O
and	O
tuber	O
sprout	O
using	O
the	O
expression	O
data	O
retrieved	O
from	O
the	O
StCoExpNet	B-BT
database	O
[	O
37	O
].	O

Briefly	O
,	O
total	O
RNA	O
was	O
isolated	O
from	O
the	O
leaf	O
tissues	O
of	O
six	O
samples	O
(	O
each	O
with	O
three	O
biological	O
replications	O
)	O
using	O
a	O
modified	O
c	O
-	O
TAB	O
and	O
lithium	O
chloride	O
method	O
(	O
Rubio	O
-	O
Pifia	O
and	O
Zapata	O
-	O
Peter	O
,	O
2011	O
).	O

CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
extracts	O
significant	O
terms	O
for	O
each	O
condition	O
,	O
and	O
exports	O
visualizations	O
optimized	O
for	O
clarity	O
and	O
robustness	O
.	O

The	O
code	O
for	O
the	O
evaluations	O
and	O
experiments	O
is	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
mourisl	O
/	O
centrifuger_evaluations	B-BT
[	O
57	O
].	O

The	O
protein	O
IDs	O
of	O
the	O
key	O
targets	O
were	O
obtained	O
from	O
the	O
utility	O
module	O
of	O
TCMNPAS	B-BT
and	O
converted	O
into	O
Protein	O
Data	O
Bank	O
(	O
PDB	O
)	O
IDs	O
(	O
every	O
molecular	O
model	O
in	O
the	O
PDB	O
has	O
a	O
unique	O
accession	O
or	O
identification	O
code	O
).	O

High	O
-	O
quality	O
truly	O
domain	O
-	O
centric	O
GO	O
annotations	O
that	O
were	O
supported	O
by	O
both	O
single	O
domain	O
UniProts	O
and	O
all	O
UniProts	O
(	O
including	O
multidomain	O
UniProts	O
)	O
were	O
downloaded	O
as	O
the	O
file	O
Domain2GO_supported_by_both	B-BT
.	O
txt	O
.	O

Table	O
3Subgroup	O
analysis	O
of	O
per	O
case	O
medical	O
expenditure	O
(	O
US	O
$)	O
of	O
six	O
cancersLung	O
cancerBreast	O
cancerColorectal	O
cancerEsophageal	O
cancerLiver	O
cancerGastric	O
cancerMean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Overall	O
10	O
,	O
286	O
(	O
9	O
,	O
187	O
,	O
11	O
,	O
386	O
)	O
10	O
,	O
772	O
(	O
10	O
,	O
161	O
,	O
11	O
,	O
382	O
)	O
10	O
,	O
886	O
(	O
10	O
,	O
232	O
,	O
11	O
,	O
541	O
)	O
10	O
,	O
236	O
(	O
9	O
,	O
566	O
,	O
10	O
,	O
905	O
)	O
9	O
,	O
663	O
(	O
9	O
,	O
005	O
,	O
10	O
,	O
322	O
)	O
10	O
,	O
766	O
(	O
9	O
,	O
782	O
,	O
11	O
,	O
749	O
)	O
Region	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001North10	O
,	O
530	O
(	O
5	O
,	O
201	O
,	O
15	O
,	O
859	O
)	O
9	O
,	O
453	O
(	O
8	O
,	O
609	O
,	O
10	O
,	O
297	O
)	O
12	O
,	O
553	O
(	O
10	O
,	O
709	O
,	O
14	O
,	O
397	O
)	O
7	O
,	O
570	O
(	O
6	O
,	O
353	O
,	O
8	O
,	O
786	O
)	O
8	O
,	O
476	O
(	O
6	O
,	O
915	O
,	O
10	O
,	O
038	O
)	O
14	O
,	O
221	O
(	O
12	O
,	O
771	O
,	O
15	O
,	O
672	O
)	O
East11	O
,	O
852	O
(	O
10	O
,	O
722	O
,	O
12	O
,	O
983	O
)	O
12	O
,	O
462	O
(	O
11	O
,	O
053	O
,	O
13	O
,	O
872	O
)	O
11	O
,	O
407	O
(	O
10	O
,	O
319	O
,	O
12	O
,	O
495	O
)	O
11	O
,	O
040	O
(	O
9	O
,	O
663	O
,	O
12	O
,	O
417	O
)	O
9	O
,	O
935	O
(	O
8	O
,	O
433	O
,	O
11	O
,	O
437	O
)	O
11	O
,	O
342	O
(	O
8	O
,	O
271	O
,	O
14	O
,	O
413	O
)	O
Middle11	O
,	O
410	O
(	O
9	O
,	O
600	O
,	O
13	O
,	O
221	O
)	O
10	O
,	O
827	O
(	O
9	O
,	O
259	O
,	O
12	O
,	O
395	O
)	O
9	O
,	O
121	O
(	O
8	O
,	O
312	O
,	O
9	O
,	O
930	O
)	O
10	O
,	O
555	O
(	O
9	O
,	O
378	O
,	O
11	O
,	O
733	O
)	O
9	O
,	O
815	O
(	O
8	O
,	O
635	O
,	O
10	O
,	O
994	O
)	O
10	O
,	O
498	O
(	O
9	O
,	O
289	O
,	O
11	O
,	O
706	O
)	O
South11	O
,	O
015	O
(	O
9	O
,	O
621	O
,	O
12	O
,	O
410	O
)	O
14	O
,	O
851	O
(	O
12	O
,	O
811	O
,	O
16	O
,	O
891	O
)	O
16	O
,	O
262	O
(	O
13	O
,	O
393	O
,	O
19	O
,	O
131	O
)	O
13	O
,	O
633	O
(	O
11	O
,	O
469	O
,	O
15	O
,	O
797	O
)	O
12	O
,	O
115	O
(	O
10	O
,	O
150	O
,	O
14	O
,	O
080	O
)	O
7	O
,	O
020	O
(	O
6	O
,	O
223	O
,	O
7	O
,	O
817	O
)	O
West6	O
,	O
891	O
(	O
6	O
,	O
150	O
,	O
7	O
,	O
632	O
)	O
7	O
,	O
038	O
(	O
6	O
,	O
244	O
,	O
7	O
,	O
832	O
)	O
7	O
,	O
138	O
(	O
6	O
,	O
055	O
,	O
8	O
,	O
222	O
)	O
7	O
,	O
670	O
(	O
6	O
,	O
515	O
,	O
8	O
,	O
824	O
)	O
7	O
,	O
638	O
(	O
6	O
,	O
636	O
,	O
8	O
,	O
639	O
)	O
8	O
,	O
083	O
(	O
6	O
,	O
827	O
,	O
9	O
,	O
338	O
)	O
Hospital	O
type	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001General	O
hospital9	O
,	O
098	O
(	O
7	O
,	O
130	O
,	O
11	O
,	O
066	O
)	O
7	O
,	O
579	O
(	O
6	O
,	O
969	O
,	O
8	O
,	O
190	O
)	O
9	O
,	O
939	O
(	O
9	O
,	O
122	O
,	O
10	O
,	O
755	O
)	O
9	O
,	O
029	O
(	O
7	O
,	O
965	O
,	O
10	O
,	O
093	O
)	O
8	O
,	O
101	O
(	O
7	O
,	O
344	O
,	O
8	O
,	O
859	O
)	O
9	O
,	O
848	O
(	O
8	O
,	O
705	O
,	O
10	O
,	O
991	O
)	O
Specialized	O
hospital11	O
,	O
613	O
(	O
10	O
,	O
849	O
,	O
12	O
,	O
377	O
)	O
13	O
,	O
348	O
(	O
12	O
,	O
379	O
,	O
14	O
,	O
316	O
)	O
12	O
,	O
181	O
(	O
11	O
,	O
111	O
,	O
13	O
,	O
250	O
)	O
11	O
,	O
247	O
(	O
10	O
,	O
402	O
,	O
12	O
,	O
092	O
)	O
11	O
,	O
014	O
(	O
9	O
,	O
982	O
,	O
12	O
,	O
047	O
)	O
11	O
,	O
452	O
(	O
9	O
,	O
960	O
,	O
12	O
,	O
943	O
)	O
Diagnostic	O
method	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
0010	O
.	O
0830	O
.	O
4	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001Free	O
screening	O
by	O
government7	O
,	O
610	O
(	O
5	O
,	O
815	O
,	O
9	O
,	O
405	O
)	O
16	O
,	O
058	O
(	O
11	O
,	O
686	O
,	O
20	O
,	O
431	O
)	O
10	O
,	O
528	O
(	O
7	O
,	O
825	O
,	O
13	O
,	O
230	O
)	O
7	O
,	O
300	O
(	O
5	O
,	O
797	O
,	O
8	O
,	O
804	O
)	O
17	O
,	O
881	O
(	O
9	O
,	O
337	O
,	O
26	O
,	O
426	O
)	O
16	O
,	O
861	O
(	O
1	O
,	O
357	O
,	O
35	O
,	O
080	O
)	O
Physical	O
examination12	O
,	O
655	O
(	O
8	O
,	O
344	O
,	O
16	O
,	O
966	O
)	O
12	O
,	O
337	O
(	O
10	O
,	O
690	O
,	O
13	O
,	O
983	O
)	O
14	O
,	O
077	O
(	O
10	O
,	O
495	O
,	O
17	O
,	O
658	O
)	O
11	O
,	O
930	O
(	O
9	O
,	O
522	O
,	O
14	O
,	O
338	O
)	O
10	O
,	O
253	O
(	O
9	O
,	O
096	O
,	O
11	O
,	O
411	O
)	O
13	O
,	O
982	O
(	O
11	O
,	O
975	O
,	O
15	O
,	O
989	O
)	O
Incidentally	O
detected10	O
,	O
487	O
(	O
8	O
,	O
880	O
,	O
12	O
,	O
094	O
)	O
8	O
,	O
454	O
(	O
5	O
,	O
421	O
,	O
11	O
,	O
488	O
)	O
10	O
,	O
241	O
(	O
8	O
,	O
081	O
,	O
12	O
,	O
400	O
)	O
10	O
,	O
760	O
(	O
6	O
,	O
817	O
,	O
14	O
,	O
704	O
)	O
11	O
,	O
352	O
(	O
8	O
,	O
563	O
,	O
14	O
,	O
142	O
)	O
10	O
,	O
422	O
(	O
7	O
,	O
683	O
,	O
13	O
,	O
160	O
)	O
With	O
symptoms9	O
,	O
566	O
(	O
8	O
,	O
805	O
,	O
10	O
,	O
327	O
)	O
10	O
,	O
336	O
(	O
9	O
,	O
665	O
,	O
11	O
,	O
008	O
)	O
10	O
,	O
528	O
(	O
9	O
,	O
882	O
,	O
11	O
,	O
173	O
)	O
10	O
,	O
075	O
(	O
9	O
,	O
357	O
,	O
10	O
,	O
793	O
)	O
9	O
,	O
083	O
(	O
8	O
,	O
290	O
,	O
9	O
,	O
877	O
)	O
10	O
,	O
264	O
(	O
9	O
,	O
165	O
,	O
11	O
,	O
362	O
)	O
Comorbidity	O
0	O
.	O
20	O
.	O
40	O
.	O
50	O
.	O
2	O
<	O
0	O
.	O
0010	O
.	O
2Yes10	O
,	O
332	O
(	O
9	O
,	O
419	O
,	O
11	O
,	O
245	O
)	O
10	O
,	O
286	O
(	O
9	O
,	O
272	O
,	O
11	O
,	O
300	O
)	O
10	O
,	O
771	O
(	O
9	O
,	O
337	O
,	O
12	O
,	O
206	O
)	O
11	O
,	O
194	O
(	O
9	O
,	O
798	O
,	O
12	O
,	O
591	O
)	O
10	O
,	O
581	O
(	O
9	O
,	O
600	O
,	O
11	O
,	O
562	O
)	O
10	O
,	O
199	O
(	O
9	O
,	O
103	O
,	O
11	O
,	O
295	O
)	O
No10	O
,	O
263	O
(	O
8	O
,	O
666	O
,	O
11	O
,	O
859	O
)	O
10	O
,	O
949	O
(	O
10	O
,	O
202	O
,	O
11	O
,	O
696	O
)	O
10	O
,	O
944	O
(	O
10	O
,	O
273	O
,	O
11	O
,	O
615	O
)	O
9	O
,	O
838	O
(	O
9	O
,	O
088	O
,	O
10	O
,	O
588	O
)	O
8	O
,	O
787	O
(	O
7	O
,	O
906	O
,	O
9	O
,	O
669	O
)	O
11	O
,	O
078	O
(	O
9	O
,	O
677	O
,	O
12	O
,	O
479	O
)	O
Complication	O
<	O
0	O
.	O
0010	O
.	O
0910	O
.	O
4	O
<	O
0	O
.	O
0010	O
.	O
0510	O
.	O
9Yes15	O
,	O
832	O
(	O
10	O
,	O
152	O
,	O
21	O
,	O
512	O
)	O
10	O
,	O
743	O
(	O
8	O
,	O
464	O
,	O
13	O
,	O
021	O
)	O
11	O
,	O
200	O
(	O
9	O
,	O
289	O
,	O
13	O
,	O
112	O
)	O
13	O
,	O
816	O
(	O
11	O
,	O
412	O
,	O
16	O
,	O
221	O
)	O
13	O
,	O
935	O
(	O
9	O
,	O
924	O
,	O
17	O
,	O
946	O
)	O
13	O
,	O
214	O
(	O
5	O
,	O
107	O
,	O
21	O
,	O
321	O
)	O
No9	O
,	O
888	O
(	O
8	O
,	O
783	O
,	O
10	O
,	O
993	O
)	O
10	O
,	O
773	O
(	O
10	O
,	O
143	O
,	O
11	O
,	O
403	O
)	O
10	O
,	O
854	O
(	O
10	O
,	O
159	O
,	O
11	O
,	O
549	O
)	O
9	O
,	O
641	O
(	O
8	O
,	O
973	O
,	O
10	O
,	O
309	O
)	O
9	O
,	O
185	O
(	O
8	O
,	O
608	O
,	O
9	O
,	O
762	O
)	O
10	O
,	O
516	O
(	O
9	O
,	O
809	O
,	O
11	O
,	O
222	O
)	O
Treatment	O
phases	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001Initial10	O
,	O
102	O
(	O
8	O
,	O
641	O
,	O
11	O
,	O
563	O
)	O
10	O
,	O
142	O
(	O
9	O
,	O
438	O
,	O
10	O
,	O
845	O
)	O
10	O
,	O
750	O
(	O
10	O
,	O
007	O
,	O
11	O
,	O
492	O
)	O
11	O
,	O
275	O
(	O
10	O
,	O
408	O
,	O
12	O
,	O
142	O
)	O
9	O
,	O
640	O
(	O
8	O
,	O
888	O
,	O
10	O
,	O
392	O
)	O
11	O
,	O
848	O
(	O
10	O
,	O
538	O
,	O
13	O
,	O
158	O
)	O
Follow	O
-	O
up4	O
,	O
726	O
(	O
3	O
,	O
697	O
,	O
5	O
,	O
755	O
)	O
6	O
,	O
057	O
(	O
4	O
,	O
851	O
,	O
7	O
,	O
264	O
)	O
8	O
,	O
276	O
(	O
6	O
,	O
044	O
,	O
10	O
,	O
507	O
)	O
4	O
,	O
170	O
(	O
3	O
,	O
370	O
,	O
4	O
,	O
970	O
)	O
6	O
,	O
487	O
(	O
5	O
,	O
293	O
,	O
7	O
,	O
681	O
)	O
5	O
,	O
587	O
(	O
3	O
,	O
673	O
,	O
7	O
,	O
501	O
)	O
Relapse	O
/	O
metastasis13	O
,	O
461	O
(	O
11	O
,	O
458	O
,	O
15	O
,	O
465	O
)	O
16	O
,	O
452	O
(	O
14	O
,	O
756	O
,	O
18	O
,	O
148	O
)	O
13	O
,	O
368	O
(	O
11	O
,	O
671	O
,	O
15	O
,	O
066	O
)	O
11	O
,	O
975	O
(	O
10	O
,	O
284	O
,	O
13	O
,	O
666	O
)	O
11	O
,	O
328	O
(	O
9	O
,	O
480	O
,	O
13	O
,	O
176	O
)	O
10	O
,	O
382	O
(	O
8	O
,	O
872	O
,	O
11	O
,	O
892	O
)	O
Clinical	O
stages	O
0	O
.	O
045	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
0010	O
.	O
0770	O
.	O
40	O
.	O
3I10	O
,	O
141	O
(	O
6	O
,	O
686	O
,	O
13	O
,	O
597	O
)	O
7	O
,	O
859	O
(	O
7	O
,	O
053	O
,	O
8	O
,	O
666	O
)	O
9	O
,	O
658	O
(	O
7	O
,	O
856	O
,	O
11	O
,	O
459	O
)	O
9	O
,	O
681	O
(	O
7	O
,	O
904	O
,	O
11	O
,	O
458	O
)	O
9	O
,	O
120	O
(	O
7	O
,	O
822	O
,	O
10	O
,	O
418	O
)	O
9	O
,	O
945	O
(	O
8	O
,	O
449	O
,	O
11	O
,	O
442	O
)	O
II8	O
,	O
718	O
(	O
7	O
,	O
735	O
,	O
9	O
,	O
701	O
)	O
9	O
,	O
415	O
(	O
8	O
,	O
510	O
,	O
10	O
,	O
319	O
)	O
8	O
,	O
951	O
(	O
8	O
,	O
245	O
,	O
9	O
,	O
657	O
)	O
9	O
,	O
304	O
(	O
8	O
,	O
223	O
,	O
10	O
,	O
386	O
)	O
8	O
,	O
745	O
(	O
7	O
,	O
797	O
,	O
9	O
,	O
694	O
)	O
9	O
,	O
726	O
(	O
8	O
,	O
305	O
,	O
11	O
,	O
146	O
)	O
III10	O
,	O
453	O
(	O
9	O
,	O
465	O
,	O
11	O
,	O
441	O
)	O
12	O
,	O
599	O
(	O
10	O
,	O
959	O
,	O
14	O
,	O
238	O
)	O
10	O
,	O
086	O
(	O
9	O
,	O
309	O
,	O
10	O
,	O
862	O
)	O
11	O
,	O
053	O
(	O
9	O
,	O
785	O
,	O
12	O
,	O
321	O
)	O
10	O
,	O
883	O
(	O
9	O
,	O
250	O
,	O
12	O
,	O
515	O
)	O
9	O
,	O
833	O
(	O
8	O
,	O
940	O
,	O
10	O
,	O
727	O
)	O
IV11	O
,	O
137	O
(	O
9	O
,	O
678	O
,	O
12	O
,	O
597	O
)	O
15	O
,	O
378	O
(	O
13	O
,	O
665	O
,	O
17	O
,	O
090	O
)	O
15	O
,	O
021	O
(	O
13	O
,	O
159	O
,	O
16	O
,	O
882	O
)	O
10	O
,	O
471	O
(	O
9	O
,	O
142	O
,	O
11	O
,	O
801	O
)	O
9	O
,	O
602	O
(	O
8	O
,	O
503	O
,	O
10	O
,	O
700	O
)	O
13	O
,	O
040	O
(	O
10	O
,	O
146	O
,	O
15	O
,	O
933	O
)	O

As	O
shown	O
in	O
Figure	O
4	O
,	O
PhageTB	B-BT
outperform	O
previous	O
studies	O
at	O
each	O
taxonomic	O
level	O
,	O
with	O
an	O
accuracy	O
of	O
67	O
.	O
90	O
,	O
80	O
.	O
60	O
,	O
85	O
.	O
5	O
,	O
90	O
.	O
0	O
,	O
and	O
93	O
.	O
5	O
%	O
at	O
Genus	O
,	O
Family	O
,	O
Order	O
,	O
Class	O
,	O
and	O
Phylum	O
levels	O
.	O

The	O
nodes	O
in	O
the	O
BoostDiff	B-BT
network	O
have	O
a	O
small	O
overlap	O
with	O
the	O
list	O
of	O
DEGs	O
(	O
Jaccard	O
similarity	O
=	O
0	O
.	O
008	O
).	O

What	O
’	O
s	O
more	O
,	O
T33	O
is	O
composed	O
of	O
five	O
traditional	O
Chinese	O
herbs	O
,	O
namely	O
,	O
Kansui	O
Radix	O
,	O
Glycyrrhizae	O
Radix	O
et	O
Rhizoma	O
Praeparata	O
cum	O
Melle	O
,	O
Paeoniae	O
Radix	O
Alba	O
,	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Zingibere	O
et	O
Alumine	O
,	O
and	O
Rhei	O
Radix	O
et	O
Rhizoma	O
.	O

The	O
input	O
for	O
PyCoMo	B-BT
are	O
the	O
metabolic	O
models	O
of	O
the	O
community	O
members	O
,	O
in	O
any	O
of	O
the	O
file	O
formats	O
supported	O
by	O
COBRApy	O
(	O
SBML	O
,	O
MATLAB	O
,	O
JSON	O
,	O
and	O
YAML	O
).	O

Overall	O
,	O
CovEpiAb	B-BT
provides	O
an	O
important	O
resource	O
for	O
SARS	O
-	O
CoV	O
-	O
2	O
-	O
related	O
research	O
and	O
facilitates	O
the	O
development	O
of	O
broad	O
-	O
spectrum	O
effective	O
vaccines	O
and	O
neutralizing	O
antibodies	O
against	O
HCoVs	O
.	O

OralExplorer	B-BT
collects	O
oral	O
inflammatory	O
disease	O
data	O
from	O
the	O
GEO	O
database	O
and	O
performs	O
subsequent	O
analysis	O
and	O
web	O
tool	O
construction	O
.	O

Given	O
these	O
promising	O
outcomes	O
,	O
there	O
'	O
s	O
a	O
strong	O
case	O
to	O
be	O
made	O
for	O
advancing	O
the	O
Voyager	O
into	O
clinical	O
trials	O
,	O
aiming	O
to	O
further	O
explore	O
its	O
therapeutic	O
implications	O
and	O
potential	O
benefits	O
for	O
patients	O
diagnosed	O
with	O
GBM	O
.	O

Default	O
values	O
for	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}	O
}{}	O
k	O
\	O
end	O
{	O
document	O
}	O
k	O
and	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}	O
}{}	O
q	O
\	O
end	O
{	O
document	O
}	O
q	O
in	O
RmsiGUI	B-BT
are	O
100	O
and	O
98	O
%,	O
respectively	O
.	O

PCAO2	B-BT
development	O
process	O
.	O

A	O
total	O
of	O
16	O
,	O
055	O
(	O
38	O
.	O
1	O
%)	O
of	O
the	O
41	O
,	O
855	O
adult	O
TTS	O
admissions	O
had	O
composite	O
cardiovascular	O
outcomes	O
(	O
TACCO	O
).	O

A	O
slim	O
cholangioscope	O
(	O
9	O
-	O
Fr	O
eyeMAX	O
;	O
Micro	O
-	O
Tech	O
,	O
Nanjing	O
,	O
China	O
)	O
was	O
inserted	O
into	O
the	O
afferent	O
loop	O
via	O
the	O
EUS	O
-	O
HGS	O
and	O
hepaticojejunostomy	O
anastomoses	O
.	O

Another	O
benefit	O
is	O
that	O
it	O
does	O
not	O
need	O
a	O
large	O
number	O
of	O
repetitive	O
elements	O
to	O
identify	O
the	O
putative	O
sequences	O
,	O
relying	O
instead	O
on	O
the	O
presence	O
of	O
at	O
least	O
two	O
polymorphic	O
copies	O
in	O
the	O
pangenome	O
.	O

Finally	O
,	O
we	O
hypothesized	O
that	O
trigon	O
basin	O
enamel	O
decussation	O
complexity	O
would	O
be	O
greater	O
in	O
the	O
middle	O
and	O
inner	O
enamel	O
of	O
Cercocebus	O
atys	O
than	O
it	O
would	O
in	O
these	O
same	O
regions	O
of	O
Lophocebus	O
albigena	O
and	O
Cercopithecus	O
cephus	O
molars	O
.	O

cooltools	B-BT
detects	O
insulating	O
boundaries	O
as	O
local	O
minima	O
of	O
the	O
insulation	O
profile	O
and	O
quantifies	O
their	O
strength	O
as	O
their	O
topographic	O
prominence	O
.	O

To	O
view	O
syntenic	O
blocks	O
and	O
homologous	O
gene	O
pairs	O
between	O
different	O
kiwifruit	O
genome	O
assemblies	O
,	O
we	O
developed	O
‘	O
SyntenyViewer	B-BT
’,	O
an	O
extension	O
module	O
of	O
Tripal	O
,	O
in	O
KGD	O
.	O

Among	O
the	O
rPPG	O
models	O
,	O
representative	O
methods	O
that	O
are	O
used	O
as	O
baselines	O
include	O
“	O
PhysNet	O
”,	O
“	O
RhythmNet	O
”,	O
and	O
“	O
Deephys	B-BT
”;	O
each	O
has	O
a	O
unique	O
approach	O
[	O
4	O
,	O
5	O
,	O
6	O
].	O

(	O
1	O
)	O
BWA	O
v0	O
.	O
7	O
.	O
10	O
-	O
r789	O
:	O
aln	O
,	O
default	O
parameters	O
;	O
(	O
2	O
)	O
LACHESIS	O
:	O
CLUSTER_MIN_RE_SITES	O
=	O
547	O
;	O
CLUSTER_MAX_LINK_DENSITY	O
=	O
2	O
;	O
CLUSTER_NONINFORMATIVE_RATIO	O
=	O
2	O
;	O
ORDER_MIN_N_RES_IN_TRUN	O
=	O
1094	O
;	O
ORDER_MIN_N_RES_IN_SHREDS	O
=	O
1076	O
;	O
(	O
3	O
)	O
BUSCO	O
v3	O
.	O
0	O
:	O
--	O
evalue	O
1e	O
-	O
03	O
(	O
E	O
-	O
value	O
cutoff	O
for	O
BLAST	O
searches	O
),	O
-	O
sp	O
human	O
;	O
(	O
4	O
)	O
LTR_FINDER	O
:	O
default	O
parameters	O
;	O
(	O
5	O
)	O
RepeatScout	O
:	O
default	O
parameters	O
;	O
(	O
6	O
)	O
PASTEClassifier	B-BT
:	O
default	O
parameters	O
;	O
(	O
7	O
)	O
RepeatMasker	O
:	O
-	O
nolow	O
-	O
no_is	O
-	O
norna	O
-	O
engine	O
wublast	O
;	O
(	O
8	O
)	O
Genscan	O
:	O
default	O
parameters	O
;	O
(	O
9	O
)	O
Augustus	O
v2	O
.	O
4	O
:	O
default	O
parameters	O
;	O
(	O
10	O
)	O
GlimmerHMM	O
v3	O
.	O
0	O
.	O
4	O
:	O
default	O
parameters	O
;	O
(	O
11	O
)	O
GeneID	O
v1	O
.	O
4	O
:	O
default	O
parameters	O
;	O
(	O
12	O
)	O
SNAP	O
:	O
version	O
2006	O
-	O
07	O
-	O
28	O
,	O
default	O
parameters	O
;	O
(	O
13	O
)	O
GeMoMa	O
v1	O
.	O
3	O
.	O
1	O
:	O
default	O
parameters	O
;	O
(	O
14	O
)	O
Hisat	O
v2	O
.	O
0	O
.	O
4	O
:	O
--	O
max	O
-	O
intronlen	O
20000	O
,	O
--	O
min	O
-	O
intronlen	O
20	O
;	O
(	O
15	O
)	O
Stringtie	O
v1	O
.	O
2	O
.	O
3	O
:	O
default	O
parameters	O
;	O
(	O
16	O
)	O
TransDecoder	O
v2	O
.	O
0	O
:	O
default	O
parameters	O
;	O
(	O
17	O
)	O
GeneMark	O
-	O
ST	O
v5	O
.	O
1	O
:	O
default	O
parameters	O
;	O
(	O
18	O
)	O
PASA	O
v2	O
.	O
0	O
.	O
2	O
:	O
-	O
align_tools	O
gmap	O
,	O
-	O
maxIntronLen	O
20000	O
;	O
(	O
19	O
)	O
EVM	O
v1	O
.	O
1	O
.	O
1	O
:	O
default	O
parameters	O
;	O
(	O
20	O
)	O
BLAST	O
V2	O
.	O
2	O
.	O
31	O
:	O
-	O
evalue	O
1e	O
-	O
5	O
;	O
(	O
21	O
)	O
tRNAscan	O
-	O
SE	O
:	O
default	O
parameters	O
.	O

Here	O
we	O
have	O
introduced	O
MdrDB	B-BT
,	O
the	O
largest	O
drug	O
resistance	O
database	O
to	O
provide	O
all	O
information	O
highly	O
relevant	O
to	O
protein	O
mutation	O
-	O
induced	O
drug	O
binding	O
affinity	O
changes	O
.	O

These	O
scores	O
are	O
applied	O
to	O
assess	O
the	O
relevance	O
between	O
formula	O
targets	O
and	O
disease	O
targets	O
based	O
on	O
their	O
connectivity	O
within	O
the	O
Protein	O
–	O
Protein	O
Interaction	O
(	O
PPI	O
)	O
network	O
integrated	O
by	O
TCMNPAS	B-BT
,	O
derived	O
from	O
the	O
HIPPIE	O
(	O
Human	O
Integrated	O
Protein	O
–	O
Protein	O
Interaction	O
Reference	O
)	O
database	O
[	O
34	O
].	O

Nucleotide	O
coverage	O
of	O
reference	O
genomes	O
upon	O
use	O
of	O
single	O
-	O
target	O
tiled	O
amplicon	O
PCR	O
(	O
TA	O
-	O
PCR	O
)	O
custom	O
primer	O
sets	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
(	O
A	O
)	O
and	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
)	O
(	O
B	O
)	O
present	O
in	O
positive	O
control	O
samples	O
.	O

This	O
makes	O
it	O
impossible	O
to	O
directly	O
measure	O
ACE	O
activity	O
due	O
to	O
the	O
EDTA	O
-	O
mediated	O
extraction	O
of	O
zinc	O
ion	O
from	O
the	O
active	O
centers	O
of	O
the	O
enzyme	O
.	O

In	O
summary	O
,	O
the	O
SyntenyViewer	B-BT
module	O
can	O
not	O
only	O
display	O
synteny	O
blocks	O
for	O
multiple	O
genomes	O
in	O
an	O
intuitive	O
manner	O
,	O
but	O
also	O
connect	O
homologous	O
gene	O
pairs	O
among	O
different	O
cucurbit	O
species	O
.	O

Several	O
platforms	O
,	O
such	O
as	O
Integrated	O
Microbial	O
Genomes	O
and	O
Microbiomes	O
(	O
IMG	O
/	O
M	O
)	O
[	O
8	O
]	O
and	O
Marine	B-BT
Metagenomics	I-BT
Portal	I-BT
(	O
MMP	O
)	O
[	O
9	O
],	O
support	O
preliminary	O
analysis	O
of	O
metagenomic	O
or	O
genomic	O
data	O
.	O

For	O
comparison	O
,	O
the	O
corresponding	O
coefficients	O
from	O
analyzing	O
the	O
same	O
samples	O
in	O
MZmine	B-BT
are	O
given	O
.	O

coli	O
were	O
compared	O
using	O
Jalview	B-BT
.	O

Sums	O
of	O
each	O
of	O
these	O
metrics	O
across	O
all	O
were	O
computed	O
to	O
represent	O
the	O
total	O
downstream	O
impact	O
of	O
rworkflows	B-BT
.	O

As	O
depicted	O
in	O
Table	O
8	O
,	O
we	O
evaluate	O
various	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
insider	O
threat	O
detection	O
methods	O
using	O
the	O
CERT	O
r4	O
.	O
2	O
datasets	O
.	O

We	O
compared	O
these	O
with	O
the	O
high	O
frequency	O
contacts	O
identified	O
by	O
cooltools	B-BT
and	O
reported	O
by	O
Oksuz	O
et	O
al	O
.	O
20	O
for	O
the	O
combined	O
H1	O
and	O
HFFc6	O
data	O
(	O
Fig	O
.	O

Note	O
:	O
(	O
A	O
)	O
The	O
morphology	O
of	O
the	O
Pinellia	O
ternata	O
(	O
Thunb	O
.)	O
Breit	O
;	O
(	O
B	O
)	O
the	O
whole	O
plant	O
or	O
overground	O
part	O
of	O
Pinellia	O
ternata	O
(	O
Thunb	O
.)	O
Breit	O
;	O
(	O
C	O
)	O
Pinellia	O
ternata	O
decoction	O
pieces	O
;	O
(	O
D	O
)	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
(	O
Fa	O
-	O
Banxia	O
,	O
法半夏	O
);	O
(	O
E	O
)	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Zingibere	O
et	O
Alumine	O
(	O
Jiang	O
-	O
Banxia	O
,	O
姜半夏	O
);	O
(	O
F	O
)	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Alumine	O
(	O
Qing	O
-	O
Banxia清半夏	O
).	O

Text	O
and	O
interpretation	O
were	O
united	O
in	O
active	O
oral	O
performances	O
in	O
bardic	B-BT
chains	O
of	O
transmission	O
.	O

As	O
a	O
C	O
++	O
API	O
of	O
HTSlib	B-BT
,	O
vcfpp	O
inherits	O
all	O
functionalities	O
from	O
HTSlib	B-BT
and	O
is	O
implemented	O
in	O
a	O
single	O
header	O
file	O
that	O
can	O
be	O
easily	O
integrated	O
and	O
used	O
safely	O
.	O

1Two	O
SwivelLock	O
(	O
Arthrex	O
,	O
Inc	O
)	O
suture	O
anchors	O
at	O
the	O
inferior	O
pole	O
of	O
the	O
patella	O
with	O
a	O
Krackow	O
stitch	O
brought	O
down	O
the	O
patella	O
in	O
a	O
locking	O
stitch	O
configuration	O
.	O
Fig	O
.	O

If	O
Enhancer	B-BT
-	I-BT
MDLF	I-BT
is	O
pre	O
-	O
trained	O
using	O
as	O
many	O
(	O
or	O
even	O
all	O
)	O
cell	O
line	O
enhancers	O
following	O
our	O
transfer	O
learning	O
strategies	O
,	O
a	O
comprehensive	O
pre	O
-	O
trained	O
model	O
may	O
be	O
obtained	O
,	O
serving	O
as	O
an	O
effective	O
initial	O
model	O
for	O
enhancer	O
prediction	O
tasks	O
in	O
various	O
cell	O
lines	O
.	O

PhysiBoSS	O
utilizes	O
MaBoSS	B-BT
[	O
17	O
,	O
18	O
],	O
a	O
tool	O
that	O
models	O
signaling	O
pathways	O
as	O
Boolean	O
networks	O
,	O
thus	O
simplifying	O
the	O
description	O
of	O
intracellular	O
models	O
.	O

The	O
firmware	O
version	O
of	O
the	O
FlexStat	O
controller	O
is	O
R2	O
.	O
1	O
.	O
0	O
.	O
18	O
.	O

MINNO	B-BT
is	O
a	O
JavaScript	O
-	O
based	O
web	O
application	O
that	O
is	O
compatible	O
with	O
Google	O
Chrome	O
and	O
Mozilla	O
Firefox	O
browsers	O
.	O

Webserver	O
:	O
ABDpred	B-BT
web	O
server	O
was	O
developed	O
to	O
predict	O
antibiotic	O
drugs	O
using	O
four	O
best	O
-	O
performing	O
ML	O
classifiers	O
,	O
XGBoost	O
RF	O
,	O
GBC	O
and	O
DNN	O
.	O

Is	O
such	O
semantic	O
mislabeling	O
really	O
on	O
par	O
with	O
the	O
substitution	O
of	O
tuna	O
for	O
escolar	O
,	O
or	O
the	O
substitution	O
of	O
snapper	O
for	O
tilapia	O
?	O

The	O
Essex	O
Skipper	O
has	O
29	O
chromosomes	O
(	O
Federley	O
,	O
1938	O
;	O
Larsen	O
,	O
1975	O
).	O

Data	O
are	O
available	O
in	O
the	O
article	O
and	O
HIResist	B-BT
database	O
(	O
https	O
://	O
hiresist	B-BT
.	O
umn	O
.	O
edu	O
/).	O

Notably	O
,	O
most	O
healthcare	O
insurance	O
policies	O
in	O
India	O
,	O
such	O
as	O
Ayushman	O
Bharat	O
,	O
are	O
designed	O
to	O
cover	O
family	O
members	O
,	O
primarily	O
defined	O
along	O
cisheteronormative	O
lines	O
as	O
spouses	O
and	O
children	O
.	O
49	O
Consequently	O
,	O
the	O
Supreme	O
Court	O
’	O
s	O
ruling	O
places	O
same	O
-	O
sex	O
couples	O
,	O
unable	O
to	O
formalise	O
their	O
unions	O
through	O
marriage	O
,	O
at	O
risk	O
of	O
being	O
denied	O
access	O
to	O
essential	O
healthcare	O
insurance	O
as	O
co	O
-	O
dependents	O
.	O
49	O
Similarly	O
,	O
preventing	O
same	O
-	O
sex	O
marriages	O
threatens	O
the	O
potential	O
for	O
other	O
legal	O
protections	O
typically	O
granted	O
to	O
couples	O
upon	O
marriage	O
by	O
the	O
law	O
.	O

In	O
addition	O
,	O
LipidSig	O
2	O
.	O
0	O
analyzes	O
lipid	O
names	O
or	O
features	O
from	O
user	O
-	O
provided	O
lipidomics	O
data	O
using	O
Goslin	B-BT
,	O
which	O
assigns	O
corresponding	O
nomenclature	O
at	O
various	O
levels	O
,	O
including	O
species	O
(	O
only	O
total	O
carbon	O
and	O
double	O
bond	O
counts	O
),	O
molecular	O
species	O
(	O
with	O
individual	O
fatty	O
acid	O
chain	O
compositions	O
),	O
and	O
sn	O
-	O
position	O
(	O
detail	O
in	O
the	O
exact	O
positions	O
of	O
fatty	O
acids	O
on	O
the	O
backbone	O
).	O

We	O
first	O
fit	O
the	O
in	O
vitro	O
data	O
alone	O
using	O
MASSef	B-BT
and	O
found	O
that	O
the	O
model	O
was	O
able	O
to	O
perfectly	O
capture	O
the	O
data	O
(	O
Fig	O
.	O

The	O
identified	O
proteins	O
also	O
included	O
52	O
(	O
70	O
%)	O
of	O
the	O
79	O
proteins	O
previously	O
annotated	O
as	O
""""	O
sporulation	O
proteins	O
""""	O
in	O
the	O
SubtiWiki	B-BT
database	O
and	O
found	O
in	O
direct	O
protein	O
analysis	O
(	O
marked	O
in	O
yellow	O
in	O
the	O
Supplementary	O
Table	O
S4	O
).	O

The	O
extracted	O
types	O
of	O
unhealthy	O
diet	O
in	O
the	O
present	O
systematic	O
review	O
were	O
“	O
breakfast	O
skipper	O
,”	O
“	O
fast	O
food	O
,”	O
“	O
hydrogenated	O
oils	O
consumption	O
,”	O
“	O
salty	O
snacks	O
,”	O
“	O
sweetened	O
beverages	O
,”	O
“	O
breakfast	O
skipper	O
,”	O
“	O
dinner	O
skipper	O
,”	O
“	O
launch	O
skipper	O
,”	O
and	O
“	O
sweets	O
.”	O
The	O
range	O
of	O
pooled	O
prevalence	O
for	O
different	O
types	O
was	O
0	O
.	O
06	O
–	O
0	O
.	O
75	O
.	O

The	O
efficiency	O
of	O
the	O
InPACT	O
at	O
Home	O
website	O
was	O
also	O
deemed	O
low	O
,	O
and	O
errors	O
were	O
deemed	O
high	O
.	O

The	O
Supplementary	O
Material	O
includes	O
several	O
user	O
manuals	O
that	O
provide	O
more	O
results	O
of	O
this	O
application	O
example	O
and	O
in	O
-	O
depth	O
use	O
of	O
vizAPA	B-BT
.	O

Relative	O
abundance	O
(	O
a	O
)	O
and	O
biomass	O
(	O
b	O
)	O
of	O
the	O
seven	O
dominant	O
morphotypes	O
plus	O
other	O
cells	O
which	O
comprised	O
the	O
sHF	O
flow	O
-	O
sorted	O
from	O
samples	O
collected	O
in	O
the	O
South	O
Pacific	O
mesotrophic	O
(	O
SPacM	O
)	O
and	O
oligotrophic	O
(	O
SPacO	O
)	O
waters	O
.	O

packageVersion	O
"("""	O
SpacoR	B-BT
""")"	O

MZmine	B-BT
2	O
.	O
51	O
was	O
used	O
in	O
this	O
comparison	O
,	O
although	O
a	O
newer	O
version	O
MZmine	B-BT
3	O
has	O
been	O
launched	O
during	O
the	O
preparation	O
of	O
the	O
present	O
study	O
.	O

As	O
expected	O
,	O
in	O
the	O
CTR	O
biscuits	O
,	O
the	O
concentration	O
of	O
reducing	O
sugars	O
quickly	O
increased	O
during	O
the	O
early	O
stages	O
of	O
duodenal	O
digestion	O
and	O
reached	O
a	O
plateau	O
after	O
1	O
h	O
,	O
showing	O
a	O
slightly	O
decreasing	O
trend	O
afterwards	O
.	O

Power	O
over	O
different	O
signal	O
strengths	O
of	O
gbdmr	B-BT
,	O
dmrff	O
,	O
and	O
EWAS	O
across	O
different	O
block	O
sizes	O

To	O
view	O
genome	O
synteny	O
and	O
homologous	O
gene	O
pairs	O
between	O
different	O
cucurbit	O
species	O
,	O
we	O
have	O
developed	O
‘	O
SyntenyViewer	B-BT
’	O
as	O
an	O
extension	O
module	O
of	O
Tripal	O
.	O

Furthermore	O
,	O
the	O
developed	O
framework	O
can	O
integrate	O
other	O
modeling	O
methods	O
,	O
e	O
.	O
g	O
.,	O
the	O
probabilistic	O
dropout	O
model23	O
or	O
accurate	O
variance	O
estimation	O
.	O
62	O
Hence	O
,	O
prolfqua	B-BT
enables	O
the	O
implementation	O
of	O
applications	O
where	O
the	O
user	O
can	O
select	O
an	O
alternative	O
normalization	O
method	O
,	O
protein	O
abundance	O
estimation	O
method	O
,	O
or	O
DEA	O
algorithms	O
.	O

Further	O
,	O
training	O
a	O
NanoDeep	B-BT
model	O
with	O
a	O
broader	O
range	O
of	O
species	O
may	O
help	O
improve	O
the	O
performance	O
of	O
adaptive	O
sampling	O
.	O

Insider	O
activities	O
distributions	O
.	O

AuraGain	O
,	O
similar	O
to	O
Supreme	O
,	O
features	O
an	O
anatomically	O
curved	O
airway	O
tube	O
and	O
an	O
integrated	O
large	O
-	O
diameter	O
GT	O
channel	O
.	O

The	O
phageTB	B-BT
server	O
[	O
61	O
]	O
was	O
used	O
to	O
determine	O
the	O
interaction	O
of	O
the	O
phage	O
with	O
the	O
host	O
bacteria	O
.	O

Readcount	O
for	O
each	O
small	O
RNA	O
mapping	O
to	O
a	O
tRNA	O
was	O
normalised	O
using	O
the	O
size	O
factors	O
from	O
DESeq	O
calculated	O
as	O
part	O
of	O
the	O
tinyRNA	B-BT
pipeline	O
.	O

We	O
further	O
performed	O
PHARE	B-BT
on	O
another	O
bulk	O
RNA	O
-	O
seq	O
data	O
from	O
CAD	O
,	O
and	O
found	O
CAD	O
patients	O
also	O
had	O
higher	O
age	O
difference	O
than	O
HC	O
sample	O
(	O
Fig	O
.	O

2MetaTiME	B-BT
meta	O
-	O
components	O
are	O
biologically	O
interpretable	O
with	O
top	O
genes	O
.	O
a	O
Heatmap	O
of	O
top	O
ten	O
most	O
recurrent	O
clusters	O
of	O
MeCs	O
showing	O
normalized	O
gene	O
weights	O
.	O

For	O
instance	O
,	O
BoostDiff	B-BT
can	O
be	O
applied	O
to	O
proteomics	O
or	O
metabolomics	O
studies	O
that	O
aim	O
to	O
detect	O
changes	O
in	O
dependencies	O
of	O
proteins	O
or	O
metabolites	O
.	O

Therefore	O
,	O
to	O
derive	O
the	O
Pfam	O
domains	O
distribution	O
among	O
the	O
entries	O
of	O
Hmrbase	B-BT
,	O
a	O
domain	O
search	O
facility	O
has	O
been	O
embedded	O
.	O

For	O
comparison	O
,	O
the	O
new	O
datasets	O
for	O
the	O
26	O
urine	O
specimens	O
diluted	O
either	O
to	O
2	O
.	O
0	O
or	O
6	O
.	O
5	O
mM	O
creatinine	O
were	O
analyzed	O
with	O
both	O
CF4	O
and	O
with	O
MZmine	B-BT
.	O

The	O
amount	O
of	O
collagen	O
in	O
Sirius	O
red	O
–	O
stained	O
sections	O
was	O
scored	O
according	O
to	O
the	O
modified	O
Ishak	O
method34	O
as	O
described	O
in	O
Supplemental	O
Table	O
S1	O
,	O
http	O
://	O
links	O
.	O
lww	O
.	O
com	O
/	O
HC9	O
/	O
B65	O
.	O

Excerpts	O
from	O
this	O
Table	O
showing	O
only	O
ACE	O
mutations	O
for	O
which	O
blood	O
ACE	O
levels	O
were	O
estimated	O
or	O
measured	O
(	O
S2	O
Table	O
in	O
S1	O
File	O
)	O
convincingly	O
indicate	O
that	O
blood	O
ACE	O
levels	O
were	O
significantly	O
decreased	O
in	O
a	O
significant	O
number	O
of	O
patients	O
with	O
damaging	O
ACE	O
mutations	O
and	O
Alzheimer	O
’	O
s	O
disease	O
.	O

Another	O
key	O
development	O
in	O
TREE	B-BT
-	I-BT
QMC	I-BT
is	O
an	O
efficient	O
algorithm	O
for	O
constructing	O
the	O
quartet	O
graph	O
directly	O
from	O
k	O
gene	O
trees	O
,	O
each	O
on	O
n	O
species	O
.	O

To	O
better	O
understand	O
the	O
amino	O
acid	O
composition	O
of	O
anti	O
-	O
aging	O
peptides	O
,	O
a	O
comparative	O
study	O
was	O
conducted	O
between	O
the	O
AagingBase	B-BT
peptides	O
and	O
other	O
biological	O
peptides	O
obtained	O
from	O
UniProtKB	O
(	O
47	O
).	O

AuCoMe	B-BT
(	O
https	O
://	O
github	O
.	O
com	O
/	O
AuReMe	O
/	O
aucome	B-BT
)	O
is	O
not	O
independent	O
tool	O
,	O
but	O
it	O
is	O
a	O
workflow	O
for	O
the	O
reconstruction	O
of	O
several	O
models	O
,	O
making	O
it	O
possible	O
to	O
compare	O
them	O
with	O
each	O
other	O
.	O

Reference	O
table	O
for	O
sncRNAs	O
type	O
identification	O
in	O
the	O
tinyRNA	B-BT
pipeline	O
.	O

Amount	O
of	O
collagen	O
(	O
B	O
)	O
measured	O
with	O
Sirius	O
red	O
staining	O
and	O
(	O
C	O
)	O
quantified	O
with	O
collagen	O
proportionate	O
area	O
analysis	O
in	O
PCLS	O
after	O
5	O
μM	O
erlotinib	O
treatment	O
for	O
72	O
hours	O
.	O

The	O
data	O
underlying	O
this	O
article	O
are	O
available	O
in	O
this	O
article	O
and	O
its	O
supplementary	O
material	O
,	O
and	O
at	O
https	O
://	O
pypi	O
.	O
org	O
/	O
project	O
/	O
pycomo	B-BT
/.	O

The	O
limit	O
of	O
detection	O
(	O
LoD	O
)	O
of	O
RT	O
-	O
qPCR	O
for	O
assays	O
used	O
for	O
the	O
detection	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
and	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
)	O
was	O
calculated	O
using	O
synthetic	O
RNA	O
transcripts	O
.	O

Theoretical	O
FRET	O
fluorophore	O
distances	O
were	O
calculated	O
from	O
the	O
MD	O
trajectories	O
using	O
FRETpredict52	O
and	O
subsequently	O
fitted	O
with	O
a	O
normal	O
distribution	O
using	O
scipy53	O
.	O

For	O
the	O
MZmine	B-BT
analysis	O
of	O
the	O
GC	O
dataset	O
,	O
two	O
sets	O
of	O
retention	O
times	O
were	O
used	O
,	O
(	O
i	O
)	O
a	O
list	O
with	O
retention	O
times	O
as	O
used	O
by	O
ATS	O
with	O
shifts	O
in	O
the	O
range	O
of	O
−	O
1	O
.	O
1	O
to	O
−	O
0	O
.	O
9	O
min	O
simulating	O
the	O
case	O
of	O
shifted	O
and	O
not	O
optimized	O
analysis	O
conditions	O
and	O
(	O
ii	O
)	O
the	O
same	O
list	O
of	O
analytes	O
but	O
with	O
exact	O
,	O
shift	O
-	O
corrected	O
retention	O
times	O
as	O
used	O
with	O
TF	O
.	O

(	O
A	O
)	O
The	O
role	O
of	O
SpatialCells	B-BT
within	O
downstream	O
analyses	O
.	O

In	O
addition	O
,	O
AuCoMe	B-BT
could	O
also	O
be	O
used	O
to	O
homogenize	O
annotations	O
in	O
several	O
genome	O
versions	O
of	O
the	O
same	O
species	O
or	O
to	O
reconcile	O
several	O
annotations	O
performed	O
on	O
the	O
same	O
genome	O
.	O

In	O
experiments	O
,	O
PermuteDDS	B-BT
exhibits	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
performance	O
on	O
two	O
benchmark	O
data	O
sets	O
.	O

In	O
2023	O
,	O
the	O
percentage	O
of	O
adults	O
aged	O
≥	O
18	O
years	O
who	O
were	O
in	O
families	O
having	O
problems	O
paying	O
medical	O
bills	O
in	O
the	O
past	O
12	O
months	O
was	O
higher	O
among	O
those	O
with	O
disabilities	O
(	O
21	O
.	O
2	O
%)	O
compared	O
with	O
those	O
without	O
disabilities	O
(	O
9	O
.	O
6	O
%).	O

However	O
,	O
we	O
hypothesized	O
that	O
the	O
underlying	O
decussated	O
enamel	O
of	O
its	O
trigon	O
basin	O
would	O
be	O
more	O
complex	O
than	O
it	O
is	O
in	O
the	O
other	O
taxa	O
.	O

As	O
proof	O
of	O
concept	O
,	O
we	O
provide	O
three	O
examples	O
within	O
the	O
scifAI	B-BT
code	O
repository	O
on	O
how	O
to	O
analyze	O
IFC	O
datasets	O
from	O
Jurkat	O
cells	O
(	O
3	O
channels	O
per	O
image	O
)	O
24	O
,	O
white	O
blood	O
cells	O
(	O
12	O
channels	O
)	O
23	O
,	O
and	O
apoptotic	O
cells	O
(	O
2	O
channels	O
)	O
25	O
using	O
scifAI	B-BT
.	O

Thus	O
,	O
the	O
Pfam	O
domain	O
search	O
algorithm	O
has	O
been	O
embedded	O
into	O
the	O
Hmrbase	B-BT
platform	O
.	O

Centrifuger	B-BT
adopts	O
a	O
novel	O
compact	O
data	O
structure	O
,	O
run	O
-	O
block	O
compressed	O
sequence	O
,	O
to	O
achieve	O
sublinear	O
storage	O
space	O
for	O
BWT	O
sequence	O
without	O
sacrificing	O
much	O
time	O
efficiency	O
.	O

The	O
input	O
is	O
a	O
compartmentalized	O
community	O
metabolic	O
model	O
in	O
SBML	O
format	O
,	O
such	O
as	O
generated	O
by	O
PyCoMo	B-BT
(	O
Predl	O
et	O
al	O
.	O

The	O
rNMPID	B-BT
database	O
provides	O
powerful	O
data	O
analysis	O
and	O
highly	O
customizable	O
visualization	O
.	O

4	O
).	O
Table	O
2Risk	O
factors	O
of	O
mortality	O
(	O
univariate	O
model	O
).	O
Table	O
2HR	O
brutIC95	O
%	O
pATBa1	O
.	O
98	O
[	O
0	O
.	O
926	O
;	O
4	O
.	O
23	O
]	O
0	O
.	O
08Age	O
(	O
years	O
)	O
1	O
.	O
009	O
[	O
0	O
.	O
954	O
;	O
1	O
.	O
067	O
]	O
0	O
.	O
7Sex0	O
.	O
5	O
Female	O
(	O
ref	O
)	O
1	O
Male1	O
.	O
205	O
[	O
0	O
.	O
690	O
;	O
2	O
.	O
104	O
]	O
Living	O
place0	O
.	O
2	O
Home	O
(	O
ref	O
)	O
1	O
Nursing	O
home1	O
.	O
549	O
[	O
0	O
.	O
838	O
;	O
2	O
.	O
862	O
]	O
Medications	O
before	O
hospitalization1	O
.	O
005	O
[	O
0	O
.	O
9209	O
;	O
1	O
.	O
096	O
]	O
0	O
.	O
9Charlson	O
Comorbidity	O
Index0	O
.	O
974	O
[	O
0	O
.	O
826	O
;	O
1	O
.	O
148	O
]	O
0	O
.	O
7Infection0	O
.	O
4	O
Community	O
(	O
ref	O
)	O
1	O
Nosocomial0	O
.	O
751	O
[	O
0	O
.	O
362	O
;	O
1	O
.	O
556	O
]	O
MDRDb	O
at	O
admission0	O
.	O
991	O
[	O
0	O
.	O
983	O
;	O
0	O
.	O
999	O
]	O
0	O
.	O
02Corticoids1	O
.	O
449	O
[	O
0	O
.	O
790	O
;	O
2	O
.	O
658	O
]	O
0	O
.	O
2Thromboprophylaxis0	O
.	O
605	O
[	O
0	O
.	O
330	O
;	O
1	O
.	O
111	O
]	O
0	O
.	O
1CRP	O
at	O
admission1	O
.	O
005	O
[	O
1	O
.	O
002	O
;	O
1	O
.	O
008	O
]<	O
0	O
.	O
001Haemoglobin	O
at	O
admission1	O
.	O
118	O
[	O
0	O
.	O
956	O
;	O
1	O
.	O
309	O
]	O
0	O
.	O
2Leucocytes	O
at	O
admission1	O
.	O
115	O
[	O
1	O
.	O
046	O
;	O
1	O
.	O
190	O
]<	O
0	O
.	O
001Saturation	O
at	O
admission0	O
.	O
9162	O
[	O
0	O
.	O
882	O
;	O
0	O
.	O
952	O
]<	O
0	O
.	O
001O2c	O
at	O
entrance1	O
.	O
153	O
[	O
1	O
.	O
094	O
;	O
1	O
.	O
216	O
]<	O
0	O
.	O
001Temperature	O
at	O
admission	O
(°	O
C	O
)	O
1	O
.	O
324	O
[	O
0	O
.	O
975	O
;	O
1	O
.	O
80	O
]	O
0	O
.	O
07p	O
:	O
Wald	O
testaATB	O
:	O
Antibiotics	O
.	O
bMDRD	O
:	O
modification	O
of	O
diet	O
in	O
renal	O
disease	O
.	O
cO2	O
:	O
Oxygen	O
.	O
Fig	O
.	O

In	O
LipidSig	O
2	O
.	O
0	O
,	O
the	O
lipid	O
ID	O
annotation	O
process	O
has	O
been	O
significantly	O
refined	O
and	O
expanded	O
,	O
utilizing	O
data	O
curated	O
from	O
LIPID	O
MAPS	O
,	O
MetaNetX	O
(	O
18	O
),	O
and	O
SwissLipids	O
(	O
19	O
),	O
which	O
comprise	O
28	O
964	O
,	O
792	O
127	O
and	O
775	O
273	O
lipid	O
names	O
with	O
shorthand	O
notations	O
can	O
be	O
recognized	O
by	O
Goslin	B-BT
,	O
respectively	O
.	O

Algorithm	O
1A	O
single	O
iteration	O
of	O
the	O
MaBoSS	B-BT
simulation	O
of	O
a	O
trajectory	O
,	O
given	O
the	O
state	O
S	O
and	O
time	O
t	O
.	O

shaPRS	B-BT
also	O
consistently	O
outperformed	O
PRS	O
-	O
CSx	O
-	O
stage1	O
in	O
these	O
same	O
six	O
studies	O
,	O
with	O
four	O
instances	O
also	O
reaching	O
statistical	O
significance	O
(	O
Table	O
S5	O
),	O
demonstrating	O
its	O
superiority	O
in	O
situations	O
where	O
only	O
a	O
single	O
set	O
of	O
GWAS	O
summary	O
statistics	O
are	O
available	O
for	O
a	O
given	O
proximal	O
population	O
.	O

The	O
aucome	B-BT
orthology	O
command	O
runs	O
the	O
orthology	O
propagation	O
step	O
,	O
which	O
complements	O
the	O
previous	O
GSMNs	O
with	O
GPR	O
associations	O
whose	O
genes	O
are	O
predicted	O
to	O
be	O
orthologs	O
to	O
genes	O
from	O
GPR	O
relations	O
of	O
other	O
GSMNs	O
of	O
the	O
data	O
set	O
(	O
Fig	O
.	O

The	O
GeNLP	B-BT
application	O
offers	O
two	O
primary	O
modes	O
of	O
operation	O
:	O
(	O
i	O
)	O
a	O
static	O
explanatory	O
mode	O
for	O
inspecting	O
the	O
gene	O
embedding	O
space	O
and	O
(	O
ii	O
)	O
a	O
custom	O
predictive	O
mode	O
for	O
querying	O
user	O
-	O
provided	O
data	O
(	O
Fig	O
.	O

In	O
addition	O
to	O
the	O
enrichment	O
of	O
COVID	O
-	O
19	O
-	O
related	O
genes	O
that	O
are	O
consistent	O
with	O
literature	O
,	O
BoostDiff	B-BT
also	O
identified	O
edges	O
between	O
TREX1	O
and	O
IFIT1	O
,	O
IFIT3	O
,	O
IFITM3	O
,	O
ISG15	O
,	O
and	O
OAS3	O
,	O
all	O
of	O
which	O
have	O
been	O
implicated	O
with	O
COVID	O
-	O
19	O
.	O

Table	O
1Ten	O
cases	O
of	O
accidental	O
intra	O
-	O
arterial	O
administration	O
of	O
a	O
medicationCaseCannulation	O
siteAgePlace	O
of	O
occurrence	O
and	O
discoveryMedication	O
involvedClues	O
to	O
discoveryTime	O
from	O
cannulation	O
to	O
discoverySequelaePresumed	O
causes	O
and	O
backgrounds	O
of	O
misplacementPresumed	O
causes	O
and	O
backgrounds	O
of	O
administration1Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
3	O
monthsPICUMidazolam	O
,	O
morphine	O
,	O
5	O
%	O
glucosePulsatile	O
flashback	O
within	O
IV	O
tube7	O
h	O
50	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
US	O
-	O
guided	O
peripheral	O
venous	O
access	O
,	O
judgement	O
errorPoor	O
flashback	O
at	O
the	O
start	O
of	O
administration	O
,	O
non	O
-	O
bright	O
-	O
red	O
flash	O
of	O
blood	O
at	O
cannulation	O
,	O
use	O
of	O
infusion	O
pump2Subclavian	O
artery	O
(	O
left	O
)	O
27	O
daysNICUHeparin	O
,	O
5	O
%	O
glucose	O
,	O
normal	O
salineContrast	O
-	O
enhanced	O
CT26	O
days	O
,	O
2	O
h	O
22	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
PI	O
catheter	O
,	O
trisomy	O
18	O
,	O
VLBWMisdiagnosis	O
from	O
X	O
-	O
ray	O
(	O
diagnosed	O
as	O
PI	O
in	O
the	O
subclavian	O
vein	O
)	O
3Ulnar	O
artery	O
(	O
branch	O
)	O
(	O
left	O
)	O
4	O
years	O
5	O
monthsWard	O
,	O
ORFentanyl	O
,	O
rocuronium	O
,	O
phenylephrine	O
,	O
propofol	O
,	O
lidocaine	O
,	O
5	O
%	O
glucose	O
-	O
acetated	O
Ringer	O
'	O
sPulsatile	O
flashback	O
within	O
IV	O
tube	O
confirmed	O
by	O
BGA17	O
h	O
49	O
minNo	O
deficitNormal	O
vascular	O
anatomic	O
proximity	O
,	O
lack	O
of	O
anatomical	O
knowledgeConfirmation	O
of	O
free	O
IV	O
drip	O
at	O
the	O
start	O
of	O
administration	O
,	O
non	O
-	O
pulsatile	O
flashback	O
at	O
the	O
start	O
of	O
administration	O
,	O
no	O
resistance	O
to	O
drug	O
administration	O
in	O
the	O
use	O
of	O
infusion	O
pump4Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
2	O
yearsORFentanyl	O
,	O
remifentanil	O
,	O
propofol	O
,	O
rocuronium	O
,	O
atropine	O
sulfate	O
,	O
cefazolin	O
,	O
5	O
%	O
glucose	O
-	O
acetated	O
Ringer	O
’	O
sAbsence	O
of	O
free	O
IV	O
drip	O
confirmed	O
by	O
BGA2	O
h	O
23	O
mNo	O
deficitDifficult	O
IV	O
access	O
,	O
overconfidenceConfirmation	O
of	O
free	O
IV	O
drip	O
at	O
the	O
start	O
of	O
administration	O
,	O
non	O
-	O
pulsatile	O
flashback	O
at	O
start	O
of	O
administration	O
,	O
backflow	O
prevention	O
valve	O
on	O
IV	O
line5Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
8	O
years	O
3	O
monthsWardMaintenance	O
intravenous	O
fluidAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube53	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
US	O
-	O
guided	O
peripheral	O
venous	O
access	O
,	O
heparin	O
lock	O
immediately	O
after	O
cannulationConfirmation	O
of	O
free	O
IV	O
drip	O
before	O
drug	O
administration	O
IV	O
line	O
locked	O
with	O
heparin	O
before	O
administration6Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
7	O
mWardVancomycin	O
,	O
maintenance	O
IV	O
solutionPulsatile	O
flashback	O
within	O
IV	O
tube60	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
normal	O
vascular	O
anatomical	O
proximity	O
,	O
overconfidence	O
,	O
premature	O
closureNon	O
-	O
pulsatile	O
flashback	O
at	O
the	O
start	O
of	O
administration	O
,	O
poor	O
flashback	O
at	O
the	O
start	O
of	O
administration7Radial	O
artery	O
(	O
right	O
)	O
5	O
years	O
7	O
monthsER	O
,	O
wardAmpicillin	O
,	O
5	O
%	O
glucose	O
-	O
acetated	O
Ringer	O
’	O
sPulsatile	O
flashback	O
within	O
IV	O
tube	O
,	O
skin	O
discoloration	O
around	O
cannulation	O
site16	O
h	O
23	O
minNo	O
deficitNormal	O
vascular	O
anatomic	O
proximity	O
,	O
lack	O
of	O
anatomical	O
knowledge	O
,	O
overconfidence	O
,	O
premature	O
closureRecognition	O
of	O
free	O
IV	O
drip	O
at	O
the	O
start	O
of	O
administration8Dorsalis	O
pedis	O
artery	O
(	O
right	O
)	O
3	O
monthsWard	O
,	O
ORMaintenance	O
intravenous	O
fluidAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube1	O
h	O
25	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
judgement	O
error	O
,	O
overconfidenceSmooth	O
injection	O
without	O
resistance	O
,	O
backflow	O
prevention	O
valve	O
on	O
IV	O
line9Dorsalis	O
pedis	O
artery	O
(	O
right	O
)	O
4	O
years	O
11	O
monthsWardGentamicin	O
,	O
maintenance	O
intravenous	O
fluid	O
,	O
normal	O
salineAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube1	O
day	O
,	O
14	O
h	O
15	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
cannulation	O
in	O
a	O
dark	O
roomZebra	O
retreat	O
,	O
overconfidence	O
(	O
intra	O
-	O
arterial	O
cannulation	O
was	O
recognized	O
as	O
a	O
rare	O
event	O
)	O
10Anterior	O
tibial	O
artery	O
(	O
left	O
)	O
13	O
years	O
8	O
monthsPrevious	O
center	O
,	O
ERMidazolam	O
,	O
rocuronium	O
,	O
normal	O
salineAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube4	O
h	O
22	O
minNo	O
deficitDifficult	O
IV	O
accessIV	O
line	O
established	O
in	O
previous	O
medical	O
center	O
,	O
lack	O
of	O
confirmation	O
,	O
failure	O
to	O
checkAbbreviations	O
:	O
OR	O
Operating	O
room	O
,	O
ER	O
Emergency	O
room	O
,	O
US	O
Ultrasound	O
,	O
PI	O
Peripherally	O
inserted	O
central	O
catheter	O
,	O
IV	O
Intravenous	O
flashback	O
,	O
regurgitant	O
blood	O
flow	O
from	O
cannula	O
,	O
BGA	O
Blood	O
gas	O
analysis	O

We	O
have	O
made	O
EmbedPVP	B-BT
freely	O
available	O
as	O
a	O
Python	O
package	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
bio	O
-	O
ontology	O
-	O
research	O
-	O
group	O
/	O
EmbedPVP	B-BT
.	O

Similar	O
to	O
our	O
other	O
software	O
MerCat2	B-BT
for	O
massively	O
parallel	O
processing	O
(	O
MPP	O
),	O
it	O
utilizes	O
a	O
byte	O
chunking	O
algorithm	O
1	O
(‘	O
Chunker	O
’)	O
to	O
split	O
files	O
for	O
MPP	O
for	O
further	O
utilization	O
in	O
RAY	O
,	O
a	O
massive	O
open	O
-	O
source	O
parallel	O
computing	O
framework	O
to	O
scale	O
Python	O
applications	O
and	O
workflows	O
(	O
Figueroa	O
III	O
et	O
al	O
.	O

1The	O
framework	O
of	O
m6A	B-BT
-	I-BT
TCPred	I-BT
.	O

All	O
genomes	O
were	O
annotated	O
in	O
the	O
Integrated	B-BT
Microbial	I-BT
Genomes	I-BT
(	I-BT
IMG	I-BT
)	I-BT
database	O
(≥	O
IMG	O
Annotation	O
Pipeline	O
v	O
.	O
5	O
.	O
0	O
.	O
19	O
)	O
(	O
19	O
).	O

Carrot	O
motley	O
dwarf	O
(	O
CMD	O
)	O
is	O
a	O
viral	O
disease	O
complex	O
caused	O
by	O
co	O
-	O
infection	O
of	O
the	O
polerovirus	O
carrot	O
red	O
leaf	O
virus	O
with	O
the	O
umbraviruses	O
carrot	O
mottle	O
virus	O
or	O
carrot	O
mottle	O
mimic	O
virus	O
,	O
and	O
/	O
or	O
a	O
tombusvirus	O
like	O
associated	O
RNA	O
(	O
tlaRNA	O
),	O
which	O
depend	O
on	O
co	O
-	O
infection	O
with	O
a	O
helper	O
polerovirus	O
to	O
gain	O
aphid	O
transmissibility	O
.	O

Higher	O
peaks	O
and	O
brighter	O
colours	O
(	O
e	O
.	O
g	O
.,	O
red	O
and	O
yellow	O
)	O
indicate	O
regions	O
of	O
greater	O
surface	O
roughness	O
and	O
more	O
pronounced	O
corrosion	O
damage	O
,	O
while	O
lower	O
peaks	O
and	O
cooler	O
colours	O
(	O
e	O
.	O
g	O
.,	O
purple	O
and	O
blue	O
)	O
suggest	O
smoother	O
surfaces	O
with	O
less	O
corrosion	O
.	O

In	O
this	O
work	O
,	O
we	O
introduce	O
scNovel	B-BT
,	O
a	O
powerful	O
deep	O
learning	O
-	O
based	O
neural	O
network	O
that	O
specifically	O
focuses	O
on	O
novel	O
rare	O
cell	O
discovery	O
.	O

Jalview	B-BT
v2	O
.	O
11	O
.	O
2	O
.	O
0	O
(	O
Waterhouse	O
et	O
al	O
.,	O
2009	O
)	O

Yanhua	O
Song	O
,	O
Wei	O
Shu	O
,	O
Yi	O
Pei	O
,	O
Juan	O
Du	O
,	O
Guihui	O
Wu	O
and	O
Hua	O
Wang	O
contributed	O
equally	O
to	O
this	O
work	O
.	O

Drafting	O
of	O
the	O
manuscript	O
:	O
Ricardo	O
Noguera	O
Louzada	O
,	O
Dillan	O
Cunha	O
Amaral	O
,	O
Claudio	O
do	O
Carmo	O
Chaves	O
Filho	O
,	O
Daniel	O
Oliveira	O
Dantas	O
,	O
Francisco	O
Carlos	O
de	O
Castro	O
Neto	O
,	O
Milton	O
Ruiz	O
Alves	O

The	O
445	O
identified	O
proteins	O
were	O
searched	O
against	O
the	O
SubtiWiki	B-BT
and	O
UniProt	O
B	O
.	O

Similarly	O
,	O
scPrisma	B-BT
,	O
a	O
spectral	O
template	O
-	O
matching	O
method	O
,	O
was	O
recently	O
proposed	O
for	O
the	O
inference	O
,	O
filtering	O
or	O
enhancement	O
of	O
underlying	O
signals	O
based	O
on	O
prior	O
knowledge	O
of	O
their	O
structure	O
(	O
such	O
as	O
the	O
cyclic	O
structure	O
of	O
the	O
cell	O
cycle	O
)	O
16	O
.	O

We	O
consider	O
this	O
as	O
reasonable	O
costs	O
for	O
a	O
small	O
testbed	O
and	O
it	O
should	O
allow	O
other	O
research	O
groups	O
to	O
replicate	O
our	O
testbed	O
.	O
Table	O
3	O
.	O
BACnet	O
components	O
used	O
in	O
our	O
testbed	O
.	O
VendorProductBACnet	O
profileApproximate	O
costKMCBAC	O
-	O
5050Router	O
$	O
1	O
.	O
000	O
USDKMCFlexStat	O
BAC	O
-	O
131136CEWB	O
-	O
ASC	O
$	O
1	O
.	O
000	O
USDMBSBACeye	O
version	O
2	O
.	O
1	O
.	O
0	O
.	O
15B	O
-	O
OWS	O
$	O
500	O
USDJanitzaUMG	O
604	O
-	O
PROB	O
-	O
SA	O
$	O
1	O
.	O
000	O
USD	O

The	O
precisions	O
(%)	O
of	O
DeepTMP	O
,	O
CDPred	B-BT
,	O
DeepHomo2	O
.	O
0	O
,	O
GLINTER	O
,	O
DeepHomo	O
,	O
and	O
DNCON2_Inter	O
are	O
based	O
on	O
the	O
test	O
set	O
of	O
52	O
transmembrane	O
protein	O
complexes	O
when	O
the	O
experimental	O
monomer	O
structures	O
(	O
predicted	O
monomer	O
structures	O
by	O
AlphaFold2	O
)	O
are	O
used	O
as	O
input	O
.	O

The	O
C	O
API	O
of	O
HTSlib	B-BT
(	O
Bonfield	O
et	O
al	O
.	O

ABDpred	B-BT
server	O
is	O
also	O
capable	O
to	O
check	O
the	O
information	O
on	O
the	O
drugability	O
and	O
bioavailability	O
of	O
the	O
input	O
chemicals	O
.	O

In	O
response	O
to	O
the	O
Supreme	O
Court	O
’	O
s	O
directive	O
to	O
prevent	O
discrimination	O
against	O
LGBTQ	O
+	O
individuals	O
,	O
policymakers	O
are	O
also	O
urged	O
to	O
enact	O
laws	O
explicitly	O
prohibiting	O
it	O
across	O
various	O
domains	O
of	O
society	O
,	O
with	O
health	O
and	O
social	O
care	O
crucial	O
among	O
them	O
.	O

Functional	O
Enrichment	O
Analysis	O
(	O
FEA	O
)	O
was	O
performed	O
using	O
Subtiwiki	B-BT
functional	O
categories	O
.	O

•	O
Trans	B-BT
-	I-BT
PCO	I-BT
outperforms	O
existing	O
methods	O
by	O
finding	O
more	O
high	O
-	O
quality	O
trans	O
-	O
eQTLs	O
•	O
Trans	B-BT
-	I-BT
PCO	I-BT
offers	O
a	O
map	O
of	O
trans	O
regulation	O
of	O
gene	O
networks	O
and	O
biological	O
processes	O
•	O
Functional	O
annotation	O
of	O
gene	O
modules	O
helps	O
functional	O
interpretation	O
of	O
trans	O
signals	O
•	O
Trans	O
effects	O
via	O
regulatory	O
networks	O
and	O
pathways	O
reveal	O
the	O
mechanism	O
of	O
trait	O
loci	O

This	O
result	O
suggested	O
PHARE	B-BT
captured	O
aging	O
-	O
accelerated	O
features	O
,	O
which	O
can	O
help	O
assess	O
the	O
impact	O
of	O
treatment	O
.	O

By	O
contrast	O
,	O
ITHANET	B-BT
(	O
https	O
://	O
www	O
.	O
ithanet	B-BT
.	O
eu	O
/;	O
accessed	O
on	O
17	O
April	O
2024	O
)	O
is	O
a	O
web	O
portal	O
initially	O
conceived	O
specifically	O
for	O
hemoglobinopathies	O
,	O
which	O
,	O
as	O
of	O
this	O
writing	O
,	O
holds	O
in	O
its	O
databases	O
sequence	O
and	O
functional	O
annotation	O
for	O
3462	O
variants	O
in	O
538	O
genes	O
.	O

That	O
said	O
,	O
if	O
users	O
wish	O
to	O
create	O
a	O
more	O
customised	O
workflow	O
that	O
diverges	O
from	O
the	O
rworkflows	B-BT
action	O
(	O
and	O
only	O
use	O
it	O
as	O
an	O
initial	O
basis	O
for	O
their	O
script	O
),	O
a	O
full	O
workflow	O
version	O
can	O
be	O
created	O
with	O
rworkflows	B-BT
::	O
use_workflow	O
(	O
name	O
=”	O
rworkflows_static	B-BT
”),	O
which	O
offers	O
functionality	O
analogous	O
to	O
that	O
of	O
biocthis	O
.	O

scalepopgen	B-BT
is	O
mainly	O
developed	O
using	O
the	O
Nextflow	O
workflow	O
management	O
system	O
(	O
Di	O
Tommaso	O
et	O
al	O
.	O

The	O
peptide	O
report	O
is	O
then	O
used	O
as	O
input	O
to	O
CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
,	O
without	O
a	O
need	O
for	O
the	O
protein	O
table	O
(	O
Supplemental	O
Fig	O
.	O

The	O
open	O
-	O
source	O
program	O
RmsiGUI	B-BT
integrates	O
the	O
control	O
of	O
a	O
robotic	O
imaging	O
platform	O
and	O
the	O
compilation	O
of	O
imzML	O
[	O
83	O
].	O

There	O
has	O
been	O
a	O
recent	O
uptick	O
in	O
using	O
DL	O
techniques	O
to	O
assess	O
insider	O
threats	O
.	O

We	O
again	O
used	O
the	O
domain2Pfam	O
and	O
domain2GO	B-BT
annotation	O
schemes	O
to	O
search	O
for	O
homologous	O
regions	O
and	O
biological	O
roles	O
associated	O
with	O
maximum	O
height	O
(	O
log10	O
transformed	O
values	O
used	O
as	O
QVALs	O
).	O

Thereafter	O
,	O
PASTEClassifier	B-BT
(	O
pseudo	O
agent	O
system	O
for	O
transposable	O
elements	O
classification	O
)	O
[	O
28	O
]	O
was	O
used	O
to	O
classify	O
transposable	O
elements	O
and	O
repetitive	O
sequences	O
to	O
generate	O
a	O
database	O
that	O
was	O
subsequently	O
combined	O
with	O
the	O
Repbase	O
database	O
[	O
29	O
]	O
to	O
create	O
the	O
final	O
repeat	O
sequence	O
database	O
utilized	O
here	O
.	O

The	O
present	O
systematic	O
review	O
found	O
“	O
breakfast	O
skipper	O
”	O
as	O
the	O
most	O
commonly	O
investigated	O
pattern	O
of	O
unhealthy	O
diet	O
,	O
and	O
as	O
well	O
,	O
the	O
meta	O
-	O
analysis	O
part	O
reported	O
a	O
pooled	O
prevalence	O
of	O
28	O
%	O
for	O
unhealthy	O
diet	O
among	O
the	O
Iranian	O
students	O
.	O

We	O
thank	O
the	O
Nîmes	O
University	O
hospital	O
for	O
its	O
structural	O
,	O
human	O
and	O
financial	O
support	O
through	O
the	O
award	O
obtained	O
by	O
our	O
team	O
during	O
the	O
internal	O
call	O
for	O
tenders	O
«	O
Thématiques	O
phares	O
».	O

EmbedPVP	B-BT
is	O
not	O
the	O
first	O
approach	O
that	O
uses	O
ontology	O
semantics	O
in	O
detecting	O
genotype	O
–	O
phenotype	O
relations	O
;	O
in	O
particular	O
semantic	O
similarity	O
measures	O
have	O
been	O
used	O
for	O
a	O
long	O
time	O
to	O
predict	O
gene	O
–	O
disease	O
associations	O
(	O
Köhler	O
et	O
al	O
.	O

Concept	O
and	O
design	O
:	O
Ricardo	O
Noguera	O
Louzada	O
,	O
Dillan	O
Cunha	O
Amaral	O
,	O
Claudio	O
do	O
Carmo	O
Chaves	O
Filho	O
,	O
Daniel	O
Oliveira	O
Dantas	O
,	O
Francisco	O
Carlos	O
de	O
Castro	O
Neto	O
,	O
Milton	O
Ruiz	O
Alves	O

Then	O
approximately	O
0	O
.	O
05	O
g	O
of	O
freeze	O
-	O
dried	O
petals	O
were	O
pulverized	O
in	O
liquid	O
nitrogen	O
,	O
extracted	O
with	O
1	O
mL	O
of	O
extracting	O
solution	O
(	O
99	O
.	O
8	O
:	O
0	O
.	O
2	O
,	O
v	O
/	O
v	O
,	O
methanol	O
:	O
formic	O
acid	O
)	O
in	O
a	O
test	O
tube	O
,	O
sonicated	O
with	O
KQ	O
-	O
500DE	O
ultrasonic	O
cleaner	O
(	O
Ultrasonic	O
instruments	O
,	O
Jiangsu	O
Kunshan	O
,	O
China	O
)	O
at	O
20	O
°	O
C	O
for	O
20	O
min	O
,	O
and	O
then	O
centrifuged	O
in	O
SIGMA	O
3K30	O
(	O
SIGMA	O
centrifuger	O
,	O
Germany	O
)	O
with	O
10	O
,	O
000	O
g	O
for	O
10	O
min	O
.	O

To	O
reduce	O
the	O
ocean	O
-	O
scale	O
variance	O
,	O
we	O
selected	O
the	O
population	O
of	O
the	O
stHK	O
,	O
which	O
were	O
sampled	O
at	O
the	O
SPacO_3	O
station	O
(	O
Supplementary	O
Tables	O
1	O
and	O
6	O
)	O
to	O
make	O
comparisons	O
of	O
means	O
and	O
particularly	O
variances	O
with	O
the	O
clonal	O
isolates	O
of	O
P	O
.	O

For	O
instance	O
,	O
ExtraTrees	O
achieved	O
highly	O
accurate	O
on	O
the	O
TKI	O
dataset	O
when	O
training	O
on	O
the	O
subset	O
of	O
MdrDB_CoreSet	B-BT
with	O
low	O
absolute	O
errors	O
(	O
RMSE	O
=	O
0	O
.	O
656	O
kcal	O
mol	O
−	O
1	O
),	O
strong	O
correlation	O
(	O
Pearson	O
=	O
0	O
.	O
607	O
),	O
and	O
good	O
classification	O
performance	O
(	O
AUPRC	O
=	O
0	O
.	O
538	O
).	O

Since	O
there	O
are	O
many	O
molecular	O
fingerprints	O
available	O
in	O
cheminformatics	O
and	O
new	O
ones	O
can	O
be	O
created	O
for	O
a	O
collection	O
of	O
chemical	O
structures	O
,	O
IDSL_MINT	B-BT
supports	O
any	O
type	O
of	O
user	O
-	O
provided	O
fingerprint	O
as	O
long	O
as	O
it	O
is	O
in	O
the	O
binary	O
vector	O
format	O
.	O

Raw	O
images	O
and	O
segmented	O
single	O
-	O
cell	O
crops	O
associated	O
with	O
PIFiA	B-BT
are	O
available	O
for	O
download	O
at	O
https	O
://	O
thecellvision	O
.	O
org	O
/	O
pifia_files	B-BT
.	O

scDREAMER	B-BT
-	O
Sup	O
was	O
further	O
able	O
to	O
capture	O
rare	O
cell	O
identities	O
very	O
well	O
as	O
indicated	O
by	O
its	O
top	O
performance	O
in	O
terms	O
of	O
isolated	O
f1	O
score	O
(	O
Supplementary	O
Figs	O
.	O

More	O
expensive	O
amberjack	O
or	O
snapper	O
were	O
less	O
well	O
represented	O
.	O

We	O
performed	O
gene	O
expression	O
analysis	O
of	O
the	O
identified	O
StSET	O
genes	O
across	O
fifteen	O
tissues	O
using	O
the	O
expression	O
data	O
available	O
in	O
the	O
StCoExpNet	B-BT
database	O
[	O
37	O
].	O

Despite	O
the	O
convenience	O
of	O
automated	O
and	O
default	O
settings	O
in	O
PAPipe	B-BT
,	O
some	O
default	O
parameters	O
are	O
not	O
appropriate	O
for	O
specific	O
analyses	O
.	O

Definition	O
of	O
abbreviations	O
:	O
ARDS	O
=	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
Δ	O
=	O
Changes	O
;	O
OI	O
=	O
Oxygenation	O
Index	O
;	O
PCaO2	O
=	O
carbon	O
dioxide	O
arterial	O
partial	O
pressure	O
;	O
Q	O
˙	O
s	O
/	O
Q	O
˙	O
t	O
=	O
fraction	O
of	O
pulmonary	O
shunt	O
to	O
cardiac	O
output	O
;	O
Crs	O
=	O
compliance	O
respiratory	O
system	O
.	O

RNAscape	B-BT
output	O
preserves	O
the	O
L	O
-	O
shaped	O
topology	O
(	O
as	O
opposed	O
to	O
known	O
‘	O
clover	O
leaf	O
’	O
shaped	O
secondary	O
structure	O
(	O
26	O
)	O
visualizations	O
)	O
and	O
annotates	O
non	O
-	O
standard	O
bases	O
and	O
base	O
-	O
pairing	O
geometries	O
(	O
critical	O
in	O
many	O
RNA	O
interactions	O
(	O
27	O
)).	O

1A	O
Amino	O
acid	O
sequence	O
alignment	O
of	O
equine	O
TK1	O
isoforms	O
with	O
human	O
TK1	O
using	O
the	O
Clustal	O
Omega	O
algorithm	O
(	O
https	O
://	O
www	O
.	O
ebi	O
.	O
ac	O
.	O
uk	O
/	O
Tools	O
/	O
msa	O
/	O
clustalo	O
/)	O
and	O
structural	O
alignment	O
using	O
ENDscript	B-BT
2	I-BT
.	I-BT
0	I-BT
software	O
(	O
http	O
://	O
endscript	O
.	O
ibcp	O
.	O
fr	O
/	O
ESPript	O
/	O
cgi	O
-	O
bin	O
/	O
ENDscript	O
.	O
cgi	O
)	O
with	O
the	O
human	O
TK1	O
structure	O
as	O
the	O
template	O
.	O

FlexStat	B-BT
provides	O
users	O
with	O
convenient	O
options	O
to	O
download	O
protein	O
matrices	O
at	O
various	O
stages	O
of	O
processing	O
and	O
analysis	O
.	O

These	O
metrics	O
have	O
also	O
been	O
used	O
to	O
demonstrate	O
some	O
properties	O
of	O
the	O
domain2Pfam	O
and	O
domain2GO	B-BT
annotations	O
.	O

(	O
2	O
)	O
In	O
terms	O
of	O
state	O
time	O
perspective	O
,	O
depressed	O
adolescents	O
showed	O
a	O
significantly	O
higher	O
number	O
of	O
squares	O
related	O
to	O
past	O
negative	O
,	O
present	O
negative	O
,	O
and	O
future	O
negative	O
in	O
their	O
nine	O
-	O
grid	O
sandplay	O
productions	O
compared	O
to	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O
Conversely	O
,	O
they	O
had	O
significantly	O
fewer	O
squares	O
associated	O
with	O
past	O
positive	O
,	O
present	O
positive	O
,	O
future	O
positive	O
than	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

2	O
.	O
7	O
)	O
pandas	O
commands	O
and	O
the	O
MatchMiner	B-BT
ingestion	O
date	O
to	O
consent	O
date	O
time	O
period	O
was	O
analyzed	O
for	O
MMC	O
and	O
non	O
-	O
MMC	O
using	O
a	O
two	O
-	O
tailed	O
Wilcoxon	O
rank	O
sum	O
test	O
with	O
R	O
gtsummary51	O
,	O
52	O
.	O

This	O
implies	O
that	O
the	O
observed	O
discrepancies	O
in	O
haplotype	O
frequencies	O
as	O
identified	O
by	O
PHARE	B-BT
and	O
the	O
frequency	O
of	O
NF54	O
in	O
the	O
original	O
sample	O
may	O
not	O
be	O
attributed	O
to	O
the	O
PHARE	B-BT
pipeline	O
.	O

First	O
,	O
the	O
version	O
of	O
TREE	B-BT
-	I-BT
QMC	I-BT
presented	O
here	O
requires	O
binary	O
gene	O
trees	O
as	O
input	O
.	O

The	O
Open	O
LabBot	O
and	O
its	O
control	O
software	O
RmsiGUI	B-BT
were	O
released	O
as	O
a	O
community	O
development	O
kit	O
[	O
19	O
].	O

Regarding	O
the	O
modified	O
workflow	O
of	O
TACCO	B-BT
,	O
we	O
modified	O
the	O
cost	O
matrix	O
for	O
optimal	O
transport	O
.	O

In	O
addition	O
to	O
the	O
tools	O
outlined	O
above	O
for	O
studying	O
bnAb	O
reactivity	O
,	O
strain	O
sensitivity	O
,	O
and	O
bnAb	O
cross	O
-	O
sensitivity	O
,	O
several	O
graphical	O
interfaces	O
are	O
available	O
including	O
heatmaps	O
generated	O
for	O
clustering	O
selected	O
sets	O
of	O
HIV	O
-	O
1	O
strains	O
and	O
antibodies	O
,	O
pairwise	O
and	O
multiple	O
sequence	O
alignment	O
tools	O
with	O
output	O
displayed	O
in	O
a	O
standard	O
HIResist	B-BT
format	O
,	O
and	O
visualization	O
of	O
resistance	O
/	O
sensitivity	O
signatures	O
of	O
HIV	O
-	O
1	O
Envs	O
.	O

Layout	O
overview	O
of	O
PIFiA	B-BT
results	O
page	O
.	O

The	O
outputs	O
include	O
both	O
per	O
-	O
cell	O
MetaTiME	B-BT
MeC	O
signature	O
scores	O
and	O
per	O
-	O
cluster	O
enriched	O
MeC	O
state	O
.	O

In	O
this	O
analysis	O
,	O
we	O
found	O
that	O
complicated	O
hypertension	O
,	O
diabetes	O
with	O
chronic	O
complications	O
,	O
tobacco	O
use	O
disorder	O
,	O
hyperlipidemia	O
,	O
and	O
uncomplicated	O
hypertension	O
had	O
varying	O
associations	O
with	O
TACCO	O
.	O

FRETpredict	B-BT
consists	O
of	O
two	O
main	O
routines	O
:	O
rotamer	O
library	O
generation	O
(	O
a	O
,	O
b	O
)	O
and	O
FRET	O
efficiency	O
calculation	O
(	O
c	O
,	O
d	O
).	O

Consequently	O
,	O
the	O
time	O
per	O
stitch	O
also	O
increases	O
,	O
showing	O
results	O
of	O
3	O
.	O
4	O
±	O
2	O
.	O
0	O
mm	O
with	O
a	O
greater	O
time	O
investment	O
for	O
nerve	O
transfers	O
and	O
TMR	O
.	O

To	O
illustrate	O
its	O
practical	O
application	O
,	O
we	O
apply	O
DeePhys	B-BT
to	O
human	O
induced	O
pluripotent	O
stem	O
cell	O
–	O
derived	O
dopaminergic	O
neurons	O
obtained	O
from	O
both	O
patients	O
and	O
healthy	O
individuals	O
and	O
showcase	O
how	O
DeePhys	B-BT
enables	O
phenotypic	O
screenings	O
.	O

IthaPhen	O
and	O
all	O
associated	O
data	O
are	O
available	O
via	O
a	O
web	O
interface	O
at	O
https	O
://	O
ithanet	B-BT
.	O
eu	O
/	O
db	O
/	O
ithaphen	O
.	O

CF4	O
calculates	O
the	O
complete	O
ratio	O
between	O
the	O
sum	O
of	O
natural	O
abundance	O
isotopologues	O
and	O
the	O
sum	O
of	O
95	O
%	O
13C	O
isotopologues	O
,	O
in	O
contrast	O
to	O
considering	O
only	O
the	O
monoisotopic	O
peak	O
in	O
each	O
envelope	O
of	O
isotopologues	O
when	O
using	O
MZmine	B-BT
.	O

Other	O
methods	O
either	O
failed	O
to	O
integrate	O
between	O
labs	O
or	O
batches	O
effectively	O
(	O
AutoClass	O
,	O
CLEAR	O
,	O
scANVI	O
,	O
scVI	O
,	O
and	O
Scanorama	O
)	O
or	O
,	O
in	O
doing	O
so	O
,	O
did	O
not	O
preserve	O
the	O
biological	O
information	O
by	O
mixing	O
cell	O
types	O
(	O
Harmony	O
and	O
Seurat	O
),	O
location	O
information	O
(	O
scGen	O
),	O
or	O
both	O
(	O
scDREAMER	B-BT
)	O
(	O
Fig	O
.	O

Following	O
the	O
partitioning	O
,	O
SpatialCells	B-BT
can	O
enumerate	O
cell	O
types	O
within	O
each	O
tissue	O
subregion	O
for	O
detailed	O
compositional	O
analysis	O
.	O

After	O
CYP	O
induction	O
with	O
rifampicin	O
,	O
a	O
significant	O
change	O
of	O
AUC	O
ratios	O
was	O
observed	O
for	O
all	O
CYP	O
isoforms	O
except	O
for	O
CYP2C9	O
,	O
where	O
the	O
losartan	O
:	O
E3174	O
AUC	O
ratio	O
did	O
not	O
adequately	O
reflect	O
induced	O
CYP	O
activity	O
.	O
Table	O
1AUC	O
ratios	O
and	O
metabolic	O
ratios	O
after	O
administration	O
of	O
cocktail	O
probe	O
drugs	O
with	O
and	O
without	O
inhibitors	O
and	O
inducerCYPMetricTime	O
(	O
h	O
)	O
Cocktail	O
aloneCocktail	O
+	O
inhibitorsCocktail	O
+	O
inducer1A2AUC24par	O
/	O
AUC24caf0	O
.	O
63	O
(	O
0	O
.	O
58	O
–	O
0	O
.	O
71	O
)	O
0	O
.	O
38	O
(	O
0	O
.	O
35	O
–	O
0	O
.	O
45	O
)***	O
0	O
.	O
64	O
(	O
0	O
.	O
59	O
–	O
0	O
.	O
70	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
20	O
.	O
32	O
(	O
0	O
.	O
29	O
–	O
0	O
.	O
38	O
)	O
0	O
.	O
13	O
(	O
0	O
.	O
11	O
–	O
0	O
.	O
20	O
)***	O
b	O
0	O
.	O
38	O
(	O
0	O
.	O
35	O
–	O
0	O
.	O
44	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
40	O
.	O
46	O
(	O
0	O
.	O
41	O
–	O
0	O
.	O
55	O
)	O
0	O
.	O
21	O
(	O
0	O
.	O
18	O
–	O
0	O
.	O
27	O
)***	O
0	O
.	O
57	O
(	O
0	O
.	O
52	O
–	O
0	O
.	O
64	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
60	O
.	O
64	O
(	O
0	O
.	O
58	O
–	O
0	O
.	O
79	O
)	O
0	O
.	O
30	O
(	O
0	O
.	O
26	O
–	O
0	O
.	O
38	O
)***	O
a	O
0	O
.	O
78	O
(	O
0	O
.	O
72	O
–	O
0	O
.	O
89	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
80	O
.	O
80	O
(	O
0	O
.	O
71	O
–	O
0	O
.	O
97	O
)	O
0	O
.	O
39	O
(	O
0	O
.	O
35	O
–	O
0	O
.	O
49	O
)***	O
0	O
.	O
96	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
13	O
)***	O
a	O
2B6AUC24efa	O
/	O
AUC24OH	O
-	O
efa41	O
.	O
7	O
(	O
37	O
.	O
9	O
–	O
48	O
.	O
2	O
)	O
73	O
.	O
9	O
(	O
62	O
.	O
2	O
–	O
99	O
.	O
1	O
)***	O
21	O
.	O
1	O
(	O
19	O
.	O
7	O
–	O
23	O
.	O
2	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
223	O
.	O
7	O
(	O
21	O
.	O
1	O
–	O
29	O
.	O
0	O
)	O
51	O
.	O
2	O
(	O
43	O
.	O
3	O
–	O
70	O
.	O
0	O
)***	O
b	O
12	O
.	O
8	O
(	O
10	O
.	O
7	O
–	O
15	O
.	O
0	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
438	O
.	O
7	O
(	O
34	O
.	O
8	O
–	O
48	O
.	O
5	O
)	O
84	O
.	O
1	O
(	O
71	O
.	O
9	O
–	O
115	O
.	O
0	O
)***	O
19	O
.	O
3	O
(	O
17	O
.	O
9	O
–	O
21	O
.	O
3	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
643	O
.	O
7	O
(	O
39	O
.	O
5	O
–	O
51	O
.	O
3	O
)	O
77	O
.	O
6	O
(	O
69	O
.	O
3	O
–	O
94	O
.	O
2	O
)***	O
a	O
23	O
.	O
1	O
(	O
21	O
.	O
3	O
–	O
25	O
.	O
7	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
853	O
.	O
2	O
(	O
47	O
.	O
8	O
–	O
62	O
.	O
6	O
)	O
88	O
.	O
7	O
(	O
79	O
.	O
7	O
–	O
108	O
.	O
0	O
)***	O
27	O
.	O
7	O
(	O
26	O
.	O
0	O
–	O
30	O
.	O
8	O
)***	O
a	O
2C9AUClos	O
/	O
AUCE31740	O
.	O
09	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
15	O
)	O
0	O
.	O
24	O
(	O
0	O
.	O
19	O
–	O
0	O
.	O
41	O
)***	O
0	O
.	O
07	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
11	O
)	O
nsa	O
[	O
los	O
]/[	O
E3174	O
]	O
21	O
.	O
18	O
(	O
1	O
.	O
17	O
–	O
2	O
.	O
99	O
)	O
3	O
.	O
39	O
(	O
2	O
.	O
66	O
–	O
4	O
.	O
62	O
)	O
nsf	O
0	O
.	O
44	O
(	O
0	O
.	O
37	O
–	O
0	O
.	O
96	O
)**	O
b	O
[	O
los	O
]/[	O
E3174	O
]	O
40	O
.	O
17	O
(	O
0	O
.	O
14	O
–	O
0	O
.	O
37	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
03	O
–	O
2	O
.	O
09	O
)***	O
0	O
.	O
08	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
16	O
)**	O
a	O
[	O
los	O
]/[	O
E3174	O
]	O
60	O
.	O
10	O
(	O
0	O
.	O
08	O
–	O
0	O
.	O
19	O
)	O
0	O
.	O
55	O
(	O
0	O
.	O
47	O
–	O
1	O
.	O
01	O
)***	O
a	O
0	O
.	O
06	O
(	O
0	O
.	O
04	O
–	O
0	O
.	O
12	O
)***	O
c	O
[	O
los	O
]/[	O
E3174	O
]	O
80	O
.	O
05	O
(	O
0	O
.	O
04	O
–	O
0	O
.	O
08	O
)	O
0	O
.	O
24	O
(	O
0	O
.	O
20	O
–	O
0	O
.	O
42	O
)***	O
0	O
.	O
05	O
(	O
0	O
.	O
04	O
–	O
0	O
.	O
07	O
)	O
nsb	O
2C19AUCome	O
/	O
AUCOH	O
-	O
ome0	O
.	O
89	O
(	O
0	O
.	O
76	O
–	O
1	O
.	O
17	O
)	O
17	O
.	O
9	O
(	O
16	O
.	O
0	O
–	O
21	O
.	O
3	O
)***	O
0	O
.	O
22	O
(	O
0	O
.	O
19	O
–	O
0	O
.	O
30	O
)***	O
a	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
21	O
.	O
08	O
(	O
0	O
.	O
90	O
–	O
1	O
.	O
46	O
)	O
25	O
.	O
8	O
(	O
22	O
.	O
7	O
–	O
33	O
.	O
2	O
)***	O
0	O
.	O
25	O
(	O
0	O
.	O
22	O
–	O
0	O
.	O
35	O
)**	O
a	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
40	O
.	O
49	O
(	O
0	O
.	O
38	O
–	O
0	O
.	O
86	O
)	O
18	O
.	O
1	O
(	O
16	O
.	O
0	O
–	O
22	O
.	O
5	O
)***	O
0	O
.	O
18	O
(	O
0	O
.	O
15	O
–	O
0	O
.	O
24	O
)***	O
a	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
60	O
.	O
28	O
(	O
0	O
.	O
18	O
–	O
0	O
.	O
55	O
)	O
b	O
14	O
.	O
6	O
(	O
12	O
.	O
5	O
–	O
18	O
.	O
8	O
)	O
nta	O
na	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
8nanana2D6AUC24met	O
/	O
AUC24OH	O
-	O
met1	O
.	O
69	O
(	O
1	O
.	O
54	O
–	O
1	O
.	O
93	O
)	O
7	O
.	O
57	O
(	O
5	O
.	O
48	O
–	O
10	O
.	O
89	O
)*	O
g	O
1	O
.	O
45	O
(	O
1	O
.	O
34	O
–	O
1	O
.	O
62	O
)***	O
b	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
21	O
.	O
93	O
(	O
1	O
.	O
56	O
–	O
2	O
.	O
47	O
)	O
e	O
na1	O
.	O
83	O
(	O
1	O
.	O
60	O
–	O
2	O
.	O
18	O
)	O
ntd	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
42	O
.	O
20	O
(	O
2	O
.	O
00	O
–	O
2	O
.	O
54	O
)	O
6	O
.	O
60	O
(	O
5	O
.	O
90	O
–	O
7	O
.	O
85	O
)***	O
2	O
.	O
02	O
(	O
1	O
.	O
84	O
–	O
2	O
.	O
31	O
)	O
nsa	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
62	O
.	O
36	O
(	O
2	O
.	O
16	O
–	O
2	O
.	O
69	O
)	O
a	O
8	O
.	O
99	O
(	O
8	O
.	O
33	O
–	O
10	O
.	O
01	O
)***	O
1	O
.	O
88	O
(	O
1	O
.	O
69	O
–	O
2	O
.	O
20	O
)*	O
a	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
82	O
.	O
11	O
(	O
1	O
.	O
91	O
–	O
2	O
.	O
44	O
)	O
9	O
.	O
90	O
(	O
9	O
.	O
06	O
–	O
11	O
.	O
39	O
)***	O
1	O
.	O
67	O
(	O
1	O
.	O
51	O
–	O
1	O
.	O
93	O
)	O
nsb	O
3A4AUCmid	O
/	O
AUC1	O
-	O
OH	O
-	O
mid1	O
.	O
55	O
(	O
1	O
.	O
36	O
–	O
2	O
.	O
08	O
)	O
4	O
.	O
44	O
(	O
3	O
.	O
92	O
–	O
5	O
.	O
67	O
)***	O
3	O
.	O
89	O
(	O
3	O
.	O
30	O
–	O
7	O
.	O
87	O
)**	O
a	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
21	O
.	O
31	O
(	O
1	O
.	O
16	O
–	O
1	O
.	O
77	O
)	O
3	O
.	O
46	O
(	O
3	O
.	O
10	O
–	O
4	O
.	O
29	O
)***	O
1	O
.	O
73	O
(	O
1	O
.	O
54	O
–	O
2	O
.	O
11	O
)	O
nsa	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
41	O
.	O
51	O
(	O
1	O
.	O
33	O
–	O
1	O
.	O
97	O
)	O
3	O
.	O
81	O
(	O
3	O
.	O
43	O
–	O
4	O
.	O
58	O
)	O
ntna	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
61	O
.	O
64	O
(	O
1	O
.	O
35	O
–	O
2	O
.	O
31	O
)	O
c	O
4	O
.	O
50	O
(	O
3	O
.	O
94	O
–	O
5	O
.	O
60	O
)	O
nta	O
na	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
8nanana3A4	O
deglucAUCmid	O
/	O
AUCOH	O
-	O
mid	O
tot0	O
.	O
16	O
(	O
0	O
.	O
14	O
–	O
0	O
.	O
21	O
)	O
0	O
.	O
61	O
(	O
0	O
.	O
54	O
–	O
0	O
.	O
79	O
)***	O
0	O
.	O
04	O
(	O
0	O
.	O
03	O
–	O
0	O
.	O
05	O
)***	O
a	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot20	O
.	O
17	O
(	O
0	O
.	O
15	O
–	O
0	O
.	O
25	O
)	O
0	O
.	O
64	O
(	O
0	O
.	O
56	O
–	O
0	O
.	O
85	O
)***	O
0	O
.	O
06	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
08	O
)***	O
a	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot40	O
.	O
20	O
(	O
0	O
.	O
18	O
–	O
0	O
.	O
27	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
59	O
–	O
0	O
.	O
86	O
)***	O
0	O
.	O
14	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
23	O
)	O
nsh	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot60	O
.	O
18	O
(	O
0	O
.	O
15	O
–	O
0	O
.	O
26	O
)	O
0	O
.	O
65	O
(	O
0	O
.	O
59	O
–	O
0	O
.	O
78	O
)	O
nta	O
na	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot8nananaData	O
are	O
presented	O
as	O
geometric	O
mean	O
ratios	O
with	O
90	O
%	O
confidence	O
intervals	O
AUC	O
area	O
under	O
plasma	O
concentration	O
-	O
time	O
curve	O
from	O
time	O
0	O
to	O
last	O
measurable	O
concentration	O
,	O
AUC	O
24	O
area	O
under	O
the	O
plasma	O
concentration	O
-	O
time	O
curve	O
from	O
time	O
0	O
to	O
24	O
h	O
,	O
caf	O
caffeine	O
,	O
E3174	O
losartan	O
carboxylic	O
acid	O
,	O
efa	O
efavirenz	O
,	O
los	O
losartan	O
,	O
met	O
metoprolol	O
,	O
mid	O
midazolam	O
,	O
na	O
not	O
available	O
,	O
ns	O
not	O
significant	O
,	O
nt	O
not	O
tested	O
,	O
OH	O
-	O
efa	O
8	O
-	O
hydroxyefavirenz	O
,	O
OH	O
-	O
mid	O
1	O
′-	O
hydroxymidazolam	O
,	O
OH	O
-	O
mid	O
tot	O
total	O
1	O
′-	O
hydroxymidazolam	O
concentration	O
after	O
deglucuronidation	O
,	O
OH	O
-	O
met	O
α	O
-	O
hydroxymetoprolol	O
,	O
OH	O
-	O
ome	O
5	O
-	O
hydroxyomeprazole	O
,	O
par	O
paraxanthine	O
*	O
p	O
<	O
0	O
.	O
025	O
;	O
**	O
p	O
<	O
0	O
.	O
01	O
;	O
***	O
p	O
<	O
0	O
.	O
001	O
(	O
Wilcoxon	O
signed	O
rank	O
test	O
)	O
N	O
=	O
16	O
unless	O
indicated	O
otherwise	O
:	O
a	O
n	O
=	O
15	O
;	O
b	O
n	O
=	O
14	O
;	O
c	O
n	O
=	O
13	O
;	O
d	O
n	O
=	O
10	O
;	O
e	O
n	O
=	O
8	O
;	O
f	O
n	O
=	O
7	O
;	O
g	O
n	O
=	O
6	O
;	O
h	O
n	O
=	O
3	O

This	O
natural	O
‘	O
study	O
-	O
model	O
-	O
test	O
’	O
hierarchy	O
implies	O
a	O
universal	O
data	O
model	O
applicable	O
to	O
all	O
omic	O
analyses	O
and	O
it	O
is	O
therefore	O
employed	O
within	O
OmicNavigator	B-BT
(	O
Additional	O
file	O
2	O
:	O
Figs	O
.	O

Here	O
,	O
we	O
employed	O
the	O
mentioned	O
technologies	O
to	O
create	O
scalepopgen	B-BT
,	O
an	O
easily	O
scalable	O
,	O
portable	O
,	O
and	O
reproducible	O
tool	O
that	O
implements	O
workflows	O
for	O
widely	O
used	O
population	O
genomics	O
analyses	O
on	O
genome	O
-	O
wide	O
biallelic	O
single	O
nucleotide	O
polymorphism	O
(	O
SNP	O
)	O
data	O
.	O

In	O
this	O
study	O
,	O
we	O
measured	O
smFRET	O
efficiency	O
to	O
monitor	O
the	O
conformations	O
of	O
ATL1cyto	O
and	O
its	O
pathogenic	O
mutations	O
in	O
the	O
absence	O
or	O
presence	O
of	O
different	O
nucleotides	O
,	O
despite	O
some	O
discrepancies	O
between	O
the	O
theoretical	O
dye	O
-	O
dye	O
distances	O
calculated	O
by	O
the	O
FRETpredict	B-BT
tool	O
(	O
Supplementary	O
table	O
2	O
)	O
52	O
,	O
53	O
and	O
the	O
experimental	O
dye	O
-	O
dye	O
distances	O
based	O
on	O
the	O
smFRET	O
efficiency	O
(	O
see	O
Methods	O
for	O
calculation	O
,	O
Supplementary	O
tables	O
1	O
,	O
3	O
,	O
4	O
,	O
and	O
6	O
),	O
which	O
could	O
be	O
attributed	O
to	O
uncertainties	O
in	O
the	O
Förster	O
radius	O
R0	O
and	O
limited	O
MD	O
sampling	O
.	O

(	O
C	O
)	O
Bar	O
graphs	O
comparing	O
the	O
current	O
PIFiA	B-BT
architecture	O
with	O
a	O
common	O
baseline	O
,	O
DenseNet	O
-	O
121	O
,	O
across	O
four	O
different	O
standards	O
(	O
Gene	O
Ontology	O
Cellular	O
Component	O
,	O
Gene	O
Ontology	O
Bioprocess	O
Slim	O
,	O
KEGG	O
Pathways	O
,	O
EBI	O
Protein	O
complexes	O
)	O
in	O
terms	O
of	O
average	O
precision	O
,	O
F	O
-	O
score	O
and	O
adjusted	O
mutual	O
information	O
(	O
assessed	O
on	O
aFPs	O
of	O
4049	O
proteins	O
).	O

Renal	O
function	O
(	O
GFRa	O
,	O
MDRDb	O
formula	O
)	O
before	O
and	O
after	O
STZ	O
CTx	O

In	O
contrast	O
,	O
the	O
IMP	O
is	O
primarily	O
mapped	O
to	O
the	O
gp120	O
outer	O
domain	O
and	O
contains	O
the	O
N332	O
supersite	O
,	O
which	O
is	O
conserved	O
in	O
73	O
%	O
of	O
~	O
30	O
,	O
000	O
cross	O
-	O
clade	O
Env	O
sequences	O
(	O
HIResist	B-BT
database	O
:	O
https	O
://	O
hiresist	B-BT
.	O
umn	O
.	O
edu	O
/;	O
reference	O
42	O
).	O

The	O
data	O
underlying	O
this	O
article	O
are	O
available	O
at	O
github	O
.	O
com	O
/	O
raw	O
-	O
lab	O
/	O
mercat2	B-BT
and	O
https	O
://	O
osf	O
.	O
io	O
/	O
mzrvj	O
/.	O

[	O
10	O
]	O
demonstrated	O
the	O
superior	O
efficacy	O
of	O
Supreme	O
over	O
ProSeal	O
,	O
using	O
a	O
16	O
-	O
Fr	O
GT	O
,	O
regarding	O
success	O
rate	O
and	O
insertion	O
time	O
.	O

For	O
the	O
variant	O
calling	O
,	O
SAMtools	B-BT
was	O
used	O
to	O
identify	O
the	O
SNPs	O
and	O
InDels	O
from	O
the	O
sorted	O
BAM	O
file	O
of	O
the	O
mapping	O
.	O

We	O
developed	O
an	O
Embedding	O
-	O
based	O
Phenotype	O
Variant	O
Predictor	O
(	O
EmbedPVP	B-BT
),	O
a	O
computational	O
method	O
to	O
prioritize	O
variants	O
involved	O
in	O
genetic	O
diseases	O
by	O
combining	O
genomic	O
information	O
and	O
clinical	O
phenotypes	O
.	O

Users	O
interested	O
in	O
availing	O
the	O
datasets	O
of	O
AagingBase	B-BT
can	O
utilize	O
the	O
download	O
page	O
.	O

Our	O
data	O
suggest	O
that	O
enamel	O
in	O
the	O
trigon	O
basin	O
of	O
Cercocebus	O
atys	O
molars	O
gains	O
fracture	O
resistance	O
from	O
its	O
enamel	O
decussation	O
complexity	O
and	O
wear	O
resistance	O
from	O
its	O
nanomechanical	O
properties	O
.	O

B	O
Calculations	O
done	O
in	O
PyChelator	B-BT
using	O
the	O
four	O
sets	O
of	O
stability	O
constants	O
,	O
sourced	O
from	O
the	O
National	O
Institute	O
of	O
Standards	O
and	O
Technology	O
‘	O
NIST	O
’	O
[	O
11	O
],	O
‘	O
SPECS	O
’	O
by	O
Fabiato	O
[	O
2	O
],	O
‘	O
Chelator	O
’	O
by	O
Schoenmakers	O
et	O
al	O
.	O

For	O
each	O
fatty	O
acid	O
in	O
the	O
biscuit	O
prototypes	O
,	O
the	O
mean	O
values	O
followed	O
by	O
different	O
letters	O
(	O
a	O
,	O
b	O
,	O
c	O
)	O
are	O
significantly	O
different	O
(	O
p	O
≤	O
0	O
.	O
05	O
)	O
according	O
to	O
Bonferroni	O
post	O
hoc	O
test	O
.	O

MS	O
and	O
MS	O
/	O
MS	O
spectra	O
were	O
extracted	O
using	O
MZmine	B-BT
2	O
.	O
51	O
with	O
a	O
mass	O
detection	O
noise	O
level	O
set	O
to	O
1E3	O
and	O
1E0	O
,	O
respectively	O
.	O

The	O
dataset	O
is	O
provided	O
by	O
the	O
Carnegie	O
Mellon	O
University	O
Software	O
Engineering	O
Institute	O
as	O
the	O
Insider	B-BT
Threat	O
Test	O
Dataset54	O
.	O

The	O
alignment	O
was	O
visualised	O
using	O
ESPript	O
3	O
.	O
0	O
,	O
and	O
the	O
E	O
.	O
coli	O
LexA	O
structural	O
features	O
with	O
the	O
docked	O
compound	O
1	O
was	O
visualised	O
with	O
ENDscript	B-BT
2	I-BT
.	I-BT
0	I-BT
(	O
Robert	O
and	O
Gouet	O
,	O
2014	O
).	O

SyntenyViewer	B-BT
is	O
a	O
web	O
resource	O
to	O
perform	O
comparative	O
genomics	O
in	O
plants	O
;	O

Sixty	O
recreational	O
male	O
runners	O
with	O
a	O
heel	O
-	O
toe	O
running	O
pattern	O
participated	O
in	O
this	O
study	O
and	O
were	O
divided	O
into	O
three	O
groups	O
of	O
LA	O
,	O
HA	O
and	O
normal	O
arch	O
.	O

Supplemental	O
Figure	O
S1CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
flowchart	O
indicating	O
different	O
features	O
,	O
capabilities	O
and	O
results	O
generated	O
.	O

A	O
total	O
of	O
six	O
putative	O
umbravirus	O
sequences	O
—	O
CMoV	O
,	O
CMoMV	O
,	O
wild	O
carrot	O
mottle	O
virus	O
(	O
WCMoV	O
),	O
parsley	O
mottle	O
virus	O
,	O
parsley	O
mottle	O
mimic	O
virus	O
,	O
and	O
tobacco	O
bushy	O
top	O
virus	O
(	O
TBTV	O
)	O
were	O
identified	O
by	O
RNAseq	O
analysis	O
,	O
however	O
parsley	O
mottle	O
virus	O
,	O
parsley	O
mottle	O
mimic	O
virus	O
,	O
and	O
TBTV	O
were	O
excluded	O
from	O
further	O
analysis	O
as	O
they	O
were	O
poorly	O
represented	O
in	O
the	O
overall	O
dataset	O
,	O
in	O
that	O
only	O
a	O
few	O
(	O
1	O
–	O
3	O
)	O
short	O
(<	O
700	O
nt	O
)	O
contigs	O
that	O
were	O
represented	O
by	O
<	O
1	O
%	O
of	O
the	O
total	O
virus	O
reads	O
for	O
the	O
sample	O
group	O
and	O
/	O
or	O
had	O
<	O
100x	O
genome	O
coverage	O
were	O
retrieved	O
for	O
each	O
of	O
these	O
viruses	O
(	O
Tables	O
2	O
,	O
3	O
).	O

The	O
HIResist	B-BT
database	O
contains	O
a	O
search	O
engine	O
to	O
retrieve	O
data	O
at	O
three	O
levels	O
using	O
auto	O
-	O
complete	O
fields	O
(	O
Fig	O
.	O

Wild	O
-	O
type	O
profilaggrin	O
sequence	O
and	O
its	O
mutated	O
variants	O
were	O
analysed	O
in	O
silico	O
using	O
the	O
DEGRONOPEDIA	B-BT
and	O
Clustal	O
Omega	O
tool	O
.	O

The	O
individuals	O
were	O
descendants	O
of	O
lizards	O
captured	O
in	O
the	O
Cevennes	O
,	O
France	O
,	O
in	O
2010	O
and	O
2013	O
,	O
maintained	O
in	O
the	O
Metatron	O
(	O
Ariège	O
,	O
France	O
)	O
for	O
several	O
experiments	O
(	O
Bestion	O
et	O
al	O
.,	O
2017	O
,	O
2019	O
;	O
Bestion	O
,	O
Teyssier	O
,	O
et	O
al	O
.,	O
2015	O
)	O
and	O
intermixed	O
regularly	O
before	O
the	O
present	O
experiment	O
to	O
prevent	O
high	O
levels	O
of	O
inbreeding	O
.	O

(	O
B	O
)	O
NanoDeep	O
(	O
Ambrosetti	O
et	O
al	O
.,	O
2021	O
),	O
which	O
can	O
transform	O
the	O
organization	O
information	O
of	O
membrane	O
proteins	O
into	O
a	O
DNA	O
sequencing	O
readout	O
.	O

AagingBase	B-BT
serves	O
as	O
a	O
valuable	O
resource	O
for	O
researchers	O
,	O
scientists	O
and	O
clinicians	O
,	O
offering	O
several	O
key	O
functionalities	O
.	O

b	O
Visualization	O
of	O
scDREAMER	B-BT
’	O
s	O
latent	O
space	O
embeddings	O
,	O
cells	O
are	O
colored	O
based	O
on	O
the	O
batch	O
information	O
.	O

We	O
have	O
integrated	O
cytoviewer	B-BT
into	O
our	O
widely	O
adopted	O
data	O
analysis	O
pipeline	O
for	O
multiplexed	O
imaging	O
data	O
[	O
10	O
]	O
(	O
https	O
://	O
bodenmillergroup	O
.	O
github	O
.	O
io	O
/	O
IMCDataAnalysis	O
/)	O
and	O
envision	O
that	O
the	O
package	O
will	O
meet	O
the	O
needs	O
of	O
the	O
fast	O
-	O
growing	O
community	O
of	O
highly	O
multiplexed	O
imaging	O
users	O
[	O
11	O
].	O

REAGENT	O
or	O
RESOURCESOURCEIDENTIFIERAntibodiesRabbit	O
anti	O
-	O
SAM68Iijima	O
et	O
al	O
.	O
35N	O
/	O
ARabbit	O
anti	O
-	O
SLM2Iijima	O
et	O
al	O
.	O
35N	O
/	O
AGuinea	O
pig	O
polyclonal	O
anti	O
-	O
SLM2Iijima	O
et	O
al	O
.	O
35N	O
/	O
AMouse	O
anti	O
-	O
NeuNChemicon	O
#	O
MAB377Rat	O
anti	O
-	O
HA	O
monoclonal	O
clone	O
3F10Roche	O
#	O
11867431001Rabbit	O
anti	O
-	O
Ctip2	O
polyclonalNovus	O
Biological	O
#	O
NB100	O
-	O
2600Donkey	O
anti	O
-	O
guinea	O
pig	O
IgG	O
Cy5	O
-	O
conjugatedJackson	O
ImmunoResearch	O
#	O
706	O
-	O
175	O
-	O
148Donkey	O
anti	O
-	O
rabbit	O
IgG	O
Cy3	O
-	O
conjugatedJackson	O
ImmunoResearch	O
#	O
711	O
-	O
165	O
-	O
152Donkey	O
anti	O
-	O
guinea	O
pig	O
IgG	O
Cy3	O
-	O
conjugatedJackson	O
ImmunoResearch	O
#	O
706	O
-	O
165	O
-	O
148Donkey	O
anti	O
-	O
rabbit	O
IgG	O
Alexa	O
488	O
-	O
conjugatedThermo	O
Fisher	O
#	O
A	O
-	O
21206Chemicals	O
,	O
peptides	O
,	O
and	O
recombinant	O
proteinsanti	O
-	O
HA	O
magnetic	O
beads	O
clone	O
2	O
–	O
2	O
.	O
2	O
.	O
14Thermo	O
Fisher	O
/	O
Pierce	O
#	O
88836Complete	O
mini	O
Protease	O
Inhibitors	O
,	O
EDTA	O
-	O
freeRoche	O
#	O
04693159001RNAsinPromega	O
#	O
N2115CycloheximideSigma	O
#	O
C7698HeparinSigma	O
#	O
H3393IGEPAL	O
-	O
CA640	O
(	O
NP	O
-	O
40	O
)	O
Sigma	O
#	O
18896RNeasy	O
Micro	O
plus	O
kitQiagen	O
#	O
74034Dynabeads	O
™	O
Protein	O
AInvitrogen	O
#	O
10001DTURBO	O
™	O
DNase	O
(	O
2	O
U	O
/	O
ul	O
)	O
Invitrogen	O
#	O
AM2238Ambion	O
™	O
RNase	O
I	O
(	O
100	O
U	O
/	O
ul	O
)	O
Invitrogen	O
#	O
AM2295T4	O
PNK	O
(	O
10	O
U	O
/	O
ul	O
)	O
NEB	O
#	O
M0314LT4	O
RNA	O
Ligase	O
1	O
(	O
ssRNA	O
Ligase	O
),	O
High	O
ConcentrationNEB	O
#	O
M0437MProteinase	O
K	O
,	O
Molecular	O
Biology	O
Grade	O
(	O
0	O
.	O
8	O
U	O
/	O
ul	O
)	O
NEB	O
#	O
P8107SQ5	O
®	O
High	O
-	O
Fidelity	O
2X	O
Master	O
MixNEB	O
#	O
M0492SExoSAP	O
-	O
IT	O
™	O
Applied	O
Biosystems	O
#	O
78200	O
.	O
200	O
.	O
ULSuperScript	O
™	O
III	O
Reverse	O
TranscriptaseInvitrogen	O
#	O
18080093Dynabeads	O
™	O
MyOne	O
™	O
SilaneInvitrogen	O
#	O
37002DNuPAGE	O
™	O
Transfer	O
Buffer	O
(	O
20X	O
)	O
Invitrogen	O
#	O
NP0006NuPAGE	O
™	O
4	O
–	O
12	O
%,	O
Bis	O
-	O
Tris	O
,	O
1	O
.	O
5	O
mm	O
,	O
Mini	O
Protein	O
GelsInvitrogen	O
#	O
NP0335BOXNuPAGE	O
™	O
MOPS	O
SDS	O
Running	O
Buffer	O
(	O
20X	O
)	O
Invitrogen	O
#	O
NP0001Amersham	O
™	O
Protran	O
®	O
Western	O
blotting	O
membranes	O
,	O
nitrocelluloseSigma	O
#	O
GE10600002RNA	O
Clean	O
&	O
Concentrator	O
-	O
5Zymo	O
Research	O
#	O
R1015Acid	O
-	O
Phenol	O
:	O
Chloroform	O
,	O
pH	O
4	O
.	O
5Invitrogen	O
#	O
AM9720Phase	O
Lock	O
Gel	O
™	O
Heavy	O
tubes5	O
PRIME	O
#	O
2302830Urea	O
for	O
molecular	O
biologyAppliChem	O
#	O
A1049Prolong	O
Diamond	O
Antifade	O
MountantLife	O
Technologies	O
#	O
P36970Dako	O
Fluorescence	O
Mounting	O
mediumAgilent	O
#	O
S3023OCTTissue	O
-	O
TekCritical	O
commercial	O
assaysHiSeq	O
SBS	O
Kit	O
v4Illumina	O
#	O
FC	O
-	O
401	O
-	O
4003NGS	O
Fragment	O
Analysis	O
KitAdvanced	O
Analytica	O
#	O
DNF	O
-	O
473RNA	O
6000	O
Pico	O
ChipAgilent	O
#	O
5067	O
–	O
1513QuantiFluor	O
RNA	O
SystemPromega	O
#	O
E3310Deposited	O
dataRNA	O
-	O
seq	O
dataThis	O
paperGEO	O
:	O
GSE209870CLIP	O
-	O
seq	O
dataThis	O
paperGEO	O
:	O
GSE220062RNA	O
-	O
seq	O
data	O
Sam68KOWitte	O
et	O
al	O
.	O
66PRIDE	O
:	O
PRJEB27529RNA	O
-	O
seq	O
data	O
Slm2KOTraunmüller	O
et	O
al	O
.	O
37GEO	O
:	O
GSE79902Experimental	O
models	O
:	O
Organisms	O
/	O
strainsMouse	O
:	O
C57BL	O
/	O
6JJanvierN	O
/	O
AMouse	O
:	O
Grik4	O
-	O
creJackson	O
Laboratoriesstrain	O
#:	O
006	O
,	O
474Mouse	O
:	O
Camk2a	O
-	O
creJackson	O
Laboratoriesstrain	O
#:	O
005	O
,	O
359Mouse	O
:	O
Sst	O
-	O
IRES	O
-	O
CreJackson	O
Laboratoriesstrain	O
#:	O
013	O
,	O
044Mouse	O
:	O
Ai32	O
ROSA	O
-	O
stop	O
-	O
ChR2	O
/	O
H134RJackson	O
Laboratoriesstrain	O
#:	O
024	O
,	O
109Mouse	O
:	O
Slm2	O
/	O
KHDRBS3	O
floxTraunmüller	O
et	O
al	O
.	O
36N	O
/	O
AMouse	O
:	O
Ai9	O
ROSA	O
-	O
stop	O
-	O
tomatoJackson	O
Laboratoriesstrain	O
#:	O
007	O
,	O
909Mouse	O
:	O
RjOrl	O
:	O
SWISSJanvierN	O
/	O
AMouse	O
:	O
Rpl22	O
-	O
HAJackson	O
Laboratoriesstrain	O
#:	O
029	O
,	O
977OligonucletidesFor	O
oligonucleotides	O
,	O
see	O
Table	O
S3N	O
/	O
AN	O
/	O
ASoftware	O
and	O
algorithmsFijiTraunmüller	O
et	O
al	O
.	O
67RRID	O
:	O
SCR_002285FeatureCountsLiao	O
et	O
al	O
.	O
68RRID	O
:	O
SCR_012919CTKShah	O
et	O
al	O
.	O
42RRID	O
:	O
SCR_019034mCrossFeng	O
et	O
al	O
.	O
44N	O
/	O
AFastQC	O
0	O
.	O
11	O
.	O
8N	O
/	O
ARRID	O
:	O
SCR_014583Picard	O
v1	O
.	O
119N	O
/	O
ARRID	O
:	O
SCR_006525RSeQC	O
v2	O
.	O
3	O
.	O
9N	O
/	O
ARRID	O
:	O
SCR_005275SAMTOOLS	O
1	O
.	O
13Li	O
et	O
al	O
.	O
69RRID	O
:	O
SCR_002105STAR	O
2	O
.	O
7	O
.	O
9aDobin	O
et	O
al	O
.	O
70RRID	O
:	O
SCR_004463DESEQ2Love	O
et	O
al	O
.	O
71RRID	O
:	O
SCR_015687CLIPper	O
2	O
.	O
0	O
.	O
0Yeo	O
et	O
al	O
.	O
72https	O
://	O
github	O
.	O
com	O
/	O
YeoLab	O
/	O
clipperIDR	O
2	O
.	O
0	O
.	O
3Li	O
et	O
al	O
.	O
73RRID	O
:	O
SCR_017237Sashimi	O
.	O
pyZhang	O
et	O
al	O
.	O
74https	O
://	O
github	O
.	O
com	O
/	O
ygidtu	O
/	O
sashimi	O
.	O
pyDAVIDHuang	O
et	O
al	O
.	O
75RRID	O
:	O
SCR_001881SynGOKoopmans	O
et	O
al	O
.	O
45RRID	O
:	O
SCR_017330Ethovision10NoldusN	O
/	O
AStimfitGuzman	O
et	O
al	O
.	O
76RRID	O
:	O
SCR_016050pyABFN	O
/	O
Ahttp	O
://	O
swharden	O
.	O
com	O
/	O
pyabfImaris	O
7	O
.	O
0	O
.	O
0Bitplane	O
AGRRID	O
:	O
SCR_007370Cutadapt	O
3	O
.	O
4N	O
/	O
ARRID	O
:	O
SCR_011841UMI	O
-	O
tools	O
1	O
.	O
1	O
.	O
1Smith	O
et	O
al	O
.	O
77RRID	O
:	O
SCR_017048	O

This	O
operative	O
technique	O
includes	O
the	O
well	O
-	O
known	O
Krakow	O
locking	O
stitch	O
in	O
addition	O
to	O
FiberTape	O
sutures	O
crisscrossing	O
in	O
a	O
suture	O
bridge	O
configuration	O
.	O

S9	O
)	O
due	O
to	O
it	O
using	O
the	O
-	O
meta	O
option	O
in	O
Prodigal	O
;	O
whereas	O
,	O
MetaCerberus	B-BT
but	O
still	O
can	O
annotate	O
archaeal	O
viruses	O
and	O
phage	O
genomes	O
better	O
than	O
DRAM	O
-	O
v	O
on	O
a	O
much	O
smaller	O
database	O
(	O
Supplementary	O
Fig	O
.	O

Neoplastic	O
plasma	O
cells	O
with	O
concomitant	O
azurophilic	O
crystalline	O
inclusions	O
and	O
Snapper	O
‐	O
Schneid	O
bodies	O
.	O

Influence	O
of	O
different	O
retention	O
periods	O
on	O
the	O
efficiency	O
of	O
cowpea	O
mild	O
mottle	O
virus	O
transmission	O
by	O
single	O
individuals	O
of	O
Bemisia	O
tabaci	O
MEAM1	O
and	O
MED	O
species	O
.	O

The	O
complete	O
list	O
of	O
collaborating	O
studies	O
and	O
their	O
respective	O
institutions	O
can	O
be	O
found	O
at	O
https	O
://	O
voyager	O
.	O
iarc	O
.	O
who	O
.	O
int	O
/	O
co	O
-	O
investigators	O
/.	O

Irrespective	O
of	O
the	O
surface	O
treatment	O
methods	O
,	O
IPS	O
e	O
.	O
max	O
CAD	O
ceramic	O
showed	O
a	O
relatively	O
smoother	O
surface	O
than	O
did	O
Suprinity	O
and	O
Celtra	O
Duo	O
.	O

Thanks	O
to	O
a	O
light	O
rod	O
attached	O
to	O
the	O
back	O
of	O
the	O
skull	O
,	O
a	O
systematic	O
rotation	O
with	O
a	O
final	O
average	O
angle	O
of	O
nearly	O
17	O
degrees	O
is	O
revealed	O
,	O
always	O
in	O
the	O
direction	O
of	O
the	O
“	O
smoother	O
”	O
half	O
of	O
the	O
skull	O
.	O

Hi	O
-	O
M	O
data	O
were	O
analyzed	O
using	O
pyHiM	B-BT
release	O
0	O
.	O
6	O
,	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
marcnol	O
/	O
pyHiM	B-BT
.	O

2017	O
),	O
converted	O
into	O
a	O
community	O
metabolic	O
model	O
using	O
PyCoMo	B-BT
(	O
Predl	O
et	O
al	O
.	O

The	O
tissue	O
was	O
ground	O
on	O
ice	O
and	O
then	O
centrifuged	O
at	O
5000	O
r	O
/	O
min	O
for	O
five	O
minutes	O
in	O
a	O
centrifuger	O
(	O
NEST	O
Biotech	O
.,	O
Wuxi	O
,	O
China	O
),	O
and	O
the	O
supernatants	O
were	O
collected	O
.	O

In	O
such	O
cases	O
,	O
DandD	B-BT
initializes	O
the	O
search	O
for	O
the	O
union	O
k	O
∗	O
by	O
taking	O
the	O
maximum	O
of	O
the	O
previously	O
-	O
computed	O
k	O
∗	O
s	O
of	O
the	O
inputs	O
.	O
Figure	O
1Different	O
pangenomes	O
find	O
their	O
maxima	O
at	O
different	O
values	O
of	O
kVertical	O
axis	O
shows	O
dk	O
(	O
S	O
)	O
k	O
standardized	O
to	O
between	O
0	O
and	O
1	O
per	O
pangenome	O
.	O

Acquisition	O
,	O
analysis	O
,	O
or	O
interpretation	O
of	O
data	O
:	O
Kai	O
Yoshinaga	O
,	O
Carson	O
Clark	O
,	O
Artem	O
Tkachenko	O
,	O
Thomas	O
Murphy	O

However	O
,	O
15	O
months	O
after	O
angioplasty	O
,	O
repeat	O
catheterization	O
revealed	O
a	O
9	O
-	O
mm	O
Hg	O
gradient	O
that	O
was	O
then	O
treated	O
with	O
a	O
12	O
-	O
mm	O
(	O
InPact	O
)	O
paclitaxel	O
-	O
coated	O
balloon	O
followed	O
by	O
a	O
high	O
-	O
pressure	O
14	O
-	O
mm	O
(	O
Vida	O
)	O
balloon	O
with	O
complete	O
resolution	O
of	O
the	O
stenosis	O
angiographically	O
(	O
Figures	O
3D	O
and	O
3E	O
).	O
Figure	O
3Angiogram	O
During	O
Catheterization	O
From	O
Case	O
2	O
:	O
Before	O
and	O
AfterYellow	O
arrows	O
showing	O
the	O
site	O
of	O
stenosis	O
before	O
and	O
after	O
DCB	O
angioplasty	O
in	O
A	O
,	O
D	O
,	O
B	O
,	O
and	O
E	O
,	O
respectively	O
.	O

A	O
gapped	O
consensus	O
sequence	O
was	O
produced	O
using	O
SAMtools	B-BT
v	O
.	O
0	O
.	O
1	O
.	O
18	O
and	O
BEDTools	O
(	O
7	O
).	O

Features	O
unique	O
to	O
IBDTransDB	B-BT
or	O
shared	O
with	O
other	O
tools	O

In	O
LipidSig	O
2	O
.	O
0	O
,	O
the	O
assignment	O
of	O
lipid	O
characteristics	O
to	O
each	O
lipid	O
species	O
has	O
been	O
substantially	O
enhanced	O
,	O
encompassing	O
29	O
characteristics	O
derived	O
from	O
a	O
combination	O
of	O
resources	O
,	O
including	O
the	O
packages	O
LipidOne	O
,	O
LION	O
,	O
and	O
Goslin	B-BT
,	O
and	O
three	O
individual	O
studies	O
(	O
13	O
–	O
15	O
).	O

[	O
30	O
]	O
was	O
used	O
to	O
determine	O
the	O
thickness	O
,	O
spread	O
ratio	O
and	O
diameter	O
of	O
biscuits	O
,	O
with	O
slight	O
modifications	O
.	O

For	O
Windows	O
and	O
macOS	O
,	O
please	O
refer	O
to	O
the	O
official	O
website	O
of	O
Python	O
to	O
download	O
and	O
set	O
up	O
a	O
Python	O
environment	O
if	O
you	O
need	O
.#	O
install	O
from	O
PyPIpip	O
install	O
spaco	B-BT
-	O
release	O
#	O
or	O
install	O
from	O
latest	O
source	O
from	O
github	O
(	O
Recommended	O
)	O
pip	O
install	O
git	O
+	O
https	O
://	O
github	O
.	O
com	O
/	O
BrainStOrmics	O
/	O
Spaco	B-BT
.	O
git	O
.	O
Note	O
:	O
In	O
the	O
code	O
blocks	O
,	O
the	O
'#'	O
symbol	O
is	O
used	O
to	O
indicate	O
comments	O
,	O
which	O
are	O
not	O
executable	O
as	O
code	O
.	O
Note	O
:	O
When	O
you	O
install	O
this	O
package	O
,	O
all	O
required	O
dependencies	O
will	O
also	O
be	O
installed	O
automatically	O
by	O
'	O
pip	O
'.	O

Time	O
per	O
stitch	O
did	O
not	O
differ	O
between	O
nerve	O
transfers	O
(	O
5	O
.	O
4	O
±	O
1	O
.	O
6	O
min	O
)	O
or	O
TMR	O
(	O
5	O
.	O
1	O
±	O
0	O
.	O
5	O
min	O
),	O
but	O
with	O
neurotized	O
free	O
flaps	O
(	O
2	O
.	O
4	O
±	O
0	O
.	O
8	O
min	O
)	O
(	O
Fig	O
.	O

The	O
ORFs	O
were	O
annotated	O
using	O
MetaPathways	B-BT
v2	O
.	O
5	O
with	O
default	O
settings	O
(	O
24	O
,	O
25	O
).	O

Full	O
summary	O
statistics	O
for	O
VOYAGER	B-BT
GWAS	O
can	O
be	O
accessed	O
via	O
dbGaP	O
(	O
OncoArray	O
:	O
Oral	O
and	O
Pharynx	O
Cancer	O
;	O
study	O
accession	O
number	O
:	O
phs001202	O
.	O
v1	O
.	O
p1	O
),	O
and	O
published	O
data	O
from	O
this	O
study	O
can	O
be	O
accessed	O
at	O
Lesseur	O
,	O
C	O
.	O

To	O
address	O
these	O
challenges	O
,	O
we	O
introduce	O
admix	B-BT
-	I-BT
kit	I-BT
,	O
an	O
integrated	O
and	O
flexible	O
python	O
toolkit	O
along	O
with	O
workflows	O
developed	O
using	O
Workflow	O
Development	O
Language	O
(	O
WDL	O
),	O
specifically	O
designed	O
for	O
the	O
simulation	O
and	O
analysis	O
of	O
genetic	O
data	O
from	O
admixed	O
populations	O
.	O

SynDesign	B-BT
determines	O
the	O
top	O
pegRNAs	O
for	O
each	O
position	O
according	O
to	O
our	O
DeepPrime	O
/	O
DeepPrime	O
-	O
FT	O
prediction	O
models	O
and	O
automatically	O
incorporates	O
a	O
synonymous	O
mutation	O
marker	O
that	O
further	O
enhances	O
pegRNA	O
efficiency	O
and	O
sequenced	O
product	O
identification	O
.	O

b	O
The	O
top	O
L	O
precisions	O
of	O
DeepTMP	O
,	O
CDPred	B-BT
,	O
DeepHomo2	O
.	O
0	O
,	O
GLINTER	O
,	O
DeepHomo	O
,	O
and	O
DNCON2_Inter	O
in	O
different	O
ranges	O
of	O
ln	O
(	O
Meff	O
).	O

To	O
demonstrate	O
the	O
use	O
of	O
vizAPA	B-BT
,	O
here	O
we	O
adopted	O
a	O
mouse	O
spermatogenesis	O
scRNA	O
-	O
seq	O
dataset	O
(	O
Shulman	O
and	O
Elkon	O
2019	O
),	O
which	O
sequenced	O
three	O
differentiation	O
stages	O
,	O
including	O
early	O
stage	O
(	O
spermatocytes	O
,	O
SC	O
),	O
intermediate	O
stage	O
(	O
round	O
spermatids	O
,	O
RS	O
),	O
and	O
late	O
stage	O
(	O
elongating	O
spermatids	O
,	O
ES	O
).	O

Among	O
these	O
admissions	O
,	O
16	O
,	O
055	O
(	O
38	O
.	O
3	O
%)	O
had	O
composite	O
adverse	O
cardiovascular	O
outcomes	O
(	O
TACCO	O
)	O
during	O
hospitalization	O
.	O

Structural	O
domains	O
functional	O
ontology	O
(	O
SDFO	O
)	O
that	O
mapped	O
information	O
from	O
a	O
theoretic	O
analysis	O
of	O
Domain2GO	B-BT
annotation	O
profiles	O
were	O
reported	O
from	O
the	O
file	O
SDFO	O
.	O
txt	O
.	O

Finally	O
,	O
we	O
overlapped	O
the	O
5000	O
bp	O
square	O
bins	O
found	O
by	O
this	O
approach	O
with	O
the	O
high	O
frequency	O
bins	O
identified	O
by	O
cooltools	B-BT
and	O
reported	O
by	O
Oksuz	O
et	O
al	O
.	O

Sven	O
Ivar	O
Seldinger	O
'	O
s	O
innovative	O
technique	O
has	O
been	O
lauded	O
by	O
several	O
prominent	O
figures	O
in	O
the	O
field	O
.	O

Fiji	O
also	O
has	O
a	O
sugar	O
-	O
sweetened	O
beverage	O
tax	O
;	O
however	O
,	O
previous	O
research	O
has	O
shown	O
that	O
this	O
tax	O
needs	O
to	O
be	O
higher	O
to	O
achieve	O
health	O
impacts	O
[	O
18	O
,	O
19	O
,	O
34	O
].	O

Microtiter	O
(	O
96	O
-	O
well	O
)	O
plates	O
(	O
Corning	O
,	O
Corning	O
,	O
NY	O
)	O
were	O
coated	O
with	O
anti	O
-	O
ACE	O
mAbs	O
via	O
goat	O
anti	O
-	O
mouse	O
IgG	O
(	O
Invitrogen	O
,	O
Rockford	O
,	O
IL	O
or	O
IMTEK	O
,	O
Moscow	O
,	O
Russia	O
)	O
bridge	O
and	O
incubated	O
with	O
plasma	O
samples	O
diluted	O
10	O
times	O
.	O

From	O
the	O
outermost	O
:	O
Track1	O
:	O
Top	O
24	O
largest	O
scaffolds	O
of	O
the	O
red	O
snapper	O
genome	O
.	O

The	O
Hmrbase	B-BT
entries	O
provide	O
links	O
to	O
many	O
external	O
databases	O
such	O
as	O
Swiss	O
-	O
Prot	O
,	O
NCBI	O
Gene	O
,	O
PDB	O
,	O
Pfam	O
etc	O
.	O

Reprocessing	O
of	O
the	O
data	O
using	O
MZmine	B-BT
to	O
deconvolute	O
the	O
results	O
(	O
to	O
take	O
account	O
of	O
the	O
isotopic	O
contribution	O
,	O
for	O
example	O
)	O
and	O
obtain	O
a	O
matrix	O
in	O
which	O
one	O
line	O
corresponds	O
to	O
one	O
compound	O
.	O

sRNAfrag	B-BT
’	O
s	O
ability	O
to	O
analyze	O
historical	O
data	O
offers	O
the	O
prospect	O
of	O
uncovering	O
evolutionary	O
patterns	O
,	O
such	O
as	O
the	O
conservation	O
of	O
the	O
5	O
’	O
miRNA	O
seed	O
sequence	O
across	O
different	O
miRNA	O
RNA	O
genes	O
.	O

Examples	O
include	O
the	O
market	O
names	O
of	O
snapper	O
,	O
tuna	O
,	O
and	O
cod	O
,	O
which	O
could	O
acceptably	O
be	O
used	O
in	O
Canada	O
for	O
the	O
sale	O
of	O
96	O
,	O
14	O
,	O
and	O
two	O
species	O
,	O
respectively	O
.	O

SyntenyViewer	B-BT
allows	O
deep	O
investigation	O
of	O
evolutionary	O
fates	O
of	O
ancestral	O
genes	O
/	O
genomes	O
,	O
through	O
precise	O
identification	O
of	O
the	O
changes	O
involved	O
(	O
gains	O
and	O
losses	O
of	O
genes	O
and	O
associated	O
gene	O
ontologies	O
)	O
and	O
their	O
assignment	O
to	O
specific	O
species	O
or	O
botanical	O
families	O
(	O
Figure	O
3a	O
).	O

The	O
study	O
population	O
consisted	O
of	O
individuals	O
included	O
in	O
the	O
VOYAGER	O
(	O
Human	O

High	O
-	O
coverage	O
domain	O
-	O
centric	O
GO	O
annotations	O
that	O
were	O
supported	O
only	O
by	O
all	O
UniProts	O
(	O
including	O
multidomain	O
UniProts	O
)	O
were	O
downloaded	O
as	O
the	O
file	O
Domain2GO_supported_only_by_all	B-BT
.	O
txt	O
.	O

Table	O
2Correlations	O
of	O
the	O
mean	O
NC	O
curves	O
among	O
synergies	O
across	O
groups	O
with	O
Pearson	O
correlation	O
coefficient	O
test	O
.	O
Normal	O
p	O
-	O
valueLow	O
Arch	O
p	O
-	O
valueNC	O
1	O
Low	O
Arch0	O
.	O
935	O
0	O
.	O
01	O
High	O
Arch0	O
.	O
771	O
0	O
.	O
0290	O
.	O
776	O
0	O
.	O
032NC	O
2	O
Low	O
Arch0	O
.	O
804	O
0	O
.	O
02	O
High	O
Arch0	O
.	O
860	O
0	O
.	O
0110	O
.	O
820	O
0	O
.	O
01NC	O
3	O
Low	O
Arch0	O
.	O
940	O
0	O
.	O
01	O
High	O
Arch0	O
.	O
675	O
0	O
.	O
0380	O
.	O
663	O
0	O
.	O
036NC	O
4	O
Low	O
Arch0	O
.	O
634	O
0	O
.	O
027	O
High	O
Arch0	O
.	O
645	O
0	O
.	O
0310	O
.	O
871	O
0	O
.	O
03NC	O
5	O
Low	O
Arch0	O
.	O
866	O
0	O
.	O
02	O
High	O
Arch0	O
.	O
938	O
0	O
.	O
010	O
.	O
854	O
0	O
.	O
01Significant	O
correlations	O
are	O
indicated	O
by	O
bold	O
values	O
(	O
p	O
˂	O
0	O
.	O
001	O
).	O

These	O
libraries	O
perform	O
file	O
access	O
in	O
a	O
single	O
-	O
threaded	O
manner	O
(	O
HTSLIB	B-BT
does	O
support	O
multi	O
-	O
threaded	O
decompression	O
,	O
but	O
not	O
file	O
reading	O
),	O
which	O
is	O
a	O
reasonable	O
design	O
choice	O
when	O
(	O
i	O
)	O
informatics	O
analysis	O
is	O
compute	O
bottlenecked	O
,	O
and	O
therefore	O
cannot	O
benefit	O
from	O
faster	O
data	O
access	O
;	O
or	O
(	O
ii	O
)	O
the	O
file	O
storage	O
and	O
transport	O
media	O
are	O
incapable	O
of	O
high	O
performance	O
,	O
e	O
.	O
g	O
.	O

Before	O
trimming	O
,	O
we	O
perform	O
manual	O
inspection	O
for	O
sequence	O
alignment	O
using	O
Jalview	B-BT
and	O
exclude	O
one	O
sequence	O
(	O
in	O
red	O
rectangle	O
)	O
for	O
its	O
error	O
alignment	O
(	O
Figure	O
2	O
).	O

The	O
most	O
prominent	O
databases	O
in	O
the	O
latter	O
category	O
include	O
IMG	O
/	O
M	O
[	O
23	O
],	O
[	O
24	O
],	O
MGnify	O
[	O
25	O
],	O
SPIRE	O
[	O
26	O
],	O
and	O
MG	O
-	O
RAST	O
[	O
27	O
].	O
Table	O
1Databases	O
and	O
Repositories	O
.	O
Table	O
1Database	O
NameDescriptionData	O
TypesAccessibilityUser	O
SubmissionGenBankArchive	O
for	O
sequencing	O
dataGenomes	O
,	O
Metagenomes	O
,	O
Metatranscriptomes	O
,	O
AmpliconsPublicly	O
accessibleYesSequence	O
Read	O
Archive	O
(	O
SRA	O
)	O
Archive	O
for	O
sequencing	O
dataRaw	O
sequencing	O
dataPublicly	O
accessibleYesEuropean	O
Nucleotide	O
Archive	O
(	O
ENA	O
)	O
Archive	O
for	O
all	O
publicly	O
available	O
nucleotide	O
sequencesGenomes	O
,	O
Metagenomes	O
,	O
Metatranscriptomes	O
,	O
AmpliconsPublicly	O
accessibleYesDOE	O
Systems	O
Biology	O
Knowledgebase	O
(	O
KBase	O
)	O
A	O
platform	O
for	O
sharing	O
,	O
integrating	O
,	O
and	O
analyzing	O
microbial	O
,	O
plant	O
,	O
and	O
community	O
dataGenomes	O
,	O
Metagenomes	O
,	O
Metatranscriptomes	O
,	O
AmpliconsPublicly	O
accessibleYesGenomes	O
OnLine	O
Database	O
(	O
GOLD	O
)	O
Repository	O
for	O
genome	O
projects	O
and	O
metadata	O
(	O
ecosystems	O
)	O
EcosystemsPublicly	O
accessibleYesIntegrated	O
Microbial	O
Genomes	O
&	O
Microbiomes	O
(	O
IMG	O
/	O
M	O
)	O
Community	O
-	O
driven	O
repository	O
hosting	O
genomes	O
of	O
cultivated	O
and	O
uncultivated	O
microbial	O
taxa	O
,	O
metagenomes	O
,	O
metatranscriptomes	O
,	O
amplicons	O
,	O
plasmids	O
,	O
and	O
genome	O
fragmentsMetagenomes	O
,	O
Metatranscriptomes	O
,	O
Amplicons	O
,	O
GenomesPublicly	O
accessibleYesMGnifyArchive	O
for	O
exploration	O
,	O
and	O
analysis	O
,	O
of	O
microbiome	O
sequencing	O
datasetsMetagenomes	O
,	O
Metatranscriptomes	O
,	O
Amplicons	O
,	O
MAGsPublicly	O
accessibleYesMetagenome	O
RAST	O
(	O
MG	O
-	O
RAST	O
)	O
Microbiome	O
repository	O
with	O
a	O
unified	O
pipeline	O
for	O
automated	O
analysis	O
of	O
metagenomic	O
samplesMetagenomesRegistered	O
usersYesIntegrated	O
Microbial	O
Viral	O
Genomes	O
(	O
IMG	O
/	O
VR	O
)	O
Viral	O
genomes	O
and	O
metagenomesViral	O
Genomes	O
,	O
Viral	O
MetagenomesPublicly	O
accessibleYesNMPFamsDBNovel	O
protein	O
families	O
from	O
IMG	O
’	O
s	O
metagenomes	O
and	O
metatranscriptomesProtein	O
FamiliesPublicly	O
accessibleNoFESnov	O
catalogCatalog	O
reporting	O
functionally	O
unannotated	O
proteins	O
derived	O
from	O
MAGsProteinsPublicly	O
accessibleNoNIH	O
Human	O
Microbiome	O
ProjectMetagenomes	O
from	O
human	O
host	O
-	O
associated	O
systems	O
,	O
such	O
as	O
the	O
gut	O
microbiomeHuman	O
Microbiome	O
MetagenomesPublicly	O
accessibleNoTerrestrialMetagenomeDBAnnotation	O
of	O
metagenomes	O
obtained	O
from	O
soil	O
samplesSoil	O
MetagenomesPublicly	O
accessibleYesMarineMetagenomeDBAnnotation	O
of	O
metagenomes	O
obtained	O
from	O
marine	O
samplesMarine	O
MetagenomesPublicly	O
accessibleYesHumanMetagenomeDBAnnotation	O
of	O
metagenomes	O
obtained	O
from	O
human	O
microbiome	O
samplesHuman	O
Microbiome	O
MetagenomesPublicly	O
accessibleYesSPIRESearchable	O
resource	O
of	O
ecosystem	O
metadata	O
obtained	O
from	O
MAGsEcosystem	O
MetadataPublicly	O
accessibleNoMarine	B-BT
Metagenomics	I-BT
Portal	I-BT
(	O
MMP	O
)	O
Collection	O
of	O
databases	O
annotating	O
marine	O
-	O
oriented	O
metagenomic	O
datasetsMarine	O
MetagenomesPublicly	O
accessibleNoNational	O
Microbiome	O
Data	O
Collaborative	O
(	O
NMDC	O
)	O
A	O
platform	O
for	O
collaboration	O
and	O
data	O
sharing	O
among	O
researchers	O
studying	O
microbiomes	O
across	O
diverse	O
ecosystemsMicrobiome	O
DataPublicly	O
accessibleYes	O

Another	O
example	O
concerns	O
scDREAMER	B-BT
,	O
which	O
utilizes	O
batch	O
label	O
information	O
for	O
batch	O
alignment	O
but	O
does	O
not	O
incorporate	O
cell	O
type	O
labels	O
in	O
the	O
data	O
compression	O
and	O
decompression	O
process	O
.	O

Carriers	O
of	O
the	O
R1250Q	O
mutation	O
in	O
the	O
cytoplasmic	O
tail	O
(	O
Figure	O
7	O
)	O
exhibited	O
neither	O
altered	O
blood	O
ACE	O
levels	O
(	O
Figure	O
2	O
)	O
nor	O
any	O
changes	O
in	O
the	O
ZPHL	O
/	O
HHL	O
ratio	O
when	O
precipitated	O
with	O
different	O
mAbs	O
(	O
Figure	O
5	O
and	O
Figure	O
S4F	O
).	O

aureus	O
),	O
a	O
single	O
annotation	O
file	O
was	O
made	O
for	O
comparison	O
by	O
pooling	O
the	O
annotations	O
that	O
are	O
available	O
from	O
GenBank	O
with	O
the	O
annotations	O
provided	O
by	O
SubtiWiki	B-BT
,	O
EcoCyc	O
,	O
and	O
AureoWiki	O
,	O
respectively	O
,	O
in	O
order	O
to	O
encompass	O
as	O
many	O
known	O
annotations	O
as	O
possible	O
.	O

Clinical	O
variables	O
such	O
as	O
N	O
stage	O
,	O
age	O
,	O
and	O
T	O
stage	O
were	O
identified	O
as	O
having	O
the	O
most	O
significant	O
impact	O
on	O
DM	O
prediction	O
in	O
the	O
DM	O
-	O
slim	O
cohort	O
(	O
Figure	O
3D	O
).	O

Within	O
the	O
same	O
type	O
of	O
CRISPR	O
-	O
Sirius	O
system	O
,	O
sgRNAs	O
C6_sg1	O
and	O
C6_sg2	O
individually	O
were	O
equally	O
efficient	O
.	O

The	O
resulting	O
software	O
package	O
,	O
termed	O
MASSef	B-BT
(	O
the	O
Mass	O
Action	O
Stoichiometry	O
Simulation	O
Enzyme	O
Fitting	O
package	O
),	O
can	O
handle	O
standard	O
‘	O
macroscopic	O
’	O
kinetic	O
parameters	O
,	O
including	O
Km	O
,	O
kcat	O
,	O
Ki	O
,	O
Keq	O
,	O
and	O
nh	O
,	O
as	O
well	O
as	O
diverse	O
reaction	O
mechanisms	O
defined	O
in	O
terms	O
of	O
mass	O
action	O
reactions	O
and	O
‘	O
microscopic	O
’	O
rate	O
constants	O
.	O

WebMaBoSS	B-BT
also	O
allows	O
the	O
simulation	O
of	O
more	O
complex	O
tasks	O
such	O
as	O
parameter	O
sensitivity	O
analyses	O
.	O

Ghino	O
di	O
Tacco	O
,	O
having	O
cured	O
the	O
abbot	O
,	O
kneels	O
before	O
Pope	O
Boniface	O
VIII	O
.	O

Taken	O
together	O
,	O
to	O
our	O
best	O
knowledge	O
,	O
we	O
believe	O
LiverSCA	O
is	O
currently	O
one	O
of	O
the	O
most	O
comprehensive	O
liver	O
-	O
related	O
cell	O
atlases	O
and	O
we	O
will	O
continue	O
to	O
work	O
towards	O
future	O
enhancement	O
that	O
pinpointing	O
more	O
sample	O
cohorts	O
,	O
larger	O
cell	O
count	O
,	O
more	O
comprehensive	O
annotation	O
of	O
cell	O
types	O
and	O
the	O
possibility	O
to	O
identify	O
rare	O
cell	O
subpopulations	O
.	O
Table	O
2Comparison	O
of	O
functionality	O
of	O
cell	O
atlases	O
.	O
Table	O
2Functional	O
ModulesGene	O
ExpressionDEGORAGSEACCCTrajectorySurvivalLiverSCA	O
√√√√√√×	O
GepLiver	O
√√××××√	O
CancerLiver	B-BT
××√√×××	O
Liver	O
Cell	O
Atlas	O
√××××××	O
Liver	O
Single	O
Cell	O
Atlas	O
√××××××	O
Note	O
:	O
DEG	O
:	O
differently	O
expressed	O
gene	O
;	O
ORA	O
:	O
over	O
-	O
representation	O
analysis	O
of	O
DEG	O
;	O
GSEA	O
:	O
gene	O
set	O
enrichment	O
analysis	O
;	O
CCC	O
:	O
cell	O
-	O
cell	O
communication	O

The	O
TPM	O
values	O
are	O
retrieved	O
from	O
StCoExpNet	B-BT
[	O
37	O
].	O

This	O
short	O
-	O
term	O
exposure	O
of	O
PCLS	O
slices	O
to	O
erlotinib	O
did	O
not	O
significantly	O
reduce	O
the	O
amount	O
of	O
collagen	O
measured	O
with	O
Sirius	O
red	O
staining	O
(	O
Figures	O
2C	O
,	O
D	O
).	O

The	O
primary	O
aim	O
of	O
this	O
article	O
is	O
to	O
explore	O
the	O
enduring	O
legacy	O
of	O
Sven	O
Ivar	O
Seldinger	O
(	O
Figure	O
1	O
),	O
whose	O
technique	O
fundamentally	O
altered	O
the	O
practice	O
of	O
catheterization	O
.	O

Table	O
4Impact	O
of	O
complications	O
on	O
direct	O
medical	O
cots	O
across	O
different	O
cancer	O
typesLung	O
cancerBreast	O
cancerColorectal	O
cancerEsophageal	O
cancerLiver	O
cancerGastric	O
cancer	O
Complication	O
rate	O
192	O
/	O
2866	O
(	O
7	O
.	O
2	O
%)	O
121	O
/	O
2808	O
(	O
4	O
.	O
5	O
%)	O
227	O
/	O
2420	O
(	O
10	O
.	O
4	O
%)	O
243	O
/	O
1706	O
(	O
16	O
.	O
6	O
%)	O
192	O
/	O
1906	O
(	O
11	O
.	O
2	O
%)	O
189	O
/	O
2039	O
(	O
10	O
.	O
2	O
%)	O
CIC	O
(	O
Cost	O
increment	O
associated	O
with	O
complication	O
)	O
30	O
%	O
(	O
14	O
–	O
46	O
%)	O
22	O
%	O
(	O
3	O
–	O
41	O
%)	O
4	O
%	O
(-	O
11	O
–	O
19	O
%)	O
38	O
%	O
(	O
21	O
–	O
54	O
%)	O
8	O
%	O
(-	O
8	O
–	O
24	O
%)	O
2	O
%	O
(-	O
15	O
–	O
19	O
%)	O
Per	O
case	O
direct	O
medical	O
costs	O
Surgical	O
-	O
related	O
treatment11	O
,	O
911862211	O
,	O
35113	O
,	O
38610	O
,	O
42014	O
,	O
366Non	O
-	O
surgical	O
treatment907011	O
,	O
11810	O
,	O
28510	O
,	O
17193089690Follow	O
-	O
up	O
treatment472660578276417064875587Treatment	O
after	O
relapse	O
/	O
metastasis13	O
,	O
46116	O
,	O
45213	O
,	O
36811	O
,	O
97511	O
,	O
32810	O
,	O
382	O
PAF	O
%*	O
2	O
.	O
1	O
%	O
1	O
%	O
0	O
.	O
4	O
%	O
5	O
.	O
9	O
%	O
2	O
.	O
4	O
%	O
2	O
.	O
2	O
%	O
Cancer	O
-	O
related	O
direct	O
medical	O
costs	O
per	O
case	O
**	O
Surgical	O
-	O
related	O
treatment11	O
,	O
660853711	O
,	O
30412	O
,	O
59110	O
,	O
16914	O
,	O
050Non	O
-	O
surgical	O
treatment887911	O
,	O
00910	O
,	O
243956790849477Follow	O
-	O
up	O
treatment462659988242392263315464Treatment	O
after	O
relapse	O
/	O
metastasis13	O
,	O
17716	O
,	O
29113	O
,	O
31311	O
,	O
26411	O
,	O
05610	O
,	O
154Note	O
*	O
PAF	O
%,	O
Population	O
Attributable	O
Fraction	O
%,	O
calculated	O
by	O
:	O
complication	O
rate	O
*	O
CIC	O
/(	O
complication	O
rate	O
*	O
CIC	O
+	O
1	O
)**	O
Cancer	O
-	O
related	O
direct	O
medical	O
costs	O
per	O
case	O
=	O
Per	O
case	O
direct	O
medical	O
costs	O
*	O
PAF	O
%	O

The	O
high	O
correlation	O
suggests	O
that	O
the	O
probability	O
of	O
inter	O
-	O
chain	O
contacts	O
predicted	O
by	O
CDPred	B-BT
can	O
be	O
used	O
to	O
estimate	O
the	O
confidence	O
of	O
the	O
inter	O
-	O
chain	O
prediction	O
.	O
Fig	O
.	O

A	O
Amino	O
acid	O
sequence	O
alignment	O
of	O
equine	O
TK1	O
isoforms	O
with	O
human	O
TK1	O
using	O
the	O
Clustal	O
Omega	O
algorithm	O
(	O
https	O
://	O
www	O
.	O
ebi	O
.	O
ac	O
.	O
uk	O
/	O
Tools	O
/	O
msa	O
/	O
clustalo	O
/)	O
and	O
structural	O
alignment	O
using	O
ENDscript	B-BT
2	I-BT
.	I-BT
0	I-BT
software	O
(	O
http	O
://	O
endscript	O
.	O
ibcp	O
.	O
fr	O
/	O
ESPript	O
/	O
cgi	O
-	O
bin	O
/	O
ENDscript	O
.	O
cgi	O
)	O
with	O
the	O
human	O
TK1	O
structure	O
as	O
the	O
template	O
.	O

DeePhys	B-BT
allows	O
for	O
phenotypic	O
screenings	O
at	O
the	O
cellular	O
and	O
network	O
levels	O

In	O
brief	O
,	O
the	O
‘	O
SyntenyViewer	B-BT
’	O
module	O
can	O
not	O
only	O
reveal	O
syntenic	O
blocks	O
between	O
any	O
two	O
genome	O
sequences	O
but	O
also	O
connect	O
homologous	O
gene	O
pairs	O
in	O
syntenic	O
blocks	O
.	O

MaBoSS	B-BT
,	O
integrated	O
into	O
PhysiBoSS	O
2	O
.	O
0	O
,	O
can	O
perform	O
simulations	O
changing	O
the	O
proportion	O
of	O
activated	O
and	O
inhibited	O
status	O
of	O
a	O
given	O
node	O
.	O

The	O
interactive	O
cluster	O
for	O
Cluster_30	O
can	O
be	O
accessed	O
at	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
/	O
cluster	O
/	O
graph	O
/	O
367	O

The	O
milking	O
parlor	O
was	O
equipped	O
with	O
Metatron	O
electronic	O
milk	O
metres	O
,	O
P21	O
bail	O
controllers	O
,	O
and	O
electronic	O
identification	O
tags	O
(	O
Metatron	O
DairyPlan	O
,	O
GEA	O
GmbH	O
).	O

SHAPRs	B-BT
hyperparameters	O
,	O
such	O
as	O
the	O
learning	O
rate	O
and	O
number	O
of	O
model	O
weights	O
have	O
been	O
fixed	O
before	O
training	O
.	O

All	O
attacks	O
are	O
executed	O
against	O
the	O
thermostat	O
FlexStat	O
BAC	O
-	O
131136CEW	O
(	O
BACnet	O
Application	O
-	O
Specific	O
Controller	O
).	O

CDPred	B-BT
achieves	O
the	O
highest	O
contact	O
prediction	O
precision	O
across	O
the	O
board	O
among	O
all	O
the	O
methods	O
.	O

The	O
accuracy	O
of	O
the	O
annotation	O
transfer	O
procedure	O
by	O
AuCoMe	B-BT
was	O
further	O
assessed	O
using	O
two	O
pathways	O
in	O
which	O
there	O
were	O
clear	O
biological	O
expectations	O
in	O
the	O
algal	O
data	O
set	O
.	O

The	O
concordance	O
of	O
SNPs	O
called	O
by	O
GATK	O
and	O
BCFtools	B-BT
on	O
each	O
chromosome	O
.	O

“	O
Problems	O
paying	O
medical	O
bills	O
”	O
is	O
based	O
on	O
a	O
positive	O
response	O
to	O
the	O
question	O
,	O
“	O
In	O
the	O
past	O
12	O
months	O
,	O
did	O
you	O
/	O
anyone	O
in	O
the	O
family	O
have	O
problems	O
paying	O
or	O
were	O
unable	O
to	O
pay	O
any	O
medical	O
bills	O
?	O

In	O
response	O
to	O
these	O
challenges	O
,	O
our	O
research	O
has	O
developed	O
m6A	B-BT
-	I-BT
TCPred	I-BT
,	O
a	O
computational	O
predictor	O
that	O
integrates	O
sequence	O
feature	O
information	O
and	O
genomic	O
features	O
.	O

This	O
study	O
examines	O
the	O
formidable	O
and	O
complex	O
challenge	O
of	O
insider	O
threats	O
to	O
organizational	O
security	O
,	O
addressing	O
risks	O
such	O
as	O
ransomware	O
incidents	O
,	O
data	O
breaches	O
,	O
and	O
extortion	O
attempts	O
.	O

Lastly	O
,	O
trans	B-BT
-	I-BT
PCO	I-BT
tests	O
the	O
association	O
between	O
SNPs	O
and	O
gene	O
sets	O
by	O
using	O
PCO	O
.	O

The	O
EE	O
of	O
the	O
ACE	O
-	O
I	O
-	O
ALG	O
-	O
CS	O
NPs	O
was	O
calculated	O
by	O
subtracting	O
the	O
amount	O
of	O
residual	O
peptide	O
in	O
the	O
supernatant	O
after	O
centrifugation	O
from	O
the	O
total	O
amount	O
of	O
peptide	O
initially	O
added	O
for	O
encapsulation	O
according	O
to	O
the	O
following	O
relation	O
:	O

Enhancer	B-BT
-	I-BT
MDLF	I-BT
undergoes	O
thorough	O
evaluation	O
across	O
multiple	O
dimensions	O
to	O
assess	O
its	O
performance	O
.	O

In	O
summary	O
,	O
we	O
used	O
MINNO	B-BT
to	O
predict	O
six	O
reactions	O
in	O
purine	O
metabolism	O
for	O
B	O
.	O

We	O
considered	O
separately	O
the	O
best	O
prediction	O
by	O
iPHoP	B-BT
versus	O
the	O
set	O
of	O
hosts	O
predicted	O
by	O
iPHoP	B-BT
when	O
evaluating	O
its	O
performance	O
on	O
the	O
complete	O
host	O
range	O
studies	O
.	O

Recently	O
,	O
we	O
used	O
SynDesign	B-BT
to	O
develop	O
a	O
saturation	O
resistance	O
profiling	O
library	O
of	O
the	O
EGFR	O
gene	O
against	O
various	O
the	O
chemotherapy	O
drugs	O
,	O
afatinib	O
and	O
osimertinib	O
.	O

Various	O
types	O
of	O
cytoplasmic	O
inclusions	O
have	O
been	O
documented	O
in	O
plasma	O
cell	O
neoplasms	O
,	O
including	O
Russell	O
bodies	O
,	O
crystals	O
,	O
and	O
Auer	O
rod	O
‐	O
like	O
inclusions	O
,	O
while	O
azurophilic	O
granules	O
and	O
Snapper	O
‐	O
Schneid	O
bodies	O
remain	O
uncommon	O
.	O

A	O
guide	O
sheath	O
(	O
UMIDAS	O
sheath	O
cannula	O
;	O
UMIDAS	O
Inc	O
.,	O
Kanagawa	O
,	O
Japan	O
)	O
was	O
inserted	O
into	O
the	O
stricture	O
and	O
a	O
biliary	O
metallic	O
stent	O
with	O
an	O
ultraslim	O
delivery	O
system	O
(	O
YABUSAME	O
Neo	O
;	O
KANEKA	O
Medics	O
,	O
Tokyo	O
,	O
Japan	O
)	O
was	O
successfully	O
passed	O
and	O
placed	O
through	O
the	O
guide	O
sheath	O
.	O

Conservation	O
of	O
the	O
HbYX	O
motif	O
in	O
jawed	O
vertebrates	O
A	O
total	O
of	O
379	O
GPM6A	O
sequences	O
from	O
jawed	O
vertebrates	O
were	O
retrieved	O
,	O
and	O
an	O
MSA	O
was	O
constructed	O
using	O
Jalview	B-BT
,	O
highlighting	O
the	O
conserved	O
features	O
of	O
this	O
protein	O
.	O

The	O
IDSL_MINT	B-BT
transformer	O
model	O
architecture	O
for	O
predicting	O
molecular	O
fingerprint	O
is	O
displayed	O
in	O
Figs	O
.	O

The	O
Essex	O
Skipper	O
(	O
Thymelicus	O
lineola	O
),	O
also	O
known	O
as	O
the	O
European	O
Skipper	O
,	O
is	O
a	O
widely	O
distributed	O
butterfly	O
found	O
from	O
northern	O
Finland	O
to	O
North	O
Africa	O
,	O
and	O
from	O
Central	O
Asia	O
to	O
Great	O
Britain	O
.	O

MetaCerberus	O
has	O
provided	O
a	O
solution	O
to	O
this	O
scaling	O
issue	O
using	O
RAY	O
and	O
items	O
needed	O
from	O
our	O
kmer	O
counter	O
MerCat2	B-BT
.	O

Furthermore	O
,	O
Domain2GO	B-BT
‐	O
S	O
and	O
Domain2GO	B-BT
‐	O
E	O
outperformed	O
the	O
baseline	O
predictors	O
and	O
DomFun	O
when	O
predicting	O
MF	O
and	O
BP	O
terms	O
,	O
achieving	O
Fmax	O
scores	O
of	O
0	O
.	O
48	O
and	O
0	O
.	O
46	O
for	O
MFO	O
,	O
and	O
0	O
.	O
36	O
and	O
0	O
.	O
35	O
for	O
BPO	O
,	O
respectively	O
.	O

PyChelator	B-BT
is	O
a	O
single	O
page	O
application	O
where	O
users	O
can	O
switch	O
constants	O
by	O
the	O
use	O
of	O
a	O
dropdown	O
menu	O
.	O

The	O
article	O
“	O
Concurrent	O
management	O
of	O
multiple	O
sclerosis	O
and	O
natalizumab	O
‑	O
induced	O
hepatitis	O
with	O
ofatumumab	O
:	O
a	O
case	O
report	O
”,	O
written	O
by	O
Shalom	O
Haggiag	O
,	O
Valerio	O
Giannelli	O
,	O
Luca	O
Prosperini	O
,	O
Alessandro	O
Cruciani	O
,	O
Andrea	O
Baiocchini	O
,	O
Serena	O
Ruggieri	O
,	O
Adriano	O
Pellicelli	O
,	O
Claudio	O
Gasperini	O
and	O
Carla	O
Tortorella	O
,	O
was	O
originally	O
published	O
electronically	O
on	O
the	O
publisher	O
’	O
s	O
internet	O
portal	O
on	O
11	O
July	O
2024	O
without	O
open	O
access	O
.	O

Effect	O
of	O
inoculation	O
access	O
period	O
(	O
IAP	O
)	O
on	O
the	O
transmission	O
of	O
cowpea	O
mild	O
mottle	O
virus	O
by	O
Bemisia	O
tabaci	O
Middle	O
East	O
–	O
Asia	O
Minor	O
1	O
and	O
Bemisia	O
tabaci	O
Mediterranean	O
.	O

We	O
provide	O
a	O
case	O
study	O
integrating	O
enzyme	O
modules	O
within	O
a	O
mass	O
action	O
model	O
of	O
glycolysis	O
as	O
a	O
Jupyter	O
notebook	O
workflow	O
implemented	O
in	O
Python	O
(	O
scripts	O
available	O
on	O
github	O
.	O
com	O
/	O
opencobra	O
/	O
massef	B-BT
).	O

The	O
integration	O
of	O
emerging	O
natural	O
language	O
processing	O
NLP	O
techniques	O
with	O
robust	O
classifiers	O
for	O
enhancing	O
the	O
detection	O
capabilities	O
for	O
addressing	O
insider	O
threats	O
.	O

The	O
Fiji	O
costing	O
study	O
estimated	O
the	O
costs	O
per	O
bed	O
day	O
for	O
the	O
two	O
hospitals	O
(	O
LTK	O
and	O
CWM	O
),	O
so	O
we	O
used	O
the	O
lower	O
of	O
the	O
values	O
to	O
obtain	O
conservative	O
estimates	O
.	O

Visualization	O
efficiency	O
for	O
two	O
types	O
of	O
CRISPR	O
-	O
Sirius	O
system	O
with	O
different	O
target	O
loci	O
.	O

Effect	O
of	O
retention	O
period	O
(	O
RP	O
)	O
on	O
the	O
transmission	O
of	O
cowpea	O
mild	O
mottle	O
virus	O
by	O
Bemisia	O
tabaci	O
Middle	O
East	O
–	O
Asia	O
Minor	O
1	O
and	O
Bemisia	O
tabaci	O
Mediterranean	O
.	O

The	O
three	O
-	O
dimensional	O
structures	O
of	O
each	O
PCG	O
were	O
drawn	O
in	O
SWISS	O
-	O
MODEL	O
software	O
[	O
40	O
]	O
from	O
the	O
amino	O
acid	O
sequence	O
using	O
ENDscript	B-BT
2	I-BT
.	I-BT
0	I-BT
to	O
identify	O
the	O
α	O
-	O
helices	O
and	O
β	O
-	O
sheets	O
[	O
41	O
]	O
and	O
PyMOL	O
[	O
42	O
]	O
for	O
later	O
editing	O
.	O

Provide	O
:/	O
home	O
/	O
user	O
/	O
skipper	B-BT
/	O
annotations	O
/	O
genome_ref	O

One	O
limitation	O
of	O
the	O
CAMI	O
ePGDB	O
as	O
a	O
benchmark	O
is	O
that	O
it	O
is	O
automatically	O
generated	O
using	O
MetaPathways	B-BT
but	O
the	O
predictions	O
have	O
not	O
been	O
curated	O
so	O
it	O
can	O
be	O
said	O
that	O
the	O
results	O
demonstrate	O
more	O
how	O
similar	O
the	O
other	O
prediction	O
methods	O
are	O
with	O
MetaPathways	B-BT
and	O
PathoLogic	O
than	O
their	O
actual	O
prediction	O
performance	O
.	O

The	O
names	O
(	O
alcoholic	O
liver	O
injury	O
,	O
alcoholic	O
liver	O
disease	O
,	O
middle	O
alcoholic	O
injury	O
,	O
alcoholic	O
fatty	O
liver	O
,	O
alcohol	O
hepatitis	O
,	O
alcoholic	O
hepatic	O
fibrosis	O
,	O
alcoholic	O
cirrhosis	O
)	O
of	O
the	O
disease	O
related	O
to	O
ALD	O
are	O
inputted	O
into	O
the	O
disease	O
ID	O
retrieval	O
module	O
of	O
TCMNPAS	B-BT
,	O
which	O
automatically	O
connects	O
with	O
the	O
GeneCard	O
database	O
(	O
https	O
://	O
www	O
.	O
genecards	O
.	O
org	O
/)	O
to	O
obtain	O
the	O
disease	O
ID	O
,	O
and	O
then	O
inputs	O
the	O
obtained	O
ID	O
into	O
the	O
disease	O
gene	O
retrieval	O
module	O
of	O
TCMNPAS	B-BT
to	O
automatically	O
obtain	O
the	O
related	O
gene	O
targets	O
of	O
ALD	O
.	O

Comprehensive	O
Rend	O
-	O
seq	O
annotation	O
files	O
supplied	O
from	O
publicly	O
available	O
databases	O
(	O
SubtiWiki	B-BT
[	O
33	O
],	O
EcoCyc	O
[	O
35	O
],	O
and	O
AureoWiki	O
[	O
34	O
])	O
and	O
NCBI	O
GenBank	O
files	O
for	O
B	O
.	O

To	O
address	O
these	O
challenges	O
in	O
the	O
transcriptome	O
analyses	O
,	O
we	O
propose	O
IBDTransDB	B-BT
(	O
https	O
://	O
abbviegrc	O
.	O
shinyapps	O
.	O
io	O
/	O
ibdtransdb	B-BT
/),	O
a	O
manually	O
curated	O
transcriptomic	O
database	O
for	O
IBD	O
.	O

BIDCell	B-BT
is	O
a	O
DL	O
-	O
based	O
cell	O
segmentation	O
method	O
that	O
identifies	O
each	O
individual	O
cell	O
and	O
all	O
its	O
pixels	O
as	O
a	O
cohesive	O
mask	O
.	O

Different	O
from	O
the	O
DL	O
frameworks	O
of	O
the	O
other	O
models	O
,	O
NanoDeep	B-BT
includes	O
a	O
pretrained	O
model	O
to	O
classify	O
microbes	O
from	O
mammals	O
based	O
on	O
the	O
finding	O
that	O
the	O
signals	O
of	O
6	O
-	O
mers	O
in	O
bacterial	O
genomes	O
are	O
distinct	O
from	O
those	O
in	O
the	O
human	O
genome	O
[	O
20	O
].	O

In	O
MetaTron	B-BT
,	O
two	O
Fleiss	O
’	O
kappa	O
agreement	O
values	O
are	O
computed	O
for	O
each	O
annotation	O
type	O
:	O
one	O
concerns	O
the	O
entire	O
collection	O
of	O
documents	O
,	O
and	O
one	O
concerns	O
each	O
single	O
document	O
.	O

Supplemental	O
material	O
,	O
sj	O
-	O
docx	O
-	O
1	O
-	O
qjp	O
-	O
10	O
.	O
1177_17470218231211549	O
for	O
The	O
irrepressible	O
influence	O
of	O
vocal	O
stereotypes	O
on	O
trust	O
by	O
Ilaria	O
Torre	O
,	O
Laurence	O
White	O
,	O
Jeremy	O
Goslin	O
and	O
Sarah	O
Knight	O
in	O
Quarterly	O
Journal	O
of	O
Experimental	O
Psychology	O

The	O
resulting	O
protein	O
function	O
prediction	O
set	O
contains	O
5	O
,	O
046	O
,	O
060	O
GO	O
term	O
predictions	O
for	O
291	O
,	O
519	O
proteins	O
and	O
11	O
,	O
742	O
GO	O
terms	O
,	O
which	O
are	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
HUBioDataLab	O
/	O
Domain2GO	B-BT
.	O

BUSCO	O
:	O
--	O
evalue	O
1e	O
-	O
03	O
,	O
-	O
sp	O
Arabidopsis	O
.	O
LACHESIS	O
:	O
CLUSTER_MIN_RE_SITES	O
=	O
30	O
;	O
CLUSTER_MAX_LINK_DENSITY	O
=	O
2	O
;	O
CLUSTER_NONINFORMATIVE_RATIO	O
=	O
2	O
;	O
ORDER_MIN_N_RES_IN_TRUN	O
=	O
49	O
;	O
ORDER_MIN_N_RES_IN_SHREDS	O
=	O
49	O
.	O
Software	O
parameters	O
of	O
repeat	O
annotation	O
:	O
default	O
parameters	O
for	O
LTR_FINDER	O
,	O
RepeatScout	O
,	O
and	O
PASTEClassifier	B-BT
.	O

Second	O
,	O
trans	B-BT
-	I-BT
PCO	I-BT
and	O
ARCHIE	O
are	O
designed	O
to	O
capture	O
different	O
trans	O
-	O
regulatory	O
effects	O
.	O

Once	O
data	O
preprocessing	O
and	O
MS	O
1	O
annotation	O
using	O
MZmine	B-BT
was	O
done	O
,	O
the	O
molecular	O
network	O
was	O
generated	O
.	O

In	O
this	O
study	O
,	O
patients	O
identified	O
by	O
MatchMiner	B-BT
consented	O
to	O
clinical	O
trials	O
55	O
days	O
earlier	O
than	O
those	O
included	O
through	O
traditional	O
methods	O
,	O
demonstrating	O
the	O
ability	O
of	O
these	O
tools	O
to	O
simplify	O
inclusion	O
workflows	O
.	O
16	O

KinCytE	B-BT
links	O
the	O
release	O
of	O
cytokines	O
and	O
chemokines	O
to	O
kinase	O
activity	O
and	O
recommends	O
drugs	O
that	O
target	O
specific	O
cytokine	O
sets	O
,	O
as	O
well	O
as	O
identifies	O
kinases	O
and	O
kinase	O
-	O
related	O
proteins	O
that	O
may	O
be	O
involved	O
.	O

In	O
contrast	O
,	O
for	O
the	O
Figure	O
1A	O
scenario	O
,	O
BayesKAT	B-BT
calculated	O
the	O
posterior	O
probability	O
of	O
a	O
true	O
association	O
given	O
the	O
data	O
P	O
(\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}	O
$	O
H_	O
{	O
1	O
}|	O
data	O
$\	O
end	O
{	O
document	O
})=	O
0	O
.	O
19	O
,	O
i	O
.	O
e	O
.	O

TCMNPAS	B-BT
provides	O
two	O
methods	O
for	O
consolidating	O
highly	O
similar	O
core	O
formulas	O
:	O
“	O
Together	O
,”	O
which	O
merges	O
highly	O
similar	O
core	O
formulas	O
collectively	O
,	O
and	O
“	O
Step	O
,”	O
which	O
incrementally	O
merges	O
highly	O
similar	O
core	O
formulas	O
.	O

Completed	O
Skipper	B-BT
run	O

For	O
example	O
,	O
the	O
Hmrbase	B-BT
database	O
provides	O
a	O
comprehensive	O
resource	O
of	O
available	O
information	O
on	O
hormones	O
and	O
their	O
receptors	O
[	O
78	O
].	O

Furthermore	O
,	O
our	O
method	O
has	O
a	O
very	O
good	O
balance	O
between	O
batch	O
effect	O
correction	O
and	O
biological	O
variance	O
conservation	O
,	O
compared	O
to	O
Seurat	O
and	O
scDREAMER	B-BT
for	O
example	O
,	O
who	O
received	O
high	O
batch	O
effect	O
correction	O
scores	O
but	O
low	O
biological	O
variance	O
conservation	O
scores	O
(	O
Fig	O
.	O

The	O
authors	O
have	O
developed	O
an	O
in	O
-	O
silico	O
tool	O
,	O
named	O
PhageTB	B-BT
,	O
for	O
the	O
prediction	O
of	O
phage	O
-	O
bacteria	O
interactions	O
with	O
high	O
accuracy	O
.	O

On	O
the	O
other	O
hand	O
,	O
CancerLiver	B-BT
(	O
https	O
://	O
webs	O
.	O
iiitd	O
.	O
edu	O
.	O
in	O
/	O
raghava	O
/	O
cancerliver	B-BT
/)	O
is	O
more	O
focused	O
on	O
functional	O
enrichment	O
and	O
it	O
includes	O
GSEA	O
on	O
both	O
GO	O
and	O
KEGG	O
.	O

In	O
addition	O
to	O
the	O
typical	O
viruses	O
and	O
tlaRNAs	O
known	O
to	O
cause	O
CMD	O
and	O
to	O
occur	O
in	O
the	O
U	O
.	O
S	O
.—	O
the	O
polerovirus	O
carrot	O
red	O
leaf	O
virus	O
(	O
CtRLV	O
),	O
the	O
umbraviruses	O
carrot	O
mottle	O
virus	O
(	O
CMoV	O
)	O
and	O
carrot	O
mottle	O
mimic	O
virus	O
(	O
CMoMV	O
),	O
and	O
CtRLVaRNAs	O
(	O
CtRLVaRNAs	O
)—	O
we	O
identified	O
the	O
emergent	O
poleroviruses	O
Torilis	O
crimson	O
leaf	O
virus	O
(	O
TorCLV	O
)	O
and	O
Foeniculum	O
vulgare	O
polerovirus	O
(	O
FvPV	O
),	O
two	O
potentially	O
divergent	O
,	O
strains	O
of	O
CMoV	O
,	O
which	O
we	O
refer	O
to	O
by	O
the	O
names	O
given	O
them	O
in	O
published	O
reports	O
—	O
Pastinaca	O
umbravirus	O
1	O
(	O
PasUV1	O
)	O
and	O
wild	O
carrot	O
mottle	O
virus	O
(	O
WCMoV	O
),	O
and	O
the	O
tlaRNA	O
,	O
arracacha	O
latent	O
virus	O
E	O
associated	O
RNA	O
(	O
ALVEaRNA	O
),	O
none	O
of	O
which	O
have	O
been	O
previously	O
identified	O
in	O
the	O
U	O
.	O
S	O
.	O

The	O
EMulate	O
Therapeutics	O
Voyager	O
system	O
,	O
as	O
explored	O
in	O
this	O
study	O
was	O
produced	O
for	O
EMulate	O
Therapeutics	O
Inc	O
.	O

The	O
surface	O
morphology	O
is	O
significantly	O
smoother	O
with	O
minimal	O
corrosion	O
products	O
and	O
pitting	O
.	O

The	O
rNMPID	B-BT
database	O
uses	O
datasets	O
generated	O
by	O
different	O
rNMP	O
-	O
mapping	O
techniques	O
.	O

This	O
research	O
was	O
funded	O
by	O
CHU	O
Nîmes	O
,	O
grant	O
number	O
:	O
Thematique	O
Phare	O
1	O
.	O

This	O
presentation	O
will	O
shed	O
light	O
on	O
the	O
expansion	O
of	O
digital	O
technologies	O
and	O
health	O
data	O
in	O
health	O
policy	O
in	O
the	O
face	O
of	O
data	O
science	O
,	O
highlighting	O
the	O
need	O
to	O
delve	O
into	O
the	O
terminology	O
of	O
DiPH	O
,	O
understanding	O
its	O
boundaries	O
and	O
legal	O
differences	O
from	O
its	O
neighbors	O
(	O
not	O
twins	O
)	O
outside	O
health	O
policy	O
.	O

Using	O
the	O
phageTB	B-BT
tool	O
,	O
this	O
was	O
also	O
evident	O
as	O
there	O
was	O
no	O
interaction	O
of	O
the	O
phage	O
genome	O
analysis	O
with	O
the	O
host	O
K	O
.	O

We	O
compared	O
two	O
common	O
nontargeted	O
MS2	O
acquisition	O
strategies	O
with	O
liquid	O
chromatography	O
high	O
-	O
resolution	O
mass	O
spectrometry	O
for	O
structural	O
annotation	O
accuracy	O
by	O
SIRIUS	B-BT
+	O
CSI	O
:	O
FingerID	O
and	O
MS2Tox	O
toxicity	O
prediction	O
of	O
191	O
reference	O
chemicals	O
spiked	O
to	O
LC	O
-	O
MS	O
water	O
,	O
groundwater	O
,	O
surface	O
water	O
,	O
and	O
wastewater	O
.	O

Consequently	O
,	O
it	O
is	O
unknown	O
if	O
the	O
specimens	O
were	O
initially	O
smoother	O
or	O
rougher	O
and	O
whether	O
the	O
difference	O
shown	O
following	O
the	O
treatments	O
was	O
actually	O
brought	O
about	O
by	O
the	O
variations	O
in	O
traditional	O
oven	O
-	O
and	O
microwave	O
-	O
glazing	O
methods	O
.	O

Table	O
1An	O
overview	O
of	O
benchmarked	O
variant	O
callersVariant	O
CallerUMI	O
AwarenessType	O
of	O
VariantInput	O
Files	O
bcftools	B-BT
NoSNP	O
+	O
IndelBAM	O
FreeBayes	O
NoSNP	O
+	O
IndelBAM	O
LoFreq	O
NoSNP	O
+	O
IndelBAM	O
Mutect2	O
NoSNP	O
+	O
IndelBAM	O
UMIErrorCorrect	O
YesSNPFASTQ	O
UMI	O
-	O
VarCal	O
YesSNP	O
+	O
indelBAM	O

The	O
value	O
in	O
top	O
-	O
right	O
triangle	O
presents	O
the	O
number	O
of	O
common	O
ASRS	O
SNPs	O
;	O
the	O
value	O
in	O
bottom	O
-	O
left	O
triangle	O
presents	O
the	O
Pearson	O
correlation	O
coefficient	O
of	O
the	O
AStruct	B-BT
scores	O
.	O

There	O
is	O
currently	O
no	O
additional	O
information	O
available	O
on	O
the	O
alteration	O
in	O
activity	O
of	O
the	O
VL	O
muscle	O
and	O
its	O
connection	O
to	O
foot	O
abnormalities	O
,	O
indicating	O
a	O
need	O
for	O
further	O
research24	O
,	O
25	O
.	O

Here	O
,	O
we	O
present	O
GeNLP	B-BT
,	O
a	O
web	O
application	O
aimed	O
to	O
allow	O
users	O
to	O
explore	O
the	O
“	O
semantic	O
relationships	O
”	O
between	O
thousands	O
of	O
microbial	O
gene	O
families	O
without	O
requiring	O
any	O
programming	O
expertise	O
.	O

PathoLogic	O
was	O
not	O
included	O
in	O
the	O
comparison	O
since	O
MetaPathways	B-BT
uses	O
it	O
to	O
create	O
the	O
ePGDB	O
.	O

Additional	O
specialized	O
resources	O
are	O
related	O
to	O
the	O
environmental	O
microbiome	O
(	O
Marine	B-BT
Metagenomics	I-BT
Portal	I-BT
,	O
Coral	O
Microbiome	O
Database	O
,	O
TerrestrialMetagenomeDB	O
,	O
Animal	O
Microbiome	O
Database	O
[	O
AMDB	O
]),	O
specific	O
to	O
a	O
particular	O
site	O
in	O
the	O
human	O
body	O
(	O
Human	O
Oral	O
Microbiome	O
Database	O
,	O
SKIOME	O
Project	O
,	O
the	O
Human	O
Pan	O
-	O
Microbe	O
Communities	O
[	O
HPMC	O
]	O
database	O
,	O
GMrepo	O
:	O
data	O
repository	O
for	O
Gut	O
Microbiota	O
,	O
mBodyMap	O
)	O
or	O
related	O
to	O
microbiome	O
research	O
analysis	O
(	O
gutMDisorder	O
,	O
MicrobiomeDB	O
,	O
Disbiome	O
database	O
)	O
(	O
12	O
–	O
23	O
).	O

Here	O
we	O
introduce	O
kmerDB	B-BT
,	O
a	O
novel	O
repository	O
that	O
contains	O
kmer	O
,	O
nullomer	O
,	O
nullpeptide	O
,	O
quasi	O
-	O
prime	O
,	O
and	O
prime	O
sequences	O
for	O
54	O
,	O
039	O
reference	O
genomes	O
and	O
21	O
,	O
865	O
reference	O
proteomes	O
.	O

Cooltools	B-BT
implements	O
a	O
HiCCUPs	O
-	O
style	O
[	O
41	O
]	O
approach	O
for	O
peak	O
detection	O
(	O
Fig	O
6	O
):	O
briefly	O
,	O
(	O
i	O
)	O
maps	O
are	O
queried	O
with	O
a	O
dense	O
set	O
of	O
tiles	O
that	O
fit	O
easily	O
into	O
memory	O
,	O
(	O
ii	O
)	O
convolutional	O
kernels	O
are	O
swept	O
across	O
map	O
tiles	O
to	O
score	O
all	O
pixels	O
for	O
local	O
enrichment	O
(	O
iii	O
)	O
significant	O
pixels	O
are	O
determined	O
by	O
thresholding	O
relative	O
to	O
their	O
local	O
background	O
expected	O
values	O
,	O
using	O
a	O
modified	O
Benjamini	O
-	O
Hochberg	O
FDR	O
procedure	O
(	O
iv	O
)	O
adjacent	O
significant	O
pixels	O
are	O
optionally	O
clustered	O
and	O
further	O
filtered	O
by	O
enrichment	O
.	O

We	O
developed	O
an	O
R	O
package	O
called	O
vizAPA	B-BT
for	O
visualizing	O
APA	O
dynamics	O
from	O
bulk	O
and	O
single	O
-	O
cell	O
data	O
.	O

The	O
only	O
two	O
times	O
the	O
images	O
are	O
displayed	O
to	O
the	O
users	O
are	O
in	O
Cellpose	O
for	O
the	O
determination	O
of	O
segmentation	O
parameters	O
,	O
and	O
in	O
Fiji	B-BT
for	O
verification	O
of	O
segmentation	O
.	O

For	O
instance	O
,	O
NanoDeep	B-BT
,	O
which	O
performed	O
best	O
except	O
ReadCurrent	O
,	O
had	O
a	O
10	O
%–	O
11	O
%	O
decrease	O
.	O

We	O
first	O
started	O
modeling	O
the	O
signaling	O
pathways	O
of	O
a	O
single	O
cell	O
with	O
MaBoSS	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
sysbio	O
-	O
curie	O
/	O
MaBoSS	O
-	O
env	O
-	O
2	O
.	O
0	O
)	O
[	O
13	O
],	O
[	O
14	O
]	O
and	O
WebMaBoSS	B-BT
,	O
a	O
user	O
-	O
friendly	O
web	O
interface	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
sysbio	O
-	O
curie	O
/	O
WebMaBoSS	B-BT
)	O
[	O
35	O
].	O

The	O
chemical	O
components	O
and	O
potential	O
targets	O
of	O
QGHXR	O
obtained	O
from	O
TCMNPAS	B-BT
database	O
,	O
as	O
well	O
as	O
the	O
information	O
of	O
ALD	O
targets	O
were	O
sorted	O
out	O
,	O
and	O
QGHXR	O
-	O
chemical	O
components	O
-	O
targets	O
-	O
ALD	O
network	O
map	O
was	O
established	O
by	O
Cytoscape	O
3	O
.	O
8	O
.	O
2	O
.	O

This	O
cross	O
-	O
sectional	O
survey	O
was	O
part	O
of	O
a	O
broader	O
study	O
to	O
strengthen	O
food	O
policies	O
in	O
Fiji	O
[	O
21	O
].	O

Based	O
on	O
the	O
above	O
test	O
results	O
,	O
it	O
can	O
be	O
concluded	O
that	O
under	O
low	O
-	O
energy	O
impacts	O
,	O
the	O
toughness	O
due	O
to	O
the	O
addition	O
of	O
EMAA	O
stitching	O
can	O
absorb	O
part	O
of	O
the	O
impact	O
energy	O
,	O
so	O
that	O
the	O
damage	O
on	O
the	O
surface	O
of	O
the	O
specimen	O
is	O
less	O
serious	O
,	O
and	O
there	O
is	O
no	O
obvious	O
sign	O
of	O
damage	O
expansion	O
along	O
the	O
matrix	O
crack	O
.	O

Unlike	O
sRNAfrag	B-BT
,	O
Flaimapper	O
generates	O
annotations	O
for	O
users	O
,	O
which	O
is	O
admittedly	O
convenient	O
.	O

Specifically	O
,	O
higher	O
levels	O
of	O
benzaldehyde	O
(	O
Ald8	O
)	O
and	O
benzenecetaldehyde	O
(	O
Ald9	O
),	O
which	O
are	O
VOCs	O
with	O
a	O
high	O
sensory	O
impact	O
,	O
in	O
GP	O
-	O
20	O
and	O
GP	O
-	O
30	O
biscuits	O
should	O
stem	O
from	O
pomace	O
by	O
effect	O
of	O
the	O
characteristic	O
fermentative	O
activities	O
during	O
the	O
winemaking	O
process	O
[	O
24	O
].	O

coli	O
(	O
strain	O
s_6558	O
),	O
Klebsiella	O
pneumoniae	O
(	O
strain	O
4300STDY7045912	O
),	O
and	O
Salmonella	O
enterica	O
(	O
strain	O
350627	O
)	O
were	O
compared	O
with	O
Jalview	B-BT
.	O

Kmer	O
data	O
from	O
kmerDB	B-BT
can	O
find	O
applications	O
in	O
comparative	O
genomics	O
and	O
evolutionary	O
studies	O
[	O
42	O
],	O
[	O
50	O
],	O
aiding	O
sequence	O
specification	O
like	O
identifying	O
highly	O
-	O
specific	O
CRISPR	O
target	O
sites	O
[	O
60	O
].	O

In	O
terms	O
of	O
performance	O
comparison	O
,	O
both	O
deepDegron	O
and	O
DEGRONOPEDIA	B-BT
were	O
developed	O
for	O
predicting	O
N	O
-/	O
C	O
-	O
degrons	O
,	O
whereas	O
only	O
Degpred	O
supported	O
the	O
prediction	O
of	O
internal	O
degron	O
and	O
E3	O
-	O
degron	O
interactions	O
.	O

Acquisition	O
,	O
analysis	O
,	O
or	O
interpretation	O
of	O
data	O
:	O
Ricardo	O
Noguera	O
Louzada	O
,	O
Dillan	O
Cunha	O
Amaral	O
,	O
Claudio	O
do	O
Carmo	O
Chaves	O
Filho	O
,	O
Daniel	O
Oliveira	O
Dantas	O
,	O
Francisco	O
Carlos	O
de	O
Castro	O
Neto	O
,	O
Milton	O
Ruiz	O
Alves	O

The	O
code	O
to	O
run	O
DeePhys	B-BT
and	O
to	O
reproduce	O
the	O
figures	O
is	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
hornauerp	O
/	O
DeePhys	B-BT
.	O
git	O
.	O

The	O
steps	O
to	O
contributing	O
to	O
the	O
project	O
are	O
described	O
on	O
the	O
GitHub	O
page	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
Popgen48	O
/	O
scalepopgen	B-BT
).	O

CDPred	B-BT
simultaneously	O
uses	O
the	O
tertiary	O
structural	O
information	O
(	O
i	O
.	O
e	O
.,	O
intra	O
-	O
chain	O
distance	O
map	O
of	O
monomers	O
),	O
sequential	O
information	O
(	O
PSSM	O
),	O
and	O
residue	O
-	O
residue	O
co	O
-	O
evolutionary	O
information	O
(	O
i	O
.	O
e	O
.,	O
co	O
-	O
evolutionary	O
scores	O
calculated	O
by	O
CCMpred	O
and	O
attention	O
maps	O
by	O
MSA	O
transformer	O
)	O
as	O
input	O
to	O
predict	O
inter	O
-	O
chain	O
distance	O
maps	O
.	O

For	O
data	O
visualization	O
,	O
heatmaps	O
were	O
generated	O
by	O
GraphPad	O
Prism	O
version	O
9	O
,	O
venn	O
diagrams	O
were	O
made	O
in	O
VennDis	O
,	O
72	O
boxplots	O
were	O
made	O
in	O
BoxPlotR	O
,	O
73	O
pie	O
charts	O
were	O
made	O
in	O
Imgflip	O
(	O
https	O
://	O
imgflip	O
.	O
com	O
/	O
chart	O
-	O
maker	O
),	O
while	O
peptide	O
profiles	O
and	O
peptide	O
alignment	O
maps	O
were	O
made	O
using	O
the	O
web	O
-	O
based	O
application	O
Peptigram	O
.	O
74	O
Finally	O
,	O
iceLogos	O
were	O
generated	O
using	O
the	O
iceLogo	O
server	O
,	O
27	O
using	O
the	O
cleavage	O
environment	O
of	O
the	O
detected	O
peptides	O
obtained	O
with	O
CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
.	O
75	O
For	O
this	O
purpose	O
,	O
the	O
Uniprot	O
database71	O
was	O
used	O
to	O
retrieve	O
the	O
full	O
protein	O
sequences	O
of	O
the	O
identified	O
peptides	O
.	O

IBDTransDB	B-BT
also	O
provides	O
three	O
modules	O
for	O
data	O
analyses	O
and	O
integration	O
.	O

We	O
present	O
shinyseg	B-BT
,	O
a	O
comprehensive	O
web	O
application	O
for	O
clinical	O
cosegregation	O
analysis	O
.	O

This	O
data	O
can	O
be	O
found	O
here	O
:	O
https	O
://	O
github	O
.	O
com	O
/	O
sysbio	O
-	O
curie	O
/	O
WebMaBoSS	B-BT
.	O

These	O
databases	O
are	O
ClinVar	O
,	O
Global	O
Variome	O
shared	O
LOVD	O
,	O
the	O
Globin	O
Gene	O
Server	O
/	O
HbVar	O
,	O
the	O
Malaysian	O
Node	O
of	O
the	O
Human	O
Variome	O
Project	O
Database	O
(	O
MyHVPDb	O
),	O
and	O
ITHANET	B-BT
.	O

Several	O
parameters	O
can	O
be	O
set	O
during	O
GEMLI	B-BT
predictions	O
:	O
(	O
1	O
)	O
the	O
sampling	O
value	O
(	O
which	O
fraction	O
of	O
genes	O
is	O
selected	O
for	O
each	O
repetition	O
of	O
the	O
iterative	O
hierarchical	O
clustering	O
),	O
(	O
2	O
)	O
the	O
number	O
of	O
repetitions	O
of	O
the	O
iterative	O
clustering	O
(	O
based	O
on	O
which	O
the	O
confidence	O
level	O
is	O
calculated	O
),	O
(	O
3	O
)	O
the	O
number	O
of	O
clusters	O
in	O
which	O
clusters	O
are	O
split	O
during	O
each	O
iteration	O
(“	O
cluster	O
cut	O
”)	O
and	O
(	O
4	O
)	O
the	O
size	O
of	O
clusters	O
at	O
which	O
clustering	O
iterations	O
are	O
stopped	O
(“	O
lineage	O
size	O
parameter	O
”).	O

Most	O
steps	O
in	O
tiny	O
-	O
count	O
and	O
tinyRNA	B-BT
run	O
concurrently	O
across	O
libraries	O
to	O
minimize	O
runtime	O
.	O

The	O
gp120	O
V1	O
/	O
V2	O
loop	O
,	O
gp120	O
V3	O
-	O
glycan	O
,	O
and	O
gp120	O
/	O
gp41	O
interface	O
sites	O
were	O
identified	O
by	O
HIResist	B-BT
(	O
https	O
://	O
hiresist	B-BT
.	O
umn	O
.	O
edu	O
/)	O
using	O
data	O
sourced	O
from	O
CATNAP	O
(	O
Los	O
Alamos	O
National	O
Laboratory	O
).	O

Equally	O
,	O
30	O
/	O
82	O
(	O
37	O
%)	O
of	O
SLiM	O
-	O
positive	O
patients	O
have	O
accompanying	O
CRAB	O
criteria	O
.	O

FlexStat	B-BT
accepts	O
a	O
simpler	O
input	O
format	O
and	O
is	O
equipped	O
with	O
comprehensive	O
data	O
preprocessing	O
steps	O
including	O
missing	O
value	O
imputation	O
and	O
normalization	O
algorithms	O
.	O

IDSL_MINT	B-BT
only	O
takes	O
MS	O
/	O
MS	O
spectra	O
accompanied	O
with	O
precursor	O
m	O
/	O
z	O
values	O
in	O
the	O
.	O
msp	O
text	O
format	O
.	O

Measures	O
should	O
be	O
taken	O
in	O
design	O
to	O
strengthen	O
these	O
two	O
places	O
to	O
ensure	O
the	O
performance	O
of	O
the	O
assembled	O
arch	O
structure	O
.	O

The	O
widths	O
of	O
the	O
bars	O
indicate	O
the	O
relative	O
frequency	O
of	O
the	O
haplotype	O
written	O
on	O
the	O
bar	O
as	O
determined	O
by	O
the	O
PHARE	B-BT
pipeline	O
.	O

Finally	O
,	O
the	O
WebMaBoss	B-BT
(	O
Noël	O
et	O
al	O
.)	O
web	O
interface	O
enables	O
easy	O
manipulation	O
of	O
Boolean	O
models	O
and	O
further	O
simulation	O
of	O
Boolean	O
networks	O
,	O
such	O
as	O
biological	O
networks	O
involved	O
in	O
gene	O
regulation	O
or	O
signaling	O
,	O
followed	O
by	O
online	O
visualization	O
and	O
analysis	O
.	O

Nonetheless	O
,	O
BaRDIC	B-BT
robustly	O
captures	O
background	O
features	O
of	O
both	O
OTA	O
and	O
ATA	O
data	O
to	O
detect	O
specific	O
RNA	O
–	O
DNA	O
interactions	O
.	O

DandD	B-BT
uses	O
a	O
measure	O
from	O
data	O
compression	O
to	O
measure	O
amount	O
of	O
distinct	O
sequence	O

The	O
3D	O
profile	O
is	O
significantly	O
smoother	O
with	O
minimal	O
peaks	O
and	O
valleys	O
,	O
suggesting	O
that	O
this	O
Sr	O
concentration	O
offers	O
superior	O
protection	O
against	O
the	O
corrosive	O
environment	O
.	O

Voyager	O
,	O
susceptible	O
to	O
FHB	O
,	O
was	O
used	O
in	O
the	O
disease	O
assays	O
.	O

Furthermore	O
,	O
BayesKAT	B-BT
implements	O
a	O
scalable	O
computational	O
strategy	O
to	O
boost	O
its	O
applicability	O
,	O
especially	O
for	O
high	O
-	O
dimensional	O
cases	O
where	O
other	O
methods	O
become	O
less	O
effective	O
.	O

Recently	O
,	O
kmerDB	B-BT
was	O
made	O
public	O
containing	O
5	O
,	O
186	O
,	O
757	O
nucleic	O
and	O
214	O
,	O
904	O
,	O
089	O
peptide	O
primes	O
isolated	O
from	O
the	O
examination	O
of	O
45	O
,	O
785	O
complete	O
organismal	O
genomes	O
and	O
22	O
,	O
386	O
reference	O
organismal	O
proteomes	O
[	O
171	O
].	O

In	O
order	O
to	O
overcome	O
these	O
limitations	O
,	O
we	O
developed	O
the	O
single	O
-	O
cell	O
imaging	O
flow	O
cytometry	O
AI	O
(	O
scifAI	B-BT
)	O
framework	O
for	O
the	O
unbiased	O
analysis	O
of	O
high	O
-	O
dimensional	O
high	O
-	O
throughput	O
IFC	O
data	O
.	O

In	O
total	O
,	O
112	O
components	O
of	O
STF	O
were	O
obtained	O
from	O
the	O
TCMNPAS	B-BT
Database	O
.	O

Similarly	O
RNASeq	O
data	O
was	O
also	O
combined	O
and	O
mapped	O
to	O
the	O
genome	O
assembly	O
of	O
red	O
snapper	O
using	O
the	O
Hisat2	O
tool	O
to	O
generate	O
the	O
sam	O
file	O
and	O
subsequently	O
converted	O
to	O
and	O
sorted	O
to	O
bam	O
file	O
.	O

Some	O
have	O
suggested	O
researchers	O
with	O
lived	O
experiences	O
can	O
immerse	O
themselves	O
in	O
the	O
community	O
to	O
‘	O
expand	O
their	O
own	O
standpoint	O
on	O
the	O
topic	O
’.	O
24	O
Other	O
issues	O
include	O
that	O
insider	O
researchers	O
may	O
have	O
trouble	O
communicating	O
the	O
research	O
findings	O
with	O
outsiders	O
because	O
they	O
know	O
the	O
topic	O
intimately	O
.	O
29	O
Working	O
in	O
insider	O
-	O
outsider	O
teams	O
can	O
help	O
bring	O
additional	O
clarity	O
to	O
the	O
interpretation	O
of	O
study	O
findings	O
.	O
24	O

Hi	O
-	O
C	O
map	O
representing	O
the	O
scaffolds	O
of	O
Redsnapper	O
genome	O
assembly	O
.	O

While	O
not	O
particularly	O
designed	O
to	O
call	O
low	O
frequency	O
calls	O
,	O
we	O
include	O
bcftools	B-BT
for	O
benchmarking	O
here	O
as	O
one	O
of	O
the	O
most	O
widely	O
used	O
variant	O
callers	O
[	O
35	O
].	O

This	O
achievement	O
underscores	O
the	O
scalability	O
of	O
scNovel	B-BT
and	O
highlights	O
its	O
potential	O
for	O
deployment	O
in	O
large	O
-	O
scale	O
real	O
-	O
world	O
applications	O
.	O

The	O
later	O
analysis	O
showed	O
that	O
NanoDeep	B-BT
recovered	O
the	O
species	O
composition	O
of	O
the	O
mock	O
sample	O
,	O
indicating	O
that	O
it	O
meets	O
the	O
requirement	O
for	O
adaptive	O
sampling	O
in	O
nanopore	O
platforms	O
.	O

Proteomics	O
,	O
transcriptomics	O
,	O
mutations	O
and	O
copy	O
number	O
alteration	O
(	O
CNA	O
)	O
data	O
can	O
be	O
used	O
to	O
modify	O
different	O
variables	O
of	O
the	O
MaBoSS	B-BT
framework	O
,	O
such	O
as	O
node	O
activity	O
status	O
,	O
transition	O
rates	O
and	O
initial	O
conditions	O
.	O

The	O
small	O
number	O
of	O
matches	O
all	O
along	O
its	O
sequence	O
can	O
make	O
it	O
very	O
hard	O
to	O
find	O
based	O
only	O
on	O
repetitiveness	O
,	O
but	O
the	O
presence	O
of	O
full	O
elements	O
in	O
the	O
Maylandia	O
zebra	O
genome	O
allowed	O
us	O
to	O
obtain	O
the	O
full	O
sequence	O
.	O

scAnnoX的	B-BT
.	O

We	O
present	O
shaPRS	B-BT
,	O
a	O
method	O
that	O
leverages	O
widespread	O
pleiotropy	O
between	O
traits	O
or	O
shared	O
genetic	O
effects	O
across	O
ancestries	O
,	O
to	O
improve	O
the	O
accuracy	O
of	O
polygenic	O
scores	O
.	O

To	O
address	O
this	O
gap	O
,	O
we	O
developed	O
sRNAfrag	B-BT
,	O
a	O
modular	O
and	O
interoperable	O
tool	O
designed	O
to	O
standardize	O
the	O
quantification	O
and	O
analysis	O
of	O
small	O
RNA	O
fragmentation	O
across	O
various	O
biotypes	O
.	O

As	O
for	O
the	O
partial	O
legislative	O
omission	O
,	O
it	O
must	O
be	O
constitutionally	O
regulated	O
so	O
that	O
the	O
Supreme	O
Constitutional	O
Court	O
does	O
not	O
exercise	O
constitutional	O
despotism	O
of	O
legislation	O
,	O
and	O
its	O
authority	O
is	O
limited	O
in	O
setting	O
standards	O
or	O
controls	O
that	O
are	O
overlooked	O
by	O
the	O
unconstitutional	O
legal	O
article	O
due	O
to	O
legislative	O
omission	O
,	O
in	O
cases	O
where	O
this	O
is	O
possible	O
.	O

In	O
addition	O
to	O
running	O
tRigon	B-BT
locally	O
via	O
the	O
R	O
console	O
,	O
the	O
application	O
is	O
freely	O
available	O
online	O
in	O
the	O
ShinyApps	O
.	O
io	O
workspace	O
(	O
https	O
://	O
labooratory	O
.	O
shinyapps	O
.	O
io	O
/	O
tRigon	B-BT
),	O
albeit	O
the	O
memory	O
size	O
for	O
free	O
use	O
is	O
limited	O
to	O
1	O
GB	O
of	O
Random	O
-	O
Access	O
Memory	O
(	O
RAM	O
).	O

Figure	O
2	O
,	O
panel	O
c	O
,	O
""""	O
DCPred	O
""""	O
in	O
the	O
legend	O
should	O
be	O
""""	O
CDPred	B-BT
""""	O

Therefore	O
,	O
ordinary	O
individuals	O
do	O
not	O
have	O
the	O
power	O
or	O
right	O
to	O
file	O
a	O
direct	O
lawsuit	O
before	O
the	O
Federal	O
Supreme	O
Court	O
[	O
38	O
].	O

A	O
12	O
-	O
mm	O
(	O
Powerflex	O
)	O
balloon	O
was	O
first	O
inserted	O
and	O
dilated	O
to	O
full	O
inflation	O
followed	O
by	O
a	O
12	O
-	O
mm	O
(	O
InPact	O
)	O
paclitaxel	O
-	O
coated	O
balloon	O
,	O
which	O
improved	O
the	O
angiographic	O
appearance	O
of	O
the	O
stenosis	O
(	O
Figures	O
3A	O
and	O
3B	O
).	O

Five	O
bacterial	O
genomes	O
Agrococcus	O
pavilionensis	O
strain	O
RW1	O
,	O
Azotobacter	O
vinelandii	O
strain	O
DJ	O
,	O
Rhizobium	O
leguminosarum	O
,	O
and	O
two	O
genomes	O
of	O
Exiguobacterium	O
chiriqhucha	O
strain	O
RW2	O
and	O
strain	O
GIC31	O
were	O
compared	O
against	O
MerCat2	B-BT
,	O
kmc	O
,	O
and	O
Jellyfish	O
using	O
nucleotide	O
whole	O
-	O
genome	O
fasta	O
files	O
for	O
k	O
=	O
4	O
and	O
k	O
=	O
31	O
.	O

We	O
compared	O
the	O
processing	O
times	O
of	O
QuickVariants	O
and	O
bcftools	B-BT
on	O
the	O
same	O
computer	O
offering	O
10	O
GB	O
RAM	O
,	O
15	O
threads	O
,	O
and	O
3	O
.	O
00	O
GHz	O
CPU	O
speed	O
.	O

This	O
web	O
server	O
is	O
freely	O
available	O
at	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
.	O

shinyseg	B-BT
is	O
an	O
R	O
-	O
based	O
tool	O
built	O
with	O
Shiny	O
(	O
Chang	O
et	O
al	O
.	O

BIDCell	B-BT
captures	O
cell	O
morphologies	O
with	O
better	O
correspondence	O
to	O
the	O
input	O
images	O
,	O
with	O
a	O
more	O
diverse	O
set	O
of	O
cell	O
shapes	O
that	O
include	O
elongated	O
types	O
.	O

In	O
PAPipe	B-BT
,	O
the	O
Manhattan	O
plot	O
is	O
automatically	O
generated	O
for	O
every	O
single	O
population	O
against	O
all	O
other	O
populations	O
using	O
information	O
on	O
genomic	O
regions	O
that	O
are	O
significantly	O
differentiated	O
by	O
default	O
.	O

The	O
genotypes	O
obtained	O
by	O
BCFtools	B-BT
had	O
high	O
concordance	O
(>	O
95	O
%)	O
with	O
the	O
Versa50K	O
SNP	O
array	O
(	O
Figure	O
S2	O
).	O

TrimAL	B-BT
is	O
a	O
tool	O
for	O
automated	O
alignment	O
trimming	O
.	O

Generally	O
,	O
Prokka	O
,	O
DRAM	O
,	O
and	O
MetaCerberus	B-BT
had	O
similar	O
pORF	O
calling	O
numbers	O
;	O
however	O
,	O
DRAM	O
did	O
call	O
more	O
pORF	O
from	O
eukaryotic	O
viruses	O
(	O
Supplementary	O
Fig	O
.	O

Subsequently	O
,	O
the	O
SMILES	O
strings	O
of	O
the	O
active	O
ingredient	O
numbers	O
,	O
PDB	O
IDs	O
of	O
the	O
key	O
targets	O
,	O
and	O
3D	O
structure	O
in	O
PDB	O
format	O
obtained	O
from	O
2	O
.	O
1	O
were	O
inputted	O
to	O
the	O
molecular	O
docking	O
module	O
of	O
TCMNPAS	B-BT
.	O

SynDesign	B-BT
was	O
developed	O
using	O
Python	O
3	O
.	O
9	O
.	O
13	O
on	O
CodeIgniter	O
5	O
based	O
on	O
PHP	O
5	O
.	O
2	O
.	O
4	O
.	O

Those	O
studies	O
mainly	O
explored	O
individuals	O
’	O
attitudes	O
and	O
perceptions	O
of	O
the	O
past	O
,	O
present	O
,	O
and	O
future	O
in	O
different	O
mental	O
states	O
,	O
which	O
fall	O
under	O
the	O
research	O
category	O
of	O
state	O
TP	O
(	O
Stolarski	O
,	O
Fieulaine	O
&	O
Zimbardo	O
,	O
2018	O
).	O

Having	O
confirmed	O
the	O
proteasome	O
involvement	O
in	O
the	O
turnover	O
of	O
profilaggrin	O
,	O
we	O
next	O
set	O
out	O
to	O
determine	O
degron	O
components	O
in	O
the	O
protein	O
sequence	O
using	O
our	O
DEGRONOPEDIA	B-BT
web	O
server	O
,	O
which	O
enables	O
comprehensive	O
annotation	O
of	O
degron	O
motifs	O
and	O
potentially	O
related	O
PTMs	O
,	O
with	O
a	O
particular	O
focus	O
on	O
ubiquitination	O
and	O
phosphorylation	O
.	O

REAGENT	O
or	O
RESOURCESOURCEIDENTIFIERBiological	O
samplesPlasma	O
from	O
citrated	O
bloodHealthy	O
volunteersN	O
/	O
ASterile	O
acute	O
wound	O
fluidsProf	O
Artur	O
Schmidtchen	O
,	O
Lund	O
University	O
,	O
Sweden25	O
,	O
26	O
,	O
70N	O
/	O
AChemicals	O
,	O
peptides	O
,	O
and	O
recombinant	O
proteinsPseudomonas	O
aeruginosa	O
elastaseElastin	O
Products	O
Company	O
,	O
Inc	O
.	O
Cat	O
#	O
PE961Staphylococcus	O
aureus	O
V8Sigma	O
-	O
AldrichCat	O
#	O
P2922Human	O
neutrophil	O
elastaseSigma	O
-	O
AldrichCat	O
#	O
324681Human	O
neutrophil	O
cathepsin	O
GSigma	O
-	O
AldrichCat	O
#	O
219373NuPAGE	O
LDS	O
sample	O
buffer	O
(	O
4x	O
)	O
Invitrogen	O
™	O
Cat	O
#	O
NP0007Tris	O
-	O
Glycine	O
SDS	O
running	O
buffer	O
(	O
10x	O
)	O
Invitrogen	O
™	O
Cat	O
#	O
LC2675RapiGest	O
SFWatersCat	O
#	O
186001861Critical	O
commercial	O
assaysPierce	O
™	O
BCA	O
Protein	O
Assay	O
KitThermo	O
Scientific	O
™	O
Cat	O
#	O
23227Novex	O
™	O
Tris	O
-	O
Glycine	O
Mini	O
Protein	O
Gels	O
,	O
10	O
-	O
20	O
%	O
Invitrogen	O
™	O
Cat	O
#	O
XP10205BOXSilverQuest	O
™	O
Silver	O
Staining	O
KitInvitrogen	O
™	O
Cat	O
#	O
LC6070Deposited	O
dataMass	O
spectrometry	O
RAW	O
data	O
plasma	O
samplesThis	O
paperPRIDE	O
:	O
PXD037245Mass	O
spectrometry	O
RAW	O
data	O
wound	O
fluidsThis	O
paperPRIDE	O
:	O
PXD037047PEAKS	O
search	O
files	O
plasma	O
samplesThis	O
paperPRIDE	O
:	O
PXD037245PEAKS	O
search	O
files	O
wound	O
fluidsThis	O
paperPRIDE	O
:	O
PXD037047Mass	O
spectrometry	O
data	O
of	O
wound	O
dressing	O
extractsHartman	O
et	O
al	O
.	O
26PRIDE	O
:	O
PXD023244UniProtThe	O
UniProt	O
Consortium71https	O
://	O
www	O
.	O
uniprot	O
.	O
org	O
/	O
Software	O
and	O
algorithmsPEAKS	O
SoftwareBioinformatics	O
Solutions	O
Inc	O
.	O
https	O
://	O
www	O
.	O
bioinfor	O
.	O
com	O
/	O
peaks	O
-	O
software	O
/	O
Graphpad	O
PrismDotmaticshttps	O
://	O
www	O
.	O
graphpad	O
.	O
com	O
/	O
VennDisIgnatchenko	O
et	O
al	O
.	O
72http	O
://	O
kislingerlab	O
.	O
uhnres	O
.	O
utoronto	O
.	O
ca	O
/	O
projects	O
/	O
BoxPlotRSpitzer	O
et	O
al	O
.	O
73http	O
://	O
shiny	O
.	O
chemgrid	O
.	O
org	O
/	O
boxplotr	O
/	O
ImgflipImgflip	O
LLChttps	O
://	O
imgflip	O
.	O
com	O
/	O
chart	O
-	O
makerPeptigramManguy	O
et	O
al	O
.	O
74http	O
://	O
bioware	O
.	O
ucd	O
.	O
ie	O
/	O
peptigram	O
/	O
iceLogoColaert	O
et	O
al	O
.	O
27http	O
://	O
iomics	O
.	O
ugent	O
.	O
be	O
/	O
icelogoserver	O
/	O
CLIPPER	B-BT
2	I-BT
.	I-BT
0Kalogeropoulos	I-BT
et	O
al	O
.	O
75https	O
://	O
github	O
.	O
com	O
/	O
UadKLab	O
/	O
CLIPPER	O
-	O
2	O
.	O
0OtherMicrocon	O
-	O
30kDa	O
centrifugal	O
filtersMerckCat	O
#	O
MRCF0R030	O

Voyager	O
,	O
a	O
two	O
-	O
row	O
spring	O
barley	O
susceptible	O
to	O
FHB	O
.	O

Bars	O
show	O
FRETpredict	B-BT
estimates	O
of	O
the	O
E	O
values	O
calculated	O
using	O
medium	O
rotamer	O
libraries	O
.	O

Taxonomy	O
information	O
and	O
microbial	O
genomes	O
were	O
downloaded	O
using	O
the	O
“	O
centrifuger	B-BT
-	O
download	O
”	O
script	O
in	O
June	O
2023	O
.	O

The	O
results	O
provided	O
by	O
the	O
domain2GO	B-BT
schema	O
largely	O
support	O
the	O
same	O
conclusions	O
found	O
by	O
our	O
manual	O
curation	O
of	O
the	O
domain2Pfam	O
results	O
for	O
both	O
positive	O
and	O
negative	O
associations	O
,	O
highlighting	O
how	O
GO	O
annotation	O
provides	O
an	O
interpretability	O
that	O
appears	O
to	O
be	O
qualitatively	O
equivalent	O
to	O
human	O
curation	O
(	O
Figure	O
4C	O
;	O
Data	O
S2	O
,	O
sheet	O
“	O
domain2GOCount	B-BT
”;	O
see	O
also	O
Note	O
S6	O
for	O
additional	O
examples	O
).	O
29	O
Additionally	O
,	O
several	O
of	O
these	O
biological	O
roles	O
associated	O
with	O
prophage	O
density	O
are	O
performed	O
by	O
non	O
-	O
homologous	O
domains	O
.	O

ASRS	O
SNPs	O
with	O
high	O
AStruct	B-BT
scores	O
demonstrated	O
an	O
enrichment	O
of	O
allele	O
-	O
specific	O
RBP	O
binding	O
sites	O
(	O
ASRBP	O
)	O
and	O
m6A	O
related	O
SNPs	O
(	O
m6Asnp	O
)	O
compared	O
to	O
SNPs	O
with	O
medium	O
or	O
low	O
scores	O
.	O

3Power	O
over	O
different	O
signal	O
strengths	O
of	O
gbdmr	B-BT
,	O
dmrff	O
,	O
and	O
EWAS	O
across	O
different	O
block	O
sizes	O

Furthermore	O
,	O
all	O
SNP	O
sites	O
which	O
were	O
found	O
by	O
the	O
PHARE	B-BT
pipeline	O
in	O
pfdhps	O
and	O
pfdhfr	O
are	O
known	O
sites	O
of	O
drug	O
resistance	O
.	O

Currently	O
,	O
CITEViz	B-BT
accepts	O
Seurat	O
and	O
BioConductor	O
SingleCellExperiment	O
objects	O
.	O

2021	O
),	O
and	O
MetaCerberus	B-BT
(	O
Figueroa	O
III	O
et	O
al	O
.	O

Two	O
SwivelLock	O
(	O
Arthrex	O
,	O
Inc	O
)	O
suture	O
anchors	O
at	O
the	O
inferior	O
pole	O
of	O
the	O
patella	O
with	O
a	O
Krackow	O
stitch	O
brought	O
down	O
the	O
patella	O
in	O
a	O
locking	O
stitch	O
configuration	O
.	O

However	O
,	O
data	O
from	O
other	O
multiplexed	O
imaging	O
technologies	O
including	O
t	O
-	O
CyCIF	O
[	O
6	O
],	O
CODEX	O
[	O
7	O
],	O
or	O
MIBI	O
[	O
8	O
],	O
which	O
produce	O
pixel	O
-	O
level	O
intensities	O
and	O
(	O
optionally	O
)	O
segmentation	O
masks	O
,	O
can	O
be	O
interactively	O
visualized	O
with	O
cytoviewer	B-BT
as	O
long	O
as	O
the	O
input	O
format	O
is	O
appropriate	O
.	O

The	O
porcelain	O
glazed	O
in	O
a	O
microwave	O
had	O
a	O
smoother	O
surface	O
than	O
porcelain	O
glazed	O
in	O
an	O
oven	O
.	O

Since	O
a	O
full	O
cell	O
cycle	O
in	O
MaBoSS	B-BT
is	O
achieved	O
in	O
24	O
units	O
of	O
time	O
,	O
we	O
proceeded	O
to	O
set	O
the	O
scaling	O
value	O
to	O
60	O
,	O
similar	O
to	O
what	O
was	O
done	O
with	O
the	O
previous	O
TNF	O
model	O
.	O

IthaPhen	O
is	O
developed	O
using	O
a	O
relational	O
database	O
management	O
system	O
based	O
on	O
MySQL	O
and	O
PHP	O
and	O
is	O
fully	O
integrated	O
and	O
interconnected	O
with	O
the	O
existing	O
infrastructure	O
of	O
the	O
ITHANET	B-BT
portal	O
.	O
3	O
,	O
13	O
The	O
content	O
curation	O
of	O
IthaPhen	O
is	O
included	O
in	O
the	O
existing	O
ITHANET	B-BT
curation	O
strategy	O
with	O
weekly	O
updates	O
,	O
as	O
previously	O
described3	O
,	O
4	O
and	O
documented	O
in	O
the	O
ITHANET	B-BT
FAQ	O
page	O
(	O
https	O
://	O
www	O
.	O
ithanet	B-BT
.	O
eu	O
/	O
home	O
/	O
faqs	O
),	O
thus	O
ensuring	O
the	O
sustainability	O
and	O
relevance	O
of	O
the	O
database	O
.	O

The	O
Essex	O
Skipper	O
is	O
considered	O
at	O
low	O
risk	O
of	O
extinction	O
;	O
on	O
the	O
IUCN	O
Red	O
list	O
(	O
Europe	O
)	O
it	O
is	O
listed	O
as	O
being	O
of	O
Least	O
Concern	O
.	O

Subsequently	O
,	O
PermuteDDS	B-BT
was	O
trained	O
using	O
these	O
resulting	O
noisy	O
cell	O
lines	O
.	O

The	O
remaining	O
60	O
%	O
was	O
used	O
to	O
optimize	O
SHAPRs	B-BT
model	O
weights	O
during	O
training	O
.	O

Data	O
,	O
Analysis	O
,	O
and	O
OmicNavigator	B-BT
build	O
scripts	O
for	O
this	O
study	O
can	O
be	O
found	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
abbvie	O
-	O
external	O
/	O
OmicNavigatorExample	B-BT
.	O

All	O
the	O
retained	O
SNP	O
sites	O
were	O
divided	O
into	O
three	O
groups	O
according	O
to	O
the	O
magnitude	O
of	O
AStruct	B-BT
score	O
,	O
which	O
are	O
‘	O
Low	O
’	O
(	O
0	O
),	O
‘	O
Medium	O
’	O
(	O
0	O
,	O
1	O
],	O
and	O
‘	O
High	O
’	O
(	O
1	O
,	O
+	O
∞).	O

The	O
interactive	O
clusters	O
for	O
Cluster_90	O
and	O
Cluster_78	O
can	O
be	O
accessed	O
at	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
/	O
cluster	O
/	O
graph	O
/	O
434	O
and	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
/	O
cluster	O
/	O
graph	O
/	O
439	O
,	O
respectively	O

Consistently	O
,	O
in	O
the	O
case	O
of	O
a	O
human	O
skull	O
sinking	O
in	O
the	O
head	O
-	O
up	O
position	O
,	O
the	O
rotation	O
occurs	O
toward	O
its	O
smoother	O
part	O
,	O
i	O
.	O
e	O
.,	O
the	O
occipital	O
region	O
(	O
see	O
supplemental	O
material	O
in	O
ref	O
.	O

elegans	O
dataset	O
,	O
tinyRNA	B-BT
identified	O
numerous	O
unclassified	O
siRNAs	O
that	O
were	O
depleted	O
in	O
mut	O
-	O
16	O
mutants	O
and	O
distinguished	O
between	O
affected	O
22G	O
-	O
and	O
26G	O
-	O
RNAs	O
produced	O
from	O
the	O
same	O
genes	O
(	O
Fig	O
.	O

There	O
are	O
also	O
programs	O
written	O
in	O
Python	O
such	O
as	O
CarveMe	O
[	O
77	O
],	O
moped	O
[	O
79	O
],	O
Reconstructor	O
[	O
80	O
],	O
Bactabolize	O
[	O
81	O
]	O
and	O
AuCoMe	B-BT
[	O
82	O
]	O
that	O
provide	O
the	O
possibility	O
of	O
reconstructing	O
the	O
model	O
using	O
their	O
own	O
resources	O
.	O

Alternatively	O
,	O
one	O
could	O
remove	O
the	O
“	O
chr	O
”	O
prefix	O
from	O
BAM	O
files	O
prior	O
to	O
running	O
‘	O
01	O
-	O
filter_bam	O
.	O
sh	O
’	O
using	O
the	O
‘	O
samtools	B-BT
reheader	O
’	O
command	O
.	O

(	O
A	O
)	O
Comparison	O
of	O
localization	O
classification	O
performance	O
of	O
DeepLoc	O
versus	O
PIFiA	B-BT
feature	O
profiles	O
coupled	O
with	O
a	O
logistic	O
regression	O
.	O

FRETpredict	B-BT
systematically	O
takes	O
into	O
account	O
the	O
protein	O
conformational	O
ensemble	O
and	O
accurately	O
models	O
the	O
conformational	O
ensemble	O
of	O
the	O
fluorophore	O
labels45	O
.	O

A	O
paclitaxel	O
-	O
coated	O
10	O
-	O
mm	O
balloon	O
(	O
InPact	O
)	O
was	O
expanded	O
across	O
the	O
stenosis	O
followed	O
by	O
post	O
dilation	O
with	O
a	O
12	O
-	O
mm	O
high	O
-	O
pressure	O
(	O
Vida	O
)	O
balloon	O
completely	O
resolving	O
the	O
occlusion	O
on	O
angiography	O
(	O
Figures	O
2A	O
and	O
2B	O
).	O

The	O
presence	O
of	O
EMAA	O
stitches	O
introduces	O
a	O
discernible	O
influence	O
that	O
interacts	O
with	O
both	O
the	O
fiber	O
bundles	O
and	O
the	O
matrix	O
.	O

Since	O
sequences	O
shorter	O
than	O
50	O
aa	O
are	O
unsuitable	O
input	O
for	O
the	O
DEGRONOPEDIA	B-BT
,	O
we	O
excluded	O
them	O
from	O
our	O
FLG	O
mutant	O
variants	O
analysis	O
.	O

For	O
instance	O
,	O
iMet	B-BT
-	I-BT
Q	I-BT
[	O
17	O
]	O
and	O
apLCMS	O
[	O
18	O
]	O
deal	O
with	O
the	O
quantification	O
step	O
while	O
Metabolyzer	O
[	O
19	O
]	O
with	O
the	O
identification	O
of	O
metabolites	O
.	O

Han	O
and	O
Molloy	O
(	O
2023	O
)	O
have	O
recently	O
developed	O
TREE	B-BT
-	I-BT
QMC	I-BT
,	O
which	O
is	O
based	O
on	O
wQMC	O
and	O
offers	O
a	O
fast	O
method	O
for	O
constructing	O
the	O
quartet	O
graph	O
directly	O
from	O
input	O
gene	O
trees	O
without	O
the	O
need	O
for	O
explicitly	O
computing	O
the	O
weighted	O
quartet	O
distributions	O
as	O
in	O
the	O
case	O
of	O
wQMC	O
and	O
wQFM	O
.	O

Actions	O
such	O
as	O
rworkflows	B-BT
need	O
only	O
be	O
updated	O
on	O
the	O
centralised	O
Github	O
repository	O
(	O
see	O
Code	O
availability	O
section	O
),	O
which	O
then	O
propagates	O
to	O
all	O
users	O
who	O
call	O
the	O
rworkflows	B-BT
action	O
,	O
even	O
if	O
they	O
implemented	O
rworkflows	B-BT
in	O
their	O
package	O
prior	O
to	O
the	O
changes	O
.	O

PASTEClassifier19	B-BT
was	O
used	O
to	O
categorize	O
different	O
types	O
of	O
repetitive	O
sequences	O
.	O

Knud	O
will	O
delve	O
into	O
the	O
adaptation	O
of	O
co	O
-	O
creation	O
processes	O
within	O
the	O
Danish	O
context	O
.	O

In	O
addition	O
,	O
we	O
show	O
how	O
using	O
scPrisma	B-BT
allows	O
us	O
to	O
better	O
distinguish	O
distinct	O
cellular	O
subtypes	O
of	O
SCN	O
neurons	O
following	O
temporal	O
filtering	O
,	O
and	O
uncover	O
signal	O
-	O
related	O
gene	O
regulatory	O
networks	O
and	O
cell	O
–	O
cell	O
interactions	O
following	O
enhancement	O
of	O
the	O
circadian	O
rhythm	O
signal	O
.	O

The	O
genotypes	O
of	O
targeted	O
regions	O
were	O
called	O
by	O
bcftools	B-BT
call	O
.	O

The	O
exclusion	O
of	O
indels	O
by	O
bcftools	B-BT
also	O
leads	O
to	O
an	O
underreporting	O
of	O
the	O
major	O
variant	O
,	O
which	O
in	O
turn	O
elevates	O
the	O
frequency	O
of	O
minor	O
variants	O
,	O
contributing	O
to	O
false	O
positives	O
in	O
point	O
mutation	O
identification	O
in	O
10	O
out	O
of	O
10	O
cases	O
we	O
examined	O
.	O

trimal	B-BT
-	O
in	O
mafft_out	O
.	O
fa	O
-	O
out	O
mafftout_0	O
.	O
13	O
.	O
fas	O
-	O
gt	O
0	O
.	O
13	O

In	O
the	O
Discussion	O
section	O
,	O
we	O
explain	O
the	O
possible	O
reasons	O
for	O
the	O
performance	O
disparity	O
between	O
gbdmr	B-BT
,	O
dmrff	O
,	O
and	O
other	O
DMR	O
detection	O
methods	O
under	O
different	O
correlations	O
of	O
adjacent	O
CpG	O
sites	O
.	O

Furthermore	O
,	O
an	O
online	O
information	O
retrieval	O
system	O
was	O
designed	O
based	O
on	O
the	O
PCAO2	B-BT
.	O

Figure	O
2	O
—	O
figure	O
supplement	O
3	O
.	O
The	O
mean	O
precision	O
versus	O
contact	O
density	O
for	O
the	O
top	O
50	O
contacts	O
predicted	O
by	O
PLMGraph	O
-	O
Inter	O
,	O
GLINTER	O
,	O
DeepHomo	O
,	O
DeepHomo2	O
,	O
CDPred	B-BT
,	O
and	O
DRN	O
-	O
1D2D_Inter	O
on	O
the	O
HomoPDB	O
test	O
set	O
(	O
a	O
,	O
c	O
)	O
and	O
HeteroPDB	O
test	O
set	O
(	O
b	O
,	O
d	O
)	O
using	O
experimental	O
structures	O
(	O
first	O
row	O
)	O
and	O
AlphaFold2	O
predicted	O
structures	O
(	O
second	O
row	O
).	O

To	O
assist	O
users	O
in	O
performing	O
their	O
novel	O
analysis	O
on	O
rNMP	O
samples	O
,	O
we	O
provided	O
the	O
free	O
download	O
of	O
collected	O
rNMP	O
sample	O
data	O
,	O
reference	O
genome	O
,	O
genome	O
annotations	O
,	O
and	O
formatted	O
data	O
showing	O
the	O
rNMP	O
-	O
embedment	O
characteristics	O
used	O
in	O
the	O
rNMPID	B-BT
database	O
.	O

TCMNPAS	B-BT
,	O
a	O
network	O
pharmacological	O
analysis	O
system	O
of	O
TCM	O
,	O
was	O
independently	O
developed	O
and	O
designed	O
by	O
Professor	O
Yang	O
Ming	O
in	O
Longhua	O
Hospital	O
,	O
Shanghai	O
University	O
of	O
Traditional	O
Chinese	O
Medicine	O
(	O
TCM	O
Network	O
Pharmacology	O
Analysis	O
System	O
v1	O
.	O
0	O
[	O
CP	O
/	O
CD	O
],	O
Copyright	O
Registration	O
No	O
.,	O
2019SR1127090	O
,	O
http	O
://	O
54	O
.	O
223	O
.	O
75	O
.	O
62	O
:	O
3838	O
/).	O

The	O
median	O
lengths	O
of	O
intronic	O
terminal	O
exons	O
identified	O
by	O
InPACT	B-BT
in	O
two	O
HEK293	O
RNA	O
-	O
seq	O
replicates	O
were	O
found	O
to	O
be	O
shorter	O
compared	O
to	O
annotated	O
ones	O
(	O
Fig	O
.	O

Briefly	O
,	O
we	O
divided	O
the	O
sequencing	O
nanopore	O
array	O
(	O
512	O
nanopores	O
)	O
into	O
two	O
groups	O
with	O
the	O
same	O
number	O
of	O
channels	O
:	O
(	O
i	O
)	O
channels	O
1	O
–	O
255	O
will	O
be	O
subjected	O
to	O
adaptive	O
sampling	O
using	O
NanoDeep	B-BT
;	O
(	O
ii	O
)	O
channels	O
256	O
–	O
512	O
will	O
be	O
subjected	O
to	O
routine	O
nanopore	O
sequencing	O
pipeline	O
(	O
Figure	O
3A	O
).	O

To	O
tackle	O
more	O
advanced	O
use	O
cases	O
,	O
such	O
as	O
defining	O
a	O
new	O
feature	O
or	O
applying	O
scifAI	B-BT
to	O
an	O
entirely	O
new	O
dataset	O
,	O
more	O
programming	O
experience	O
is	O
required	O
.	O

State	O
TP	O
is	O
transient	O
concerns	O
and	O
attitudes	O
about	O
the	O
time	O
horizon	O
(	O
past	O
,	O
present	O
,	O
or	O
future	O
)	O
in	O
a	O
given	O
scenario	O
(	O
Stolarski	O
,	O
Fieulaine	O
&	O
Zimbardo	O
,	O
2018	O
),	O
significantly	O
impacting	O
an	O
individual	O
’	O
s	O
behavior	O
in	O
the	O
present	O
(	O
Klapproth	O
,	O
2011	O
).	O

Core	O
Tip	O
:	O
This	O
manuscript	O
is	O
to	O
correct	O
the	O
citations	O
of	O
images	O
in	O
Figures	O
1	O
and	O
5	O
in	O
“	O
Shu	O
YJ	O
,	O
Lao	O
B	O
,	O
Qiu	O
YY	O
.	O

We	O
then	O
asked	O
how	O
reliably	O
GEMLI	B-BT
identifies	O
categories	O
of	O
genes	O
displaying	O
gene	O
expression	O
memory	O
in	O
small	O
lineages	O
.	O

To	O
measure	O
the	O
diameter	O
,	O
three	O
biscuit	O
samples	O
were	O
placed	O
edge	O
to	O
edge	O
and	O
the	O
total	O
diameter	O
was	O
measured	O
.	O

As	O
a	O
pre	O
-	O
processing	O
step	O
before	O
the	O
actual	O
compression	O
,	O
we	O
predict	O
the	O
domain	O
boundaries	O
for	O
each	O
intra	O
-	O
chromosomal	O
contact	O
matrix	O
using	O
TAD	O
callers	O
based	O
on	O
the	O
insulation	O
score	O
[	O
36	O
]	O
that	O
is	O
an	O
integral	O
component	O
of	O
cooltools	B-BT
[	O
37	O
].	O

GeNLP	B-BT
overview	O
.	O

43	O
patients	O
had	O
more	O
than	O
one	O
MDE	O
with	O
3	O
(	O
7	O
%)	O
patients	O
having	O
SLiM	O
-	O
only	O
features	O
,	O
10	O
(	O
23	O
%)	O
patients	O
having	O
CRAB	O
-	O
only	O
features	O
,	O
and	O
30	O
(	O
70	O
%)	O
patients	O
having	O
SLiM	O
-	O
CRAB	O
features	O
.	O

The	O
strains	O
(	O
PGRG2	O
and	O
PGRG5	O
)	O
were	O
initially	O
mapped	O
to	O
the	O
reference	O
genomes	O
using	O
Burrows	O
-	O
Wheeler	O
aligner	O
“	O
mem	O
”	O
algorithm	O
(	O
BWA	O
-	O
mem	O
)	O
v	O
.	O
0	O
.	O
7	O
.	O
17	O
(	O
5	O
)	O
and	O
converted	O
and	O
sorted	O
into	O
BAM	O
file	O
using	O
SAMtools	B-BT
v	O
.	O
0	O
.	O
1	O
.	O
18	O
(	O
6	O
).	O

The	O
SVR	O
model	O
(	O
C	O
=	O
1	O
)	O
to	O
predict	O
the	O
symptom	O
severity	O
was	O
first	O
conducted	O
on	O
the	O
data	O
from	O
ABIDE	O
II	O
(	O
N	O
=	O
76	O
ASD	O
,	O
datadiscovery	O
)	O
using	O
a	O
5	O
-	O
fold	O
cross	O
-	O
validation	O
(	O
CV	O
)	O
approach	O
with	O
grid	O
search	O
for	O
the	O
model	O
tuning	O
controlling	O
the	O
regularization	O
parameter	O
to	O
be	O
relatively	O
small	O
to	O
simplify	O
the	O
model	O
[	O
37	O
–	O
39	O
]	O
and	O
the	O
significant	O
differences	O
in	O
terms	O
of	O
FCT	O
,	O
DT	O
or	O
FCT	O
-	O
DT	O
between	O
ASD	O
and	O
TD	O
were	O
defined	O
as	O
the	O
features	O
,	O
respectively	O
.	O

The	O
establishment	O
of	O
individual	O
LOVD	O
-	O
based	O
variant	O
databases	O
in	O
GGN	O
member	O
countries	O
and	O
their	O
integration	O
with	O
the	O
ITHANET	B-BT
Portal	O
as	O
a	O
central	O
resource	O
for	O
hemoglobinopathies	O
as	O
part	O
of	O
this	O
effort	O
may	O
be	O
instrumental	O
in	O
initiating	O
essential	O
data	O
-	O
guided	O
disease	O
management	O
in	O
LMICs	O
and	O
in	O
capturing	O
the	O
diversity	O
of	O
hemoglobinopathies	O
as	O
an	O
international	O
resource	O
.	O

Response	O
:	O
We	O
appreciate	O
the	O
reviewer	O
’	O
s	O
insightful	O
feedback	O
regarding	O
the	O
KinCytE	B-BT
update	O
.	O

At	O
present	O
,	O
neither	O
GenBank	O
annotation	O
files	O
nor	O
species	O
-	O
specific	O
genome	O
browsers	O
,	O
such	O
as	O
the	O
BsubCyc	O
database	O
[	O
32	O
],	O
SubtiWiki	B-BT
[	O
33	O
],	O
AureoWiki	O
[	O
34	O
],	O
or	O
EcoCyc	O
[	O
35	O
],	O
are	O
updated	O
with	O
the	O
single	O
-	O
nucleotide	O
resolution	O
transcription	O
data	O
that	O
is	O
publicly	O
available	O
.	O

PCa	O
-	O
related	O
lifestyles	O
were	O
collected	O
,	O
organized	O
and	O
classified	O
into	O
the	O
PCAO2	B-BT
based	O
on	O
systematic	O
evidence	O
-	O
based	O
analysis	O
.	O

To	O
solve	O
these	O
issues	O
,	O
PhysiBoSS	O
2	O
.	O
034	O
was	O
re	O
-	O
designed	O
and	O
re	O
-	O
implemented	O
from	O
scratch	O
as	O
an	O
add	O
-	O
on	O
interface	O
which	O
decouples	O
PhysiCell	O
and	O
MaBoSS	B-BT
minimising	O
dependencies	O
and	O
fixing	O
many	O
design	O
problems	O
of	O
version	O
1	O
.	O
0	O
(	O
Fig	O
.	O

Positional	O
annotation	O
of	O
N	O
‐	O
terminal	O
peptides	O
for	O
cleavage	O
sites	O
and	O
known	O
Merops	O
events	O
was	O
performed	O
using	O
Clipper	B-BT
2	I-BT
.	I-BT
0	I-BT
(	O
Kalogeropoulos	O
et	O
al	O
.,	O
2023	O
;	O
Rawlings	O
&	O
Bateman	O
,	O
2021	O
).	O

In	O
addition	O
to	O
a	O
naming	O
convention	O
,	O
DandD	B-BT
also	O
creates	O
a	O
directory	O
structure	O
to	O
store	O
intermediate	O
sketches	O
and	O
databases	O
for	O
easy	O
reuse	O
and	O
access	O
.	O

(	O
A	O
)	O
An	O
exophytic	O
enhanced	O
mass	O
was	O
detected	O
in	O
the	O
left	O
retromolar	O
trigon	O
in	O
MRI	O
T1	O
-	O
weighted	O
images	O
with	O
contrast	O
.	O

NanoDeep	B-BT
can	O
be	O
applied	O
to	O
microbial	O
species	O
that	O
do	O
not	O
exist	O
in	O
training	O
sets	O
,	O
albeit	O
with	O
a	O
performance	O
decrease	O
of	O
~	O
5	O
%–	O
15	O
%.	O

We	O
integrated	O
the	O
TrIQ	O
algorithm	O
into	O
RmsiGUI	B-BT
and	O
provide	O
the	O
R	O
code	O
snippets	O
for	O
facilitating	O
its	O
adoption	O
into	O
other	O
programs	O
.	O

Spread	O
ratio	O
and	O
diameter	O
of	O
the	O
biscuit	O
decreased	O
with	O
increasing	O
substitution	O
level	O
of	O
the	O
residue	O
.	O

In	O
this	O
follow	O
-	O
up	O
study	O
,	O
to	O
compare	O
the	O
effect	O
of	O
the	O
three	O
populations	O
on	O
initial	O
infection	O
and	O
mycotoxin	O
production	O
on	O
different	O
hosts	O
,	O
we	O
dip	O
-	O
inoculated	O
spikes	O
of	O
the	O
moderately	O
resistant	O
wheat	O
cultivar	O
Alsen	O
and	O
the	O
susceptible	O
barley	O
cultivar	O
Voyager	O
using	O
five	O
strains	O
from	O
each	O
population	O
to	O
evaluate	O
disease	O
,	O
trichothecene	O
mycotoxin	O
accumulation	O
,	O
and	O
trichothecene	O
production	O
per	O
unit	O
of	O
fungal	O
biomass	O
.	O

Finally	O
,	O
we	O
confirm	O
new	O
PIFiA	B-BT
predictions	O
using	O
a	O
colocalization	O
assay	O
,	O
suggesting	O
previously	O
unappreciated	O
biological	O
roles	O
for	O
several	O
proteins	O
.	O

shinyseg	B-BT
is	O
freely	O
available	O
at	O
https	O
://	O
chrcarrizosa	O
.	O
shinyapps	O
.	O
io	O
/	O
shinyseg	B-BT
,	O
and	O
runs	O
in	O
all	O
common	O
browsers	O
.	O

The	O
original	O
formula	O
evaluation	O
algorithm	O
in	O
MaBoSS	B-BT
used	O
a	O
recursive	O
traversal	O
of	O
the	O
expression	O
tree	O
,	O
which	O
(	O
apart	O
from	O
other	O
issues	O
)	O
causes	O
memory	O
usage	O
patterns	O
unsuitable	O
for	O
GPUs	O
:	O
the	O
memory	O
required	O
per	O
each	O
core	O
is	O
not	O
achievable	O
in	O
current	O
GPUs	O
,	O
and	O
there	O
are	O
typically	O
too	O
many	O
cache	O
misses	O
[	O
20	O
].	O

module	O
load	O
samtools	B-BT
/	O
1	O
.	O
16	O
.	O
1	O

The	O
short	O
story	O
tells	O
of	O
the	O
renowned	O
Italian	O
bandit	O
Ghino	O
di	O
Tacco	O
(	O
ca	O
.	O

In	O
addition	O
to	O
the	O
GI	O
KBs	O
,	O
we	O
built	O
two	O
automated	O
services	O
to	O
extend	O
the	O
existing	O
MatchMiner	B-BT
infrastructure	O
in	O
support	O
of	O
GI	O
TARGET	O
to	O
facilitate	O
case	O
review	O
and	O
report	O
generation	O
(	O
Supplemental	O
Figure	O
1	O
,	O
Data	O
Supplement	O
).	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
obtained	O
GWAS	O
summary	O
statistics	O
across	O
a	O
range	O
of	O
traits	O
from	O
diverse	O
population	O
pairs	O
(	O
Table	O
1	O
,	O
material	O
and	O
methods	O
)	O
and	O
quantified	O
the	O
extent	O
to	O
which	O
shaPRS	B-BT
’	O
use	O
of	O
the	O
adjunct	O
data	O
improved	O
the	O
performance	O
of	O
two	O
PRS	O
methods	O
(	O
PRS	O
-	O
CS	O
and	O
LDpred2	O
)	O
that	O
only	O
make	O
use	O
of	O
GWAS	O
summary	O
statistics	O
from	O
the	O
proximal	O
ancestry	O
.	O

To	O
overcome	O
the	O
problems	O
,	O
LORA	O
builds	O
on	O
the	O
Goslin	B-BT
standardization	O
approach	O
and	O
known	O
lipid	O
structural	O
characteristics	O
provided	O
by	O
novel	O
analytical	O
techniques	O
.	O

For	O
the	O
OS	O
-	O
slim	O
cohort	O
,	O
which	O
included	O
3	O
,	O
605	O
patients	O
in	O
the	O
training	O
set	O
and	O
1	O
,	O
542	O
in	O
the	O
validation	O
set	O
with	O
14	O
clinical	O
variables	O
,	O
the	O
rfSRC_plus_stepCox	O
combination	O
displayed	O
the	O
highest	O
mean	O
C	O
-	O
index	O
(	O
Figure	O
4D	O
)	O
and	O
5	O
-	O
year	O
AUC	O
(	O
Figure	O
4E	O
)	O
values	O
of	O
0	O
.	O
742	O
and	O
0	O
.	O
782	O
,	O
respectively	O
.	O

The	O
maximum	O
vertical	O
displacement	O
of	O
the	O
cover	O
arch	O
is	O
17	O
.	O
33	O
mm	O
when	O
the	O
grade	O
of	O
the	O
surrounding	O
rock	O
is	O
IV	O
,	O
and	O
the	O
soil	O
stiffness	O
is	O
0	O
.	O
65	O
GPa	O
.	O

The	O
study	O
was	O
conducted	O
in	O
accordance	O
with	O
the	O
Declaration	O
of	O
Helsinki	O
and	O
approved	O
by	O
the	O
Institutional	O
Review	O
Board	O
of	O
the	O
University	O
of	O
New	O
South	O
Wales	O
,	O
May	O
2021	O
(	O
HC200469	O
)	O
and	O
the	O
Fiji	O
National	O
University	O
College	O
of	O
Human	O
Health	O
Research	O
Ethical	O
Committee	O
May	O
2021	O
(	O
CHHREC264	O
.	O
20	O
).	O

Alignment	O
-	O
free	O
sequence	O
comparison	O
quantifies	O
distance	O
using	O
the	O
decay	O
of	O
the	O
number	O
of	O
k	O
-	O
mer	O
matches	O
between	O
two	O
sequences	O
and	O
compares	O
the	O
results	O
to	O
known	O
phylogenetic	O
trees	O
.[	O
249	O
]	O
AAF	O
[	O
276	O
],	O
FSWM	O
[	O
277	O
],	O
PhyloPythia	O
[	O
278	O
],	O
Skmer	O
[	O
279	O
],	O
Slope	O
-	O
SpaM	O
[	O
280	O
],	O
SlopeTree	O
[	O
281	O
]	O
Protein	O
Sequence	O
Searching	O
and	O
AlignmentSequence	O
match	O
is	O
determined	O
by	O
aligning	O
translated	O
DNA	O
sequences	O
to	O
a	O
reference	O
protein	O
database	O
.	O
BLAT	O
[	O
65	O
],	O
BLAST	O
[	O
68	O
],	O
BLASTX	O
[	O
64	O
],	O
[	O
282	O
],	O
DIAMOND	O
[	O
283	O
],	O
MMSeqs2	O
[	O
284	O
],	O
PAUDA	O
[	O
285	O
],	O
RAPSearch2	O
[	O
286	O
],	O
USEARCH	O
&	O
UBLAST	O
[	O
287	O
]	O
DatabasesK	O
-	O
mer	O
databases	O
provide	O
k	O
-	O
mer	O
sequences	O
that	O
are	O
present	O
or	O
absent	O
in	O
each	O
species	O
.	O
kmerDB	B-BT
.	O
com	O
[	O
171	O
],	O
nullomers	O
.	O
org	O
[	O
162	O
]	O

The	O
localization	O
of	O
52	O
of	O
these	O
445	O
proteins	O
in	O
spores	O
is	O
listed	O
in	O
the	O
SubtiWiki	B-BT
database	O
(	O
Supplementary	O
Table	O
S5	O
).	O

To	O
make	O
this	O
simulation	O
process	O
more	O
accessible	O
,	O
we	O
have	O
implemented	O
these	O
functionalities	O
as	O
command	O
-	O
line	O
tools	O
within	O
admix	B-BT
-	I-BT
kit	I-BT
(	O
Supplementary	O
Fig	O
.	O

In	O
brief	O
,	O
MetaPathways	B-BT
was	O
used	O
for	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
prediction	O
and	O
annotation	O
,	O
using	O
MetaCyc	O
(	O
2020	O
-	O
08	O
-	O
10	O
)	O
(	O
20	O
,	O
21	O
),	O
CAZy	O
(	O
2020	O
-	O
06	O
-	O
01	O
)	O
(	O
22	O
),	O
RefSeq	O
-	O
NR	O
(	O
2020	O
-	O
08	O
-	O
12	O
-	O
rel	O
-	O
201	O
)	O
(	O
23	O
),	O
and	O
UniProt	O
Sprout	O
(	O
2020	O
-	O
08	O
-	O
12	O
)	O
databases	O
(	O
24	O
).	O

1Preoperative	O
transthoracic	O
echocardiographic	O
imaging	O
of	O
the	O
incomplete	O
double	O
aortic	O
arch	O
and	O
double	O
innominate	O
veins	O
.	O

Most	O
patients	O
received	O
antibiotics	O
(	O
67	O
.	O
8	O
%	O
with	O
antibiotics	O
vs	O
32	O
.	O
2	O
%	O
without	O
).	O
Table	O
1Comparison	O
of	O
clinico	O
-	O
biological	O
characteristics	O
of	O
antibiotic	O
and	O
non	O
-	O
antibiotic	O
groups	O
at	O
admission	O
.	O
Table	O
1TotalWithout	O
antibioticsWith	O
antibioticspN	O
(%)	O
14948	O
(	O
32	O
.	O
2	O
)	O
101	O
(	O
67	O
.	O
8	O
)	O
Age	O
(	O
years	O
),	O
median	O
[	O
IQR	O
]	O
85	O
.	O
50	O
[	O
82	O
.	O
00	O
,	O
89	O
.	O
00	O
]	O
86	O
.	O
00	O
[	O
83	O
.	O
00	O
,	O
90	O
.	O
00	O
]	O
85	O
.	O
00	O
[	O
82	O
.	O
00	O
,	O
88	O
.	O
00	O
]	O
0	O
.	O
560Sex	O
,	O
N	O
(%)	O
0	O
.	O
428	O
Male66	O
(	O
44	O
.	O
3	O
)	O
19	O
(	O
39	O
.	O
6	O
)	O
47	O
(	O
46	O
.	O
5	O
)	O
Female83	O
(	O
55	O
.	O
7	O
)	O
29	O
(	O
60	O
.	O
4	O
)	O
54	O
(	O
53	O
.	O
5	O
)	O
Living	O
place	O
,	O
N	O
(%)	O
0	O
.	O
619	O
Nursing	O
Home38	O
(	O
25	O
.	O
5	O
)	O
11	O
(	O
22	O
.	O
9	O
)	O
27	O
(	O
26	O
.	O
7	O
)	O
Home111	O
(	O
74	O
.	O
5	O
)	O
37	O
(	O
77	O
.	O
1	O
)	O
74	O
(	O
73	O
.	O
3	O
)	O
Number	O
of	O
Medications	O
before	O
hospitalization	O
,	O
mean	O
(	O
SD	O
)	O
7	O
.	O
38	O
(	O
3	O
.	O
33	O
)	O
6	O
.	O
73	O
(	O
2	O
.	O
83	O
)	O
7	O
.	O
69	O
(	O
3	O
.	O
51	O
)	O
0	O
.	O
074Charlson	O
Comorbidity	O
Index	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
6	O
.	O
00	O
[	O
5	O
.	O
00	O
,	O
7	O
.	O
00	O
]	O
6	O
.	O
00	O
[	O
5	O
.	O
00	O
,	O
7	O
.	O
00	O
]	O
6	O
.	O
00	O
[	O
5	O
.	O
00	O
,	O
7	O
.	O
00	O
]	O
0	O
.	O
306Infection	O
COVID	O
-	O
19	O
,	O
N	O
(%)	O
0	O
.	O
659	O
Nosocomiala25	O
(	O
16	O
.	O
8	O
)	O
9	O
(	O
18	O
.	O
8	O
)	O
16	O
(	O
15	O
.	O
8	O
)	O
Community124	O
(	O
83	O
.	O
2	O
)	O
39	O
(	O
81	O
.	O
2	O
)	O
85	O
(	O
84	O
.	O
2	O
)	O
MDRDb	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
62	O
.	O
00	O
[	O
42	O
.	O
25	O
,	O
94	O
.	O
00	O
]	O
73	O
.	O
00	O
[	O
53	O
.	O
00	O
,	O
96	O
.	O
00	O
]	O
57	O
.	O
00	O
[	O
40	O
.	O
00	O
,	O
91	O
.	O
25	O
]	O
0	O
.	O
057Corticoids	O
,	O
N	O
(%)	O
25	O
(	O
16	O
.	O
8	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
23	O
(	O
22	O
.	O
8	O
)	O
0	O
.	O
005Thromboprophylaxis	O
(%)	O
111	O
(	O
74	O
.	O
5	O
)	O
33	O
(	O
68	O
.	O
8	O
)	O
78	O
(	O
77	O
.	O
2	O
)	O
0	O
.	O
271CRPc	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
86	O
.	O
95	O
[	O
35	O
.	O
77	O
,	O
154	O
.	O
47	O
]	O
48	O
.	O
80	O
[	O
16	O
.	O
20	O
,	O
83	O
.	O
40	O
]	O
107	O
.	O
65	O
[	O
55	O
.	O
88	O
,	O
166	O
.	O
93	O
]<	O
0	O
.	O
001Haemoglobin	O
at	O
admission	O
,	O
mean	O
(	O
SD	O
)	O
12	O
.	O
42	O
(	O
1	O
.	O
85	O
)	O
11	O
.	O
99	O
(	O
2	O
.	O
02	O
)	O
12	O
.	O
62	O
(	O
1	O
.	O
74	O
)	O
0	O
.	O
062Leucocytes	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
6	O
.	O
92	O
[	O
5	O
.	O
10	O
,	O
10	O
.	O
00	O
]	O
6	O
.	O
10	O
[	O
4	O
.	O
90	O
,	O
8	O
.	O
50	O
]	O
7	O
.	O
15	O
[	O
5	O
.	O
30	O
,	O
10	O
.	O
38	O
]	O
0	O
.	O
169Saturation	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
95	O
.	O
00	O
[	O
93	O
.	O
00	O
,	O
97	O
.	O
00	O
]	O
95	O
.	O
00	O
[	O
94	O
.	O
00	O
,	O
97	O
.	O
00	O
]	O
95	O
.	O
00	O
[	O
92	O
.	O
25	O
,	O
97	O
.	O
00	O
]	O
0	O
.	O
342Oxygen	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
2	O
.	O
00	O
[	O
0	O
.	O
00	O
,	O
4	O
.	O
00	O
]	O
0	O
.	O
00	O
[	O
0	O
.	O
00	O
,	O
3	O
.	O
00	O
]	O
3	O
.	O
00	O
[	O
1	O
.	O
00	O
,	O
4	O
.	O
00	O
]<	O
0	O
.	O
001Temperature	O
(°	O
C	O
),	O
mean	O
(	O
SD	O
)	O
37	O
.	O
03	O
(	O
0	O
.	O
88	O
)	O
36	O
.	O
97	O
(	O
0	O
.	O
73	O
)	O
37	O
.	O
06	O
(	O
0	O
.	O
95	O
)	O
0	O
.	O
557IQR	O
:	O
interquartile	O
range	O
,	O
SD	O
:	O
standard	O
deviation	O
.	O
The	O
NA	O
were	O
imputed	O
by	O
simple	O
imputation	O
to	O
not	O
exclude	O
patients	O
in	O
the	O
following	O
analysesMaximum	O
of	O
3	O
non	O
applicable	O
for	O
a	O
variable	O
.	O
Binary	O
variables	O
:	O
imputation	O
by	O
the	O
most	O
frequent	O
modality	O
.	O
Continuous	O
variables	O
:	O
imputation	O
by	O
the	O
median	O
.	O
anosocomial	O
infection	O
:	O
infection	O
occurring	O
in	O
a	O
patient	O
during	O
the	O
process	O
of	O
care	O
in	O
a	O
hospital	O
or	O
other	O
health	O
care	O
facility	O
,	O
which	O
was	O
not	O
present	O
or	O
incubating	O
at	O
the	O
time	O
of	O
admission	O
[	O
36	O
].	O
bMDRD	O
:	O
modification	O
of	O
diet	O
in	O
renal	O
disease	O
.	O
cCRP	O
:	O
C	O
-	O
reactive	O
protein	O
.	O

The	O
genome	O
was	O
also	O
analyzed	O
and	O
annotated	O
with	O
an	O
alternative	O
pipeline	O
,	O
Metapathways	B-BT
(	O
18	O
,	O
19	O
)	O
(	O
v2	O
.	O
5	O
),	O
and	O
all	O
statistics	O
and	O
annotations	O
reported	O
here	O
were	O
output	O
from	O
the	O
MetaPathways	B-BT
pipeline	O
.	O

Figure	O
2	O
—	O
figure	O
supplement	O
1	O
.	O
The	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
the	O
precisions	O
(%)	O
of	O
the	O
top	O
50	O
contacts	O
predicted	O
by	O
PLMGraph	O
-	O
Inter	O
and	O
other	O
methods	O
(	O
a	O
:	O
DRN	O
-	O
1D2D_Inter	O
;	O
b	O
:	O
DeepHomo	O
;	O
c	O
:	O
GLINTER	O
;	O
d	O
:	O
CDPred	B-BT
;	O
e	O
:	O
DeepHomo2	O
)	O
for	O
each	O
target	O
in	O
HomoPDB	O
and	O
HeteroPDB	O
using	O
experimental	O
structures	O
.	O

In	O
this	O
protocol	O
,	O
we	O
provide	O
step	O
-	O
by	O
-	O
step	O
demonstration	O
to	O
obtain	O
enhanced	O
cell	O
type	O
visualization	O
in	O
spatial	O
transcriptomic	O
data	O
,	O
using	O
the	O
Spaco	B-BT
(	O
version	O
0	O
.	O
2	O
.	O
0	O
)	O
package	O
with	O
Python	O
or	O
the	O
SpacoR	B-BT
(	O
version	O
0	O
.	O
1	O
)	O
package	O
with	O
R	O
.	O
Note	O
:	O
Although	O
we	O
limited	O
the	O
demonstration	O
to	O
spatial	O
transcriptomics	O
datasets	O
,	O
Spaco	B-BT
is	O
universally	O
applicable	O
for	O
categorical	O
data	O
visualization	O
across	O
research	O
fields	O
.	O

Four	O
groups	O
of	O
countries	O
were	O
identified	O
based	O
on	O
data	O
accessible	O
on	O
the	O
ITHANET	B-BT
portal	O
[	O
9	O
].	O

Some	O
phage	O
genomes	O
were	O
predicted	O
,	O
with	O
high	O
confidence	O
(>	O
90	O
%	O
iPHoP	B-BT
confidence	O
score	O
),	O
to	O
infect	O
bacteria	O
across	O
multiple	O
genera	O
.	O

The	O
COVEP	O
webserver	O
is	O
available	O
at	O
https	O
://	O
pgx	O
.	O
zju	O
.	O
edu	O
.	O
cn	O
/	O
covepiab	B-BT
/	O
tools	O
/	O
covep	O
.	O

The	O
predicted	O
bacterial	O
host	O
genus	O
,	O
determined	O
from	O
iPHoP	B-BT
[	O
50	O
],	O
of	O
complete	O
bacteriophage	O
genomes	O
from	O
the	O
Inoviridae	O
and	O
Microviridae	O
families	O
and	O
Caudoviricetes	O
order	O
identified	O
in	O
this	O
study	O
from	O
fecal	O
and	O
oral	O
samples	O
of	O
diverse	O
lemur	O
genera	O
(	O
Varecia	O
,	O
Eulemur	O
,	O
Lemur	O
,	O
Propithecus	O
).	O

PhageTB	B-BT
is	O
an	O
easy	O
-	O
to	O
-	O
use	O
method	O
of	O
assigning	O
hosts	O
to	O
bacteriophages	O
,	O
studying	O
their	O
interactions	O
,	O
and	O
narrowing	O
down	O
the	O
search	O
space	O
for	O
candidate	O
phages	O
that	O
can	O
successfully	O
lyse	O
the	O
query	O
bacteria	O
and	O
thus	O
be	O
utilized	O
in	O
phage	O
therapy	O
for	O
treating	O
bacterial	O
infections	O
caused	O
by	O
it	O
.	O

MetaPathways	B-BT
v2	O
.	O
5	O
[	O
37	O
]	O
was	O
used	O
to	O
create	O
the	O
benchmark	O
CAMI	O
environment	O
PGDB	O
(	O
ePGDB	O
)	O
which	O
are	O
PGDBs	O
for	O
microbial	O
communities	O
[	O
38	O
].	O

Correction	O
to	O
“	O
Shu	O
YJ	O
,	O
Lao	O
B	O
,	O
Qiu	O
YY	O
.	O

Based	O
on	O
the	O
MaBoSS	B-BT
simulations	O
,	O
the	O
two	O
parameters	O
,	O
scaling	O
and	O
intracellular_dt	O
,	O
are	O
set	O
to	O
1	O
(	O
default	O
value	O
)	O
and	O
6	O
(	O
standard	O
phenotype	O
time	O
step	O
of	O
PhysiCell	O
),	O
respectively	O
.	O

Seventy	O
-	O
eight	O
genomes	O
from	O
the	O
candidate	O
phyla	O
radiation	O
were	O
randomly	O
selected	O
as	O
whole	O
-	O
genome	O
nucleotide	O
fasta	O
where	O
compared	O
MerCat2	B-BT
,	O
kmc	O
,	O
and	O
Jellyfish	O
with	O
k	O
=	O
4	O
and	O
k	O
=	O
31	O
.	O

As	O
of	O
the	O
writing	O
of	O
this	O
article	O
,	O
there	O
were	O
more	O
than	O
400	O
precision	O
medicine	O
clinical	O
trials	O
curated	O
in	O
MatchMiner	B-BT
.	O

The	O
following	O
supporting	O
information	O
can	O
be	O
downloaded	O
at	O
:	O
https	O
://	O
www	O
.	O
mdpi	O
.	O
com	O
/	O
article	O
/	O
10	O
.	O
3390	O
/	O
v16101550	O
/	O
s1	O
,	O
Table	O
S1	O
:	O
Primers	O
used	O
in	O
this	O
study	O
;	O
Table	O
S2	O
:	O
References	O
genomes	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
RNA1	O
used	O
for	O
design	O
of	O
primer	O
;	O
Table	O
S3	O
:	O
References	O
genomes	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
RNA2	O
used	O
for	O
design	O
of	O
primer	O
;	O
Table	O
S4	O
:	O
References	O
genomes	O
of	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
)	O
used	O
for	O
design	O
of	O
primers	O
;	O
Table	O
S5	O
:	O
Summary	O
of	O
RNAseq	O
data	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
);	O
Table	O
S6	O
:	O
Summary	O
of	O
RNAseq	O
data	O
of	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
);	O
Table	O
S7	O
:	O
Primer	O
panel	O
for	O
tiled	O
amplicon	O
PCR	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
);	O
Table	O
S8	O
:	O
Primer	O
panel	O
for	O
tiled	O
amplicon	O
PCR	O
of	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
);	O
Table	O
S9	O
:	O
Summary	O
of	O
tiled	O
amplicon	O
PCR	O
data	O
for	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
);	O
Table	O
S10	O
:	O
Summary	O
of	O
tiled	O
amplicon	O
PCR	O
data	O
for	O
strawberry	O
vein	O
bending	O
virus	O
(	O
SVBV	O
).	O

OralExplorer	B-BT
is	O
a	O
user	O
-	O
friendly	O
web	O
tool	O
for	O
oral	O
disease	O
research	O
that	O
offers	O
unique	O
advantages	O
in	O
terms	O
of	O
data	O
inclusion	O
,	O
interface	O
and	O
operation	O
,	O
analysis	O
functions	O
,	O
and	O
customization	O
features	O
.	O

HIResist	B-BT
is	O
freely	O
available	O
at	O
https	O
://	O
hiresist	B-BT
.	O
ahc	O
.	O
umn	O
.	O
edu	O
/	O

The	O
input	O
and	O
output	O
data	O
are	O
provided	O
in	O
standardized	O
BED	O
and	O
narrowPeak	O
file	O
formats	O
,	O
which	O
makes	O
BaRDIC	B-BT
easy	O
to	O
use	O
and	O
simple	O
to	O
perform	O
downstream	O
analyses	O
on	O
its	O
results	O
.	O

Comparison	O
of	O
structural	O
annotation	O
accuracy	O
by	O
SIRIUS	B-BT
for	O
positive	O
and	O
negative	O
ionization	O
modes	O
reveal	O
only	O
minor	O
differences	O
for	O
LC	O
-	O
MS	O
water	O
,	O
independent	O
of	O
the	O
MS2	O
acquisition	O
mode	O
.	O

We	O
used	O
jGoslin	B-BT
,	O
the	O
Java	O
implementation	O
of	O
Goslin	B-BT
,	O
11	O
which	O
parses	O
the	O
submitted	O
lipid	O
names	O
and	O
translates	O
them	O
into	O
a	O
normalized	O
hierarchical	O
representation	O
(	O
Table	O
S1	O
).	O

1MatchMiner	B-BT
overview	O
of	O
data	O
flow	O
and	O
modes	O
of	O
use	O
.	O
a	O
Data	O
inputs	O
from	O
patients	O
and	O
trials	O
are	O
utilized	O
by	O
the	O
MatchEngine	O
to	O
match	O
patients	O
to	O
trials	O
.	O

An	O
older	O
version	O
of	O
this	O
draft	O
genome	O
is	O
available	O
in	O
the	O
US	O
DOE	O
Joint	O
Genome	O
Institute	O
’	O
s	O
Integrated	B-BT
Microbial	I-BT
Genomes	I-BT
(	I-BT
IMG	I-BT
)	I-BT
system	O
(	O
ID	O
:	O
2835707023	O
).	O

Bulleted	O
list	O
of	O
achievements	O
(	O
success	O
stories	O
)	O
derived	O
from	O
using	O
OmicNavigator	B-BT
at	O
AbbVie	O
.	O

In	O
the	O
evaluation	O
,	O
we	O
refer	O
to	O
TACCO	B-BT
methods	O
to	O
simulate	O
spots	O
with	O
different	O
bead	O
sizes	O
using	O
scRNA	O
-	O
seq	O
data	O
and	O
use	O
L2	O
error	O
to	O
measure	O
differences	O
between	O
predicted	O
and	O
known	O
cell	O
composition	O
in	O
each	O
simulated	O
spot	O
.	O

The	O
analysis	O
was	O
performed	O
using	O
our	O
pyHiM	B-BT
analysis	O
pipeline	O
(	O
https	O
://	O
pyhim	B-BT
.	O
readthedocs	O
.	O
io	O
/	O
en	O
/	O
latest	O
/).	O

Because	O
iPHoP	B-BT
outputs	O
multiple	O
predictions	O
,	O
both	O
the	O
highest	O
scoring	O
prediction	O
(“	O
iPHoP	B-BT
bp	O
”)	O
and	O
the	O
full	O
set	O
of	O
predictions	O
(“	O
iPHoP	B-BT
”)	O
were	O
reported	O
.	O

